日本臨牀　別冊　呼吸器症候群（第3版）　Ⅰ

出版社： 日本臨牀社
発行日： 2021-08-31
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 呼吸器症候群（第3版）　Ⅰ
電子書籍版： 2021-08-31 （第3版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

22,000 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

22,000 円(税込)

購入する

目次

  • 特集　呼吸器症候群（第3版）　Ⅰ
    　　　―その他の呼吸器疾患を含めて―

    Ⅰ．閉塞性肺疾患，気管支の異常, 嚢胞性肺疾患　　
    １．閉塞性肺疾患, 気管支の異常
    （１）Ectopic bronchus
    （２）Mounier-Kuhn 症候群
    （３）Small airway disease
    （４）Williams-Campbell 症候群
    （５）Young 症候群
    （６）炎症性腸疾患の肺病変
    （７）気管・気管支骨軟骨形成症
    （８）気管・気管支軟化症
    （９）気管支・肺形成異常・形成不全
    （10）気管支拡張症
    （11）気管支結石症
    （12）気管支原性嚢胞
    （13）気道内異物
    （14）急性上気道閉塞
    （15）狭窄性細気管支炎
    （16）細気管支炎：総論
    （17）再発性多発軟骨炎
    （18）若年発症COPD
    （19）先天性気管支肺前腸奇形
    （20）先天性気管支閉鎖症
    （21）嚢胞状気管支拡張症
    （22）嚢胞性線維症
    （23）びまん性嚥下性細気管支炎
    （24）びまん性汎細気管支炎
    （25）副鼻腔気管支症候群
    （26）ブロンコレアー(気管支漏)
    （27）閉塞性細気管支炎症候群（アマメシバ含む）
    （28）慢性気管支炎
    （29）慢性閉塞性肺疾患(COPD)
    （30）慢性閉塞性肺疾患(COPD)の増悪
    ２．肺気腫, 嚢胞性肺疾患, その他
    （１）Swyer-James 症候群
    （２）肺アミロイドーシス
    （３）α1－アンチトリプシン欠乏症
    （４）気腫性肺嚢胞
    （５）進行性巨大肺嚢胞
    （６）先天性嚢胞性腺腫様肺奇形
    （７）先天性肺嚢胞
    （８）嚢胞性肺疾患
    （９）肺気腫症

    II．呼吸不全，換気異常　　　　
    １．呼吸不全
    （１）Ramsay Hunt 症候群(急性呼吸不全など)
    （２）肝肺症候群
    （３）急性高山病(広義の急性高山病)、慢性高山病
    （４）急性呼吸不全
    （５）慢性呼吸不全
    （６）肺酸素中毒症
    （７）肺性脳症
    （８）肺胞－毛細管ブロック症候群
    （９）薬剤による呼吸中枢機能異常
    ２．呼吸筋不全
    （１）横隔神経麻痺
    （２）横隔膜粗動
    （３）呼吸筋疲労による呼吸不全
    （４）呼吸筋萎縮による呼吸不全
    （５）薬物による呼吸筋機能不全
    ３．睡眠呼吸障害
    （１）概日リズム睡眠・覚醒障害群
    （２）睡眠呼吸障害と過眠症
    （３）周期性四肢運動障害
    （４）睡眠時無呼吸症候群
    （５）Cheyne-Stokes呼吸
    （６）中枢型睡眠時無呼吸症候群
    （７）閉塞性睡眠時無呼吸症候群
    （８）睡眠時パニック障害
    （９）ナルコレプシー
    （10）不眠症
    （11）レストレスレッグズ症候群
    （12）睡眠時遊行症・睡眠時驚愕症（ノンレム関連睡眠時随伴症）
    （13）レム睡眠行動異常症
    ４．換気異常
    （１）過換気症候群
    （２）原発性肺胞低換気症候群
    （３）肺胞低換気症候群
    ５．小児科領域の呼吸不全
    （１）気管支肺異形成（新生児慢性肺疾患）
    （２）Wilson-Mikity 症候群
    （３）呼吸窮迫症候群
    （４）乳幼児突然死症候群
    （５）胎便吸引症候群

    III．胸膜疾患　　　
    １．Meigs症候群，pseudo-Meigs症候群
    ２．食道穿孔後胸水
    ３．特発性好酸球性胸水
    ４．術後胸水貯留
    ５．ウイルス性胸膜炎
    ６．コレステロール胸膜炎
    ７．癌性胸膜炎
    ８．結核性胸膜炎，膿胸
    ９．線維素性胸膜炎、線維性胸膜炎
    10．薬剤による胸膜病変
    11．気胸
    12．月経随伴性気胸・胸部子宮内膜症症候群
    13．膿　胸
    14．穿孔性膿胸
    15．無菌性膿胸
    16．有瘻性膿胸と無瘻性膿胸
    17．膿胸関連リンパ腫
    18．血　胸
    19．円形無気肺
    20．悪性胸膜中皮腫(びまん性悪性胸膜中皮腫)
    21．気管支胸膜瘻
    22．胸膜腫瘍(原発性，転移性)と胸膜下腫瘍
    23．胸膜孤在性線維性腫瘍
    24．胸膜真菌症
    25．乳び胸・偽性乳び胸

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 閉塞性肺疾患, 気管支の異常, 嚢胞性肺疾患

P.9 掲載の参考文献
1) Foster-Carter AF : Broncho-pulmonary abnormalities. Br J Tuberc Dis Chest 40 : 111-124, 1946.
PubMed
2) Holinger PH, et al : Congenital malformations of the trachea, bronchi and lung. Ann Otol Rhinol Laryngol 61 : 1159-1180, 1952.
PubMed
3) 雨宮隆太, ほか : 内視鏡的な気管・気管支の分岐異常. 呼吸 10 : 41-47, 1991.
Medical*Online
4) Baum G, Shaff B : The tracheal bronchus. J Thorac Surg 33 : 282-286, 1957.
 
5) McLaughlin FJ, et al : Tracheal bronchus : association with respiratory morbidity in childhood. J Pediatr 106 : 751-755, 1985.
PubMed
6) Usui N, et al : Anomalies of the tracheobronchial tree in patients with esophageal atresia. J Pediatr Surg 31 : 258-262, 1996.
PubMed
7) Mangiulea VG, Stinghe RV : The accessory cardiac bronchus. Bronchologic aspect and review of the literature. Dis Chest 54 : 433-436, 1968.
PubMed
8) Gonzalez-Crussi F, et al : "Bridging bronchus". A previously undescribed airway anomaly. Am J Dis Child 130 : 1015-1018, 1976.
PubMed
9) Henry BM, et al : The bridging bronchus : A comprehensive review of a rare, potentially life-threatening congenital airway anomaly associated with cardiovascular defects. Pediatr Pulmonol 54 : 1895-1904, 2019.
PubMed
10) 太田伸一郎, ほか : 気管気管支分岐異常71例の検討. 気管支学 8 : 122-130, 1986.
 
11) 辻志津佳 : 先天性気管・気管支形態異常の臨床的検討 第1編 形態異常の臨床的分類の検討 日本小児科学会雑誌 95 : 1344-1352, 1991.
 
12) 田代隆良, ほか : 副心臓支の3例-本邦33症例の文献的考察-. 気管支学 7 : 228-233, 1985.
 
13) Nose K, et al : Airway anomalies in patients with congenital diaphragmatic hernia. J Pediatr Surg 35 : 1562-1565, 2000.
PubMed
14) Desir A, Ghaye B : Congenital abnormalities of intrathoracic airways. Radiol Clin North Am 47 : 203-225, 2009.
PubMed
P.13 掲載の参考文献
1) Mounier-Kuhn P : Dilatation de la trachee : constatations radiographiques et bronchoscopiques. Lyon Med 150 : 106-109, 1932.
 
2) Katz I, et al : Tracheobronchiomegaly. The Mounier-Kuhn syndrome. Am J Roentgenol Radium Ther Nucl Med 88 : 1084-1094, 1962.
PubMed
3) Johnston RF, Green RA : Tracheobronchiomegaly. Report of Five Cases and Demonstration of Familial Occurrence. Am Rev Respir Dis 91 : 35-50, 1965.
PubMed
4) 桜井滋, ほか : 大気道の易虚脱性を欠いたtracheobronchomegalyの一例. 気管支学 9 : 231-236, 1987.
 
5) Aaby GV, Blake HA : Tracheobronchiomegaly. Ann Thorac Surg 2 : 64-70, 1966.
PubMed
6) Wanderer AA, et al : Tracheobronchiomegaly and acquired cutis laxa in a child. Physiologic and immunologic studies. Pediatrics 44 : 709-715, 1969.
 
7) Gay S, Dee P : Tracheobronchomegaly-the Mounier-Kuhn syndrome. Br J Radiol 57 : 640-644, 1984.
PubMed
8) 林俊治, ほか : Tracheobronchomegalyの1症例. 日本胸部疾患学会雑誌 22 : 150-153, 1984.
 
9) 鈴木隆ほか : 多発性気管・気管支憩室を伴ったTracheobronchomegalyの一例. 日本胸部疾患学会雑誌 21 : 659-664, 1983.
 
10) 甲原芳範, ほか : 3次元CT画像で気管憩室の形態が把握された気管気管支巨大症の1例. 正常気管径との比較検討を含めて. 日本胸部臨床 56 : 351-355, 1997.
 
11) 増本駿ほか : 気管気管支巨大症 (Mounier-Kuhn症候群) の1例. 気管支学 41 : 7-10, 2019.
Medical*Online
12) 荒木潤, ほか : Mounier-Kuhn症候群 (tracheobronchomegaly) の1症例. 日本内科学会雑誌 85 : 617-619, 1996.
 
13) Surprenant EL, O'Loughlin BJ : Tracheal diverticula and tracheobronchomegaly. Dis Chest 49 : 345-351, 1966.
 
14) 沖昌英, ほか : 気道ステントの適応と実際. 気管支学 42 : 470-473, 2020.
Medical*Online
P.18 掲載の参考文献
1) Ryu JH, et al : Bronchiolar disorders. Am J Respir Crit Care Med 168 : 1277-1292, 2003.
PubMed
2) Lynch DA, et al : CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease : A Statement of the Fleischner Society. Radiology 277 : 192-205, 2015.
PubMed
3) Leopold JG, Gough J : The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax 12 : 219-235, 1957.
PubMed
4) Kim WD, et al : Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities. Am Rev Respir Dis 144 : 1385-1390, 1991.
PubMed
5) Saetta M, et al : Extent of centrilobular and panacinar emphysema in smokers' lungs : pathological and mechanical implications. Eur Respir J 7 : 664-671, 1994.
PubMed
6) Hogg JC, et al : The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 : 2645-2653, 2004.
PubMed
7) McDonough JE, et al : Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365 : 1567-1575, 2011.
PubMed
8) Koo HK, et al : Small airways disease in mild and moderate chronic obstructive pulmonary disease : a cross-sectional study. Lancet Respir Med 6 : 591-602, 2018.
PubMed
9) Tanabe N, et al : Micro-Computed Tomography Comparison of Preterminal Bronchioles in Centrilobular and Panlobular Emphysema. Am J Respir Crit Care Med 195 : 630-638, 2017.
PubMed
10) Tanabe N, et al : Pathological Comparisons of Paraseptal and Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 202 : 803-811, 2020.
PubMed
11) Verleden SE, et al : The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med 189 : 292-300, 2014.
PubMed
12) van den Bosch WB, et al : Structure and function of small airways in asthma patients revisited. Eur Respir Rev 30 : 200186, 2021.
PubMed
13) Nakano Y, et al : The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 171 : 142-146, 2005.
PubMed
14) Remy-Jardin M, et al : Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 222 : 261-270, 2002.
 
15) Tanabe N, et al : Central airway and peripheral lung structures in airway disease-dominant COPD. ERJ Open Res 7 : 00672-2020, 2021.
PubMed
16) Tanabe N, et al : Quantitative measurement of airway dimensions using ultra-high resolution computed tomography. Respir Investig 56 : 489-496, 2018.
PubMed
17) Postma DS, et al : Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS) : baseline data from a prospective cohort study. Lancet Respir Med 7 : 402-416, 2019.
PubMed
P.22 掲載の参考文献
1) Williams H, Campbell P : Generalized bronchiectasis associated with deficiency of cartilage in the bronchial tree. Arch Dis Child 35 : 182-191, 1960.
PubMed
2) Williams HE, et al : Generalized bronchiectasis due to extensive deficiency of bronchial cartilage. Arch Dis Child 47 : 423-428, 1972.
PubMed
3) Manzke H : [Irreversible generalized pulmonary emphysema resulting from destructive bronchitis and bronchiolitis following adenovirus infection]. Klin Padiatr 194 : 387-392, 1982.
PubMed
4) Wayne KS, et al : Probable familial congenital bronchiectasis due to cartilage deficiency (Williams-Campbell syndrome). Am Rev Respir Dis 114 : 15-22, 1976.
PubMed
5) 河村哲治, ほか : Williams Campbell症候群と考えられる2成人例. Williams-Campbell型気管支拡張症の提唱 日本胸部疾患学会雑誌 30 : 1719-1723, 1992.
 
6) Di Scioscio V, et al : The role of spiral multidetector dynamic CT in the study of Williams-Campbell syndrome. Acta Radiol 47 : 798-800, 2006.
 
7) Rohilla M, et al : Williams-Campbell syndrome : an unusual presentation in an adult patient. BJR Case Rep 7 : 20200052, 2021.
 
8) Webb WR, et al : Williams-Campbell Syndrome. In : High-Resolution CT of the Lung, 5th ed, p588, Wolters Kluwer Health, Philadelphia, 2015.
 
9) Palmer SM Jr, et al : Lung transplantation for Williams-Campbell syndrome. Chest 113 : 534-537, 1998.
PubMed
10) Burguete SR, et al : Lung transplantation for Williams-Campbell syndrome with a probable familial association. Respir Care 57 : 1505-1508, 2012.
PubMed
P.26 掲載の参考文献
1) Young D : Surgical treatment of male infertility. J Reprod Fertil 23 : 541-542, 1970.
PubMed
2) Hendry WF, et al : Obstructive azoospermia : respiratory function tests, electron microscopy and the results of surgery. Br J Urol 50 : 598-604, 1978.
PubMed
3) Neville E, et al : Respiratory tract disease and obstructive azoospermia. Thorax 38 : 929-933, 1983.
PubMed
4) Handelsman DJ, et al : Young's syndrome. Obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med 310 : 3-9, 1984.
 
5) Bombieri C, et al : Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 10 (Suppl 2) : S86-102, 2011.
 
6) Roth RM, Gleckman RA : Recurrent bacterial pneumonia : a contemporary perspective. South Med J 78 : 573-579, 1985.
PubMed
7) Matsuda T, et al : Young's syndrome : report of two Japanese cases. Urol Int 47 : 53-56, 1991.
 
8) Guan WJ, et al : Aetiology of bronchiectasis in Guangzhou, southern China. Respirology 20 : 739-748, 2015.
PubMed
9) Hendry WF, et al : Was Young's syndrome caused by exposure to mercury in childhood? BMJ 307 : 1579-1582, 1993.
 
10) Greenstone MA, et al : Ciliary function in Young's syndrome. Thorax 43 : 153-154, 1988.
 
11) Pavia D, et al : Lung mucociliary clearance in patients wit Young's syndrome. Chest 80 : 892-895, 1981.
 
12) Lopez-Vidriero MT, et al : Viscoelastic properties of sputum from patients with Young's syndrome. Thorax 41 : 254, 1986.
 
13) Wong C, et al : Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE) : a randomised, double-blind, placebo-controlled trial. Lancet 380 : 660-667, 2012.
PubMed
P.30 掲載の参考文献
1) 炎症性腸疾患 (IBD) 診療ガイドライン 2020 [改訂第2版] (日本消化器病学会編), 南江堂, 2020.
 
2) Ott C, Scholmerich J : Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol 10 : 585-595, 2013.
PubMed
3) Camus P, et al : The lung in inflammatory bowel disease. Medicine (Baltimore) 72 : 151-183, 1993.
PubMed
4) Black H, et al : Thoracic manifestations of inflammatory bowel disease. Chest 131 : 524-532, 2007.
PubMed
5) Bernstein CN, et al : The clustering of other chronic inflammatory diseases in inflammatory bowel disease : a population-based study. Gastroenterology 129 : 827-836, 2005.
PubMed
6) Herrlinger KR, et al : Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 97 : 377-381, 2002.
PubMed
7) Marvisi M, et al : Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 16 : 965-968, 2000.
PubMed
8) Fireman Z, et al : The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol 95 : 730-734, 2000.
PubMed
9) Fireman E, et al : Induced sputum eosinophilia in ulcerative colitis patients : the lung as a mirror image of intestine? Respir Med 103 : 1025-1032, 2009.
 
10) Wallaert B, et al : Evidence of lymphocyte alveolitis in Crohn's disease. Chest 87 : 363-367, 1985.
PubMed
11) Lees CW, et al : New IBD genetics : common pathways with other diseases. Gut 60 : 1739-1753, 2011.
PubMed
12) Keely S, et al : Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol 5 : 7-18, 2012.
PubMed
13) Marsland BJ, et al : The gut-lung axis in respiratory disease. Ann Am Thorac Soc 12 (Suppl 2) : S150-156, 2015.
 
14) 各種の薬剤による肺障害. 薬剤性肺障害の診断・治療の手引き [第2版] 2018 (日本呼吸器学会薬剤性肺障害の診断・治療の手引き第2版作成委員会編), p67-102, メディカルレビュー社, 2018.
 
15) 厚生労働科学研究費補助金 難治性疾患政策研究事業「難治性炎症性腸管障害に関する調査研究」 (久松班) : 炎症性腸疾患の腸管外合併症治療指針 (2021年3月改訂). 潰瘍性大腸炎・クローン病 診断基準・治療指針 令和2年度改訂版, 令和2年度分担研究報告書, p48-57, 2021.
 
P.34 掲載の参考文献
1) 藤本公則, ほか : Tracheobronchopathia osteochondroplastica. 自験2例と本邦報告86例の文献的考察. 気管支学 13 : 650-658, 1991.
 
2) Zhu Y, et al : A clinical study of tracheobronchopathia osteochondroplastica : findings from a large Chinese cohort. PLoS One 9 : e102068, 2014.
 
3) Wilks S : Ossific deposits on the larynx, trachea and bronchi. Trans Path Soc London 8 : 88, 1857.
 
4) Aschoff L : Uber Tracheopaiscoteoplastica. Verh Dtsch Ges Pathol 14 : 125-126, 1910.
 
5) Pounder DJ, Pieterse AS : Tracheopathia osteoplastica : a study of the minimal lesion. J Pathol 138 : 235-239, 1982.
PubMed
6) Lundgren R, Stjernberg NL : Tracheobronchopathia osteochondroplastica. A clinical bronchoscopic and spirometric study. Chest 80 : 706-709, 1981.
PubMed
7) 妻鹿成治, 糸井和美 : 挿管困難を契機に発見された, 前立腺癌を合併したtracheobronchopathia osteochondroplasticaの1例 : 本邦133例の検討. 気管支学 25 : 553-557, 2003.
Medical*Online
8) Leske V, et al : Tracheobronchopathia osteochondroplastica : a study of 41 patients. Medicine (Baltimore) 80 : 378-390, 2001.
PubMed
9) Abu-Hijleh M, et al : Tracheobronchopathia osteochondroplastica : a rare large airway disorder. Lung 186 : 353-359, 2008.
PubMed
10) Oka H, et al : Tracheobronchopathia osteochondroplastica associated with sinobronchial syndrome. Intern Med 48 : 579-580, 2009.
PubMed
11) Das KM, et al : Computed tomography virtual bronchoscopy : normal variants, pitfalls, and spectrum of common and rare pathology. Can Assoc Radiol J 66 : 58-70, 2015.
PubMed
12) Sakula A : Tracheobronchopathia osteoplastica : its relationship to primary tracheobronchial amyloidosis. Thorax 23 : 105-110, 1968.
PubMed
P.38 掲載の参考文献
1) Carden KA, et al : Tracheomalacia and tracheobronchomalacia in children and adults : an indepth review. Chest 127 : 984-1005, 2005.
PubMed
2) Baxter JD, Dunbar JS : Tracheomalacia. Ann Otol Rhinol Laryngol 72 : 1013-1023, 1963.
PubMed
3) 船津武志, ほか : 気管気管支軟化症. 気管支学 4 : 123-135, 1982.
 
4) 池田貞雄, ほか : 気管・気管支軟化症の病態と外科治療. 日本胸部疾患学会雑誌 30 : 1028-1035, 1992.
 
5) Buitrago DH, et al : Current concepts in severe adult tracheobronchomalacia : evaluation and treatment. J Thorac Dis 9 : E57-E66, 2017.
PubMed
6) Ciet P, et al : Cine MRI of tracheal dynamics in healthy volunteers and patients with tracheobronchomalacia, AJR Am J Roentgenol 209 : 757-761, 2017.
PubMed
7) Wright CD, Mathisen DJ : Tracheobronchoplasty for tracheomalacia. Ann Cardiothorac Surg 7 : 261-265, 2018.
PubMed
8) Nissen R : Tracheoplastik zur Beseitigung der Erschlaffung des membranoesen Teils der intrathorakalen Luftroehre. Schweiz Med Wochenschr 84 : 219-220, 1954.
 
9) Hanawa T, et al : Development of a new surgical procedure for repairing tracheobronchomalacia. J Thorac Cardiovasc Surg 100 : 587-594, 1990.
PubMed
10) Buitrago DH, et al : Single-Center Experience of Tracheobronchoplasty for Tracheobronchomalacia : Perioperative Outcomes. Ann Thorac Surg 106 : 909-915, 2018.
PubMed
11) Lazzaro R, et al : First series of minimally invasive, robot-assisted tracheobronchoplasty with mesh for severe tracheobronchomalacia. J Thorac Cardiovasc Surg 157 : 791-800, 2019.
PubMed
12) Ozgul MA, et al : Our Experience on Silicone Y-Stent for Severe COPD Complicated With Expiratory Central Airway Collapse. J Bronchology Interv Pulmonol 24 : 104-109, 2017.
PubMed
13) Diaz Milian R, et al : Expiratory Central Airway Collapse in Adults : Corrective Treatment (Part 2). J Cardiothorac Vasc Anesth 33 : 2555-2560, 2019.
PubMed
14) 長谷川久弥 : 小児喉頭・気管・気管支軟化症の診断と治療. 小児耳鼻咽喉科 38 : 282-290, 2017.
 
15) Wallis C, et al : ERS statement on tracheomalacia and bronchomalacia in children. Eur Respir J 54 : 1-19, 2019.
 
P.45 掲載の参考文献
1) Schechter DC : Congenital absence or deficiency of lung tissue. The congenital subtractive bronchopneumonic malformations. Ann Thorac Surg 6 : 287-313, 1968.
PubMed
2) Schneider P : Die Morphologie der Missbildungen des Menschen und der Tiere (ed by Schwalbe E), Vol 3 (Part 2), p772, Gustav Fischer, Jena, 1909-1913.
 
3) 北東功, ほか : 肺発生の分子生物学的メカニズム. 周産期医学 35 : 169-174, 2005.
 
4) 新開統子, ほか : 先天性右肺無形成児の急性呼吸不全に対する外科治療-tissue expander挿入とaortopexyの効果-. 小児外科 34 : 1369-1373, 2002.
 
5) Stocker JT : Congenital pulmonary airway malformation : a new name and expanded classification of congenital cystic adenomatoid malformation of the lung. Histopathology 41 (Suppl 2) : 424-431, 2002.
 
6) 河野寿夫 : 肺低形成の概念・疫学. 周産期医学 35 : 165-168, 2005.
 
7) 北野良博 : 肺低形成を生ずるメカニズム. 周産期医学 35 : 175-178, 2005.
 
8) Huang H, et al : Cell mechanics and mechanotransduction : pathways, probes, and physiology. Am J Physiol Cell Physiol 287 : C1-11, 2004.
PubMed
9) Nicolini U, et al : Low amniotic pressure in oligohydramnios-is this the cause of pulmonary hypoplasia? Am J Obstet Gynecol 161 : 1098-1101, 1989.
PubMed
10) Deprest JA, et al : Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia. N Engl J Med 385 : 107-118, 2021. (DOI : 10.1056/NEJMoa2027030)
 
11) Moerman P, et al : Severe primary pulmonary hypoplasia ("acinar dysplasia") in sibs : a genetically determined mesodermal defect? J Med Genet 35 : 964-965, 1998.
PubMed
12) Frey B, et al : Familial isolated pulmonary hypoplasia : a case report, suggesting autosomal recessive inheritance. Eur J Pediatr 153 : 460-463, 1994.
PubMed
13) Lim FY, et al : Congenital high airway obstruction syndrome : natural history and management. J Pediatr Surg 38 : 940-945, 2003.
PubMed
14) Hirose S, et al : The ex utero intrapartum treatment procedure : Looking back at the EXIT. J Pediatr Surg 39 : 375-380 ; discussion 375-380, 2004.
 
15) Alameh J, et al : Alveolar capillary dysplasia : a cause of persistent pulmonary hypertension of the newborn. Eur J Pediatr 161 : 262-266, 2002.
PubMed
16) Szafranski P, et al : Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. Hum Genet 135 : 569-586, 2016.
PubMed
17) Kitano A, et al : A familial case of alveolar capillary dysplasia with misalignment of the pulmonary veins : the clinicopathological features and unusual glomeruloid endothelial proliferation. Diagn Pathol 15 : 48, 2020.
PubMed
P.50 掲載の参考文献
1) Fraser RG, et al : Diagnosis of Diseases of the Chest, 3rd ed (ed by Fraser RG, et al), p2186-2220, WB Saunders, Philadelphia, 1990.
 
2) Kim C, Kim DG : Bronchiectasis. Tuberc Respir Dis (Seoul) 73 : 249-257, 2012.
PubMed
3) Chalmers JD, et al : Bronchiectasis. Nat Rev Dis Primers 4 : 45, 2018.
PubMed
4) McShane PJ, et al. : Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 188 : 647-656, 2013.
PubMed
5) Kwak HJ, et al : High prevalence of bronchiectasis in adults : analysis of CT findings in a health screening program. Tohoku J Exp Med 222 : 237-242, 2010.
 
6) Kim CK, et al : Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 105 : 372-378, 2000.
PubMed
7) Dimakou K, et al : Non CF-bronchiectasis : Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med 116 : 1-7, 2016.
PubMed
8) Puechal X : Bronchiectasis in rheumatoid arthritis. Rev Rhum Engl Ed 65 : 447-450, 1998.
PubMed
9) Naidich DP : Bronchiectasis. In : Imaging of the Airways (ed by Naidich DP, et al), p107-145, Lippincott Williams & Wilkins, Philadelphia, 2005.
 
10) Polverino E, et al : European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 50 : 1700629, 2017.
PubMed
11) Kudoh S, et al : Diffuse panbronchiolitis. Clin Chest Med 33 : 297-305, 2012.
PubMed
12) Chalmers JD, et al : Long-term macrolide antibiotics for the treatment of bronchiectasis in adults : an individual participant data meta-analysis. Lancet Respir Med 7 : 845-854, 2019.
PubMed
13) King PT, et al : Outcome in adult bronchiectasis. COPD 2 : 27-34, 2005.
PubMed
14) Scheinberg P, et al : A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 127 : 1420-1426, 2005.
 
15) Osaki S, et al : Prognosis of bronchial artery embolization in the management of hemoptysis. Respiration 67 : 412-416, 2000.
PubMed
P.54 掲載の参考文献
1) Alshabani K, et al : Broncholithiasis : A Review. Chest 156 : 445-455, 2019.
PubMed
2) Chan ED, et al : Calcification and ossification of the lungs. In : UpToDate, Nov 2020.
 
3) 国立感染症研究所 : ヒストプラスマ症とは. [https://www.niid.go.jp/niid/ja/kansennohanashi/471-histoplasmosis-info.html] (2021年6月閲覧)
 
4) Garcia-Saucedo JC, et al : Broncholithiasis Masquerading as Asthma. J Allergy Clin Immunol Pract 8 : 730-731, 2020.
PubMed
5) Ford MA, et al : Bronchoesophageal fistula due to broncholithiasis : a case series. Respir Med 99 : 830-835, 2005.
PubMed
6) Zhang H, et al : Silicotuberculosis with Esophagobronchial Fistula and Broncholithiasis. Int J Occup Environ Med 8 : 50-55, 2017.
PubMed
7) Aldana GL, et al : Broncholithiasis Mimicking Malignancy. Am J Respir Crit Care Med 199 : e28-e29, 2019.
PubMed
8) Bentoor SN, Reddy KS : Broncholithiasis as recurrent pneumonia : A case report. Int J Sci Res 9 : 18-19, 2020.
 
9) Ozyurek BA, Bozbas SS : Broncholithiasis presenting with lithoptysis. Lung India 35 : 339-340, 2018.
PubMed
10) McLean TR, et al : Massive hemoptysis due to broncholithiasis. Ann Thorac Surg 52 : 1173-1175, 1991.
PubMed
11) Olson EJ, et al : Therapeutic bronchoscopy in broncholithiasis. Am J Respir Crit Care Med 160 : 766-770, 1999.
PubMed
12) Jin YX, et al : Diagnosis and Treatment Evaluation of 48 Cases of Broncholithiasis. Thorac Cardiovasc Surg 64 : 450-455, 2016.
PubMed
13) Lim SY, et al : Classification of broncholiths and clinical outcomes. Respirology 18 : 637-642, 2013.
PubMed
14) Krishnan S, et al : Management of broncholithiasis. J Thorac Dis 10 : S3419-S3427, 2018.
PubMed
P.59 掲載の参考文献
1) Murthy RA, et al : Congenital Lung Diseases. In : Sabiston & Spencer Surgery of the Chest, 9th ed (ed by Sellke FW, et al), p151-178, Elsevier, Philadelphia, 2015.
 
2) Laje P, Flake AW : Congenital bronchopulmonary malformations. In : Holcomb and Ashcraft's Pediatric Surgery, 7th ed (ed by Holcomb GW III, et al), p348-360, Elsevier, Philadelphia, 2020.
 
3) Chapters : III, XI, XIV, XXVI, XXX. In : Shields' General Thoracic Surgery, 8th ed (ed by LoCicero J III, et al), Wolters Kluwer, Philadelphia, 2018.
 
4) Langston C : Pulmonary disorders in the neonate, infant, and child. In : Thurlbeck's Pathology of the Lung, 3rd ed (ed by Churg AM, et al), p119-172, Thieme, Stuttgart, New York, 2005.
 
5) 石田治雄 : 先天性嚢胞性肺疾患の概念. 日本胸部臨床 59 : 81-90, 2000.
Medical*Online
6) 上野滋, ほか : 嚢胞性肺疾患, 第9章 気道・肺・胸壁標準小児外科学 [第7版] (高松英夫, 福澤正洋監) p118-123, 医学書院, 2017.
 
7) Bush A : Congenital Disorders of the Lower Airways and Mediastinum. In : Rudolph's Pediatrics 23rd ed (ed by Kline MW, et al), p2386-2391, McGraw Hill Education, New York, 2018.
 
8) Sodha NR, DeCamp MM : Congenital Cysts of the Mediastinum : Bronchopulmonary Foregut Anomalies. In : Fishman's Pulmonary Diseases and Disorders, 4th ed (ed by Fishman AP, et al), p1571-1581, McGraw-Hill Professional Publishing, New York, 2008.
 
9) Fraser RS : Developmental Anomalies Affecting the Airways and Lung Parenchyma. In : Fraser and Pare's Diagnosis of Diseases of the Chest, Vol 1, 4th ed (ed by Fraser RS, et al), p597-635, WB Saunders, Philadelphia, 1999.
 
10) Katzenstein ALA : Pediatric Disorders. In : Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease, 4th ed (ed by Katzenstein ALA), p385-413, WB Saunders, Philadelphia, 2006.
 
11) Trotman-Dickenson B : Congenital lung disease in the adult : guide to the evaluation and management. J Thorac Imaging 30 : 46-59, 2015.
 
12) XII. 先天性異常. 胸部のCT [第4版] (村田喜代史, ほか編), p833-845, メディカルサイエンスインターナショナル, 2018.
 
13) 三浦弘之, ほか : 発生部位からみた気管支嚢胞手術例の検討. 日本臨床外科学会雑誌 62 : 1813-1818, 2001.
 
14) 原眞咲, ほか : 縦隔嚢胞性病変のCT, MRI診断. 日本医学放射線学会雑誌 61 : 147-155, 2001.
 
15) 伊藤真樹 : 嚢胞性・空洞性病変を伴う肺炎. 小児内科 36 : 100-103, 2004.
 
P.63 掲載の参考文献
1) Heimlich HJ : A life-saving maneuver to prevent food-choking. JAMA 234 : 398-401, 1975.
PubMed
2) Taniguchi Y, et al : Epidemiology of food choking deaths in Japan : Time trends and regional variations. J Epidemiol, 2020. (DOI : 10.2188/jeaJE20200057)
 
3) Ahmed OG, et al : Protocol incorporating airway CT decreases negative bronchoscopy rates for suspected foreign bodies in pediatric patients. Int J Pediatr Otorhinolaryngol 109 : 133-137, 2018.
PubMed
4) 今泉了彦, ほか : ピーナッツ気道異物の診断とMRI. 小児外科 32 : 74-79, 2000.
 
5) 金子正博, ほか : 窒息, その他の上気道閉塞. 内科救急診療指針 2016 (日本内科学会認定医制度審議会 救急委員会編), p47-51, 総合医学社, 2016.
 
6) Sehgal IS, et al : Foreign Body Inhalation in the Adult Population : Experience of 25,998 Bronchoscopies and Systematic Review of the Literature. Respir Care 60 : 1438-1448, 2015.
PubMed
7) 朝戸裕二, ほか : 異物除去術. 気管支鏡テキスト [第3版] (日本呼吸器内視鏡学会編), p334-337, 医学書院, 2019.
 
8) 桝田幹郎, ほか : 小児気道異物の摘出におけるラリンゲルマスク (Laryngeal mask) の有用性. 気管支学 26 : 83-87, 2004.
Medical*Online
P.67 掲載の参考文献
1) Benjafield AV, et al : Estimation of the global prevalence and burden of obstructive sleep apnoea : a literature-based analysis. Lancet Respir Med 7 : 687-698, 2019.
PubMed
2) Wellman A, et al : A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol (1985) 114 : 911-922, 2013.
 
3) 小児呼吸器感染症診療ガイドライン作成委員会 : 小児呼吸器感染症診療ガイドライン 2017 (尾内一信, ほか監), 協和企画, 2016.
 
4) Ishiwada N, et al : The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines. Vaccine 32 : 5425-5431, 2014.
PubMed
5) 三浦智広 : 血管性浮腫. MB ENTONI (157) : 100-104, 2013.
Medical*Online
6) 日本循環器学会, ほか : 2020年改訂版 大動脈瘤・大動脈解離診療ガイドライン (日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン), 2020.
 
7) 鈴木詩織ほか : 水痘・帯状疱疹ウイルスによる喉頭麻痺の5例. 喉頭 32 : 189-194, 2020.
Medical*Online
8) 脊髄小脳変性症・多系統萎縮症診療ガイドライン 2018 (日本神経学会監, 「脊髄小脳変性症・多系統萎縮症診療ガイドライン」作成委員会編), 南江堂, 2018.
 
9) Christensen PM, et al : ERS/ELS/ACCP 2013 international consensus conference nomenclature on inducible laryngeal obstructions. Eur Respir Rev 24 : 445-450, 2015.
PubMed
10) Steven McGee : マクギーの身体診断学-エビデンスにもとづくグローバル・スタンダード (柴田寿彦監訳), p190-223, エルゼビア・ジャパン, 2004.
 
11) 今井丈英, ほか : 第2回 小児気管・気管支異物に関する全国調査結果. 日本小児呼吸器学会雑誌 29 : 114-121, 2018.
Medical*Online
12) 薄井佳子, ほか : 小児気道異物の診断におけるCT検査の有用性. 日本小児外科学会雑誌 52 : 927-932, 2016.
Medical*Online
13) 臨床呼吸機能検査 [第8版] (日本呼吸器学会肺生理専門委員会編), メディカルレビュー社, 2016.
 
14) Nielsen EW, et al : High prevalence of exercise-induced laryngeal obstruction in athletes. Med Sci Sports Exerc 45 : 2030-2035, 2013.
PubMed
P.73 掲載の参考文献
1) Katzenstein ALA, Askin FB : Obliterative bronchiolitis (Pure bronchiolitis obliterans). In : Surgical Pathology of Non-neoplastic Lung Disease, 2nd ed, p47-50, WB Saunders, Philadelphia, 1990.
 
2) King TE Jr, Kinder BW : Bronchiolitis. In : Fishman's Pulmonary Diseases and Disorders, 4th, ed (ed by Fishman AP, et al), p887-911, McGraw-Hill Medical, New York, 2008.
 
3) Suzuki T, et al : Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant 23 : 829-831, 1999.
 
P.77 掲載の参考文献
1) Ryu JH, et al : Bronchiolar disorders. Am J Respir Crit Care Med 168 : 1277-1292, 2003.
PubMed
2) King TE, Kinder BW : Bronchiolitis. In : Fishman's Pulmonary Diseases and Disorders, 4th ed (ed by Fishman AP, et al), p887-911, McGraw-Hill, New York, 2008.
 
3) King TE : Bronchiolitis. In : Fishman's Pulmonary Diseases and Disorders, 3rd ed (ed by Fishman AP, et al), p833-834, McGraw-Hill, New York, 1998.
 
4) Hogg JC, et al : Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278 : 1355-1360, 1968.
PubMed
5) Thurlbeck WM : Smoking, airflow limitation and the pulmonary circulation. Am Rev Respir Dis 122 : 183-186, 1980.
 
6) Penn CC, Liu C : Bronchiolitis following infection in adults and children. Clin Chest Med 14 : 645-654, 1993.
PubMed
7) Niewoehner DE, et al : Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 291 : 755-758, 1974.
PubMed
8) Colby TV : Bronchiolitis. Pathologic considerations. Am J Clin Pathol 109 : 101-109, 1998.
PubMed
9) Sato A, et al : Cellular distribution of bronchus-associated lymphoid tissue in rheumatoid arthritis. Am J Respir Crit Care Med 154 : 1903-1907, 1996.
PubMed
10) Nicholson AG : Lymphoproliferative Disorders. In : Thurlbeck's Pathology of the Lung, 3rd ed (ed by Churg AM, et al), p539-540, Thieme, New York, 2005.
 
P.82 掲載の参考文献
1) Pearson CM, et al : Relapsing polychondritis. N Engl J Med 263 : 51-58, 1960.
PubMed
2) McAdam LP, et al : Relapsing polychondritis : prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55 : 193-215, 1976.
 
3) Damiani JM, Levine HL : Relapsing polychondritis-report of ten cases. Laryngoscope 89 : 929-946, 1979.
PubMed
4) Arnaud L, et al : The Relapsing Polychondritis Disease Activity Index : development of a disease activity score for relapsing polychondritis. Autoimmun Rev 12 : 204-209, 2012.
PubMed
5) Mertz P, et al : The relapsing polychondritis damage index (RPDAM) : Development of a disease-specific damage score for relapsing polychondritis. Joint Bone Spine 86 : 363-368, 2019.
PubMed
6) Lee KS, et al : Relapsing polychondritis : prevalence of expiratory CT airway abnormalities. Radiology 240 : 565-573, 2006.
PubMed
7) Tsuruoka H, et al : Correlation between Computed Tomographic Analysis and Pulmonary Function Measurements in Patients with Relapsing Polychondritis. Respiration 100 : 109-115, 2021.
PubMed
8) De Geeter E Vandecasteele SJ : Fluorodeoxyglucose PET in relapsing Polychondritis. N Engl J Med 358 : 536-537, 2008.
 
9) Ratzinger G, et al : Successful treatment of recalcitrant relapsing polychondritis with monoclonal antibodies. J Eur Acad Dermatol Venereol 23 : 474-475, 2009.
PubMed
10) Kawai M, et al : Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. Rheumatology (Oxford) 48 : 318-319, 2009.
PubMed
11) Colt H, Murgu S : Bronchoscopy and Central Airway Disorders : A Patient-Centered Approach, 1st ed, p139, WB Saunders, Elsevier, Philadelphia, 2012.
 
12) Miyazu Y, et al : Endobronchial ultrasonography in the diagnosis and treatment of relapsing polychondritis with tracheobronchial malacia. Chest 124 : 2393-2395, 2003.
PubMed
13) Sacco O, et al : Severe endobronchial obstruction in a girl with relapsing polychondritis : treatment with Nd YAG laser and endobronchial silicon stent. Eur Respir J 10 : 494-496, 1997.
 
14) Oryoji D, et al : Sudden Respiratory Failure due to Tracheobronchomalacia by Relapsing Polychondritis, Successfully Rescued by Multiple Metallic Stenting and Tracheostomy. Intern Med 56 : 3369-3372, 2017.
PubMed
P.87 掲載の参考文献
1) 栗山喬之, ほか : 若年性肺気腫の診断基準. 厚生省特定疾患呼吸不全調査研究班, 平成8年度研究報告書, p2-3, 1997.
 
2) 藤本圭作, 久保恵嗣 : 若年発症COPD (若年性肺気腫), 肺ランゲルハンス細胞ヒスチオサイトーシス (ヒスチオサイトーシス X), 肺胞低換気症候群に関する全国疫学調査. 厚生労働科学研究費補助金難治性疾患克服研究事業 呼吸不全に関する調査研究, 平成19年度研究報告書, p25-30, 2008.
 
3) Martinez FJ, et al : At the Root : Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197 : 1540-1551, 2018.
PubMed
4) Soriano JB, et al : What is early COPD and why is it important? Eur Respir J 52 : 1801448, 2018.
PubMed
5) 若年発症重症COPDの全国疫学調査. 厚生労働科学研究費補助金難治性疾患克服研究事業呼吸不全に関する調査研究, 平成25年度総括・分担研究報告書, p19-21, 2014.
 
6) Gold DR, et al : Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 335 : 931-937, 1996.
PubMed
7) Petersen H, et al : The course of lung function in middle-aged heavy smokers : incidence and time to early onset of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 198 : 1449-1451, 2018.
PubMed
8) Vestbo J, Lange P : Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 166 : 329-332, 2002.
 
9) Aanerud M, et al : Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur Respir J 45 : 635-643, 2015.
PubMed
10) Zafari Z, et al : Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. CMAJ 188 : 1004-1011, 2016.
PubMed
11) 笠木聡ほか : 日本人のα1-アンチトリプシン欠損症. 臨床検査 47 : 894-898, 2003,
 
12) Hersh CP, et al : SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development. Am J Respir Crit Care Med 183 : 1482-1489, 2011.
PubMed
13) Foreman MG, et al : Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 44 : 316-322, 2011.
PubMed
14) Faner R, et al : Lessons from ECLIPSE : a review of COPD biomarkers. Thorax 69 : 666-672, 2014.
PubMed
15) Silverman EK, et al : Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 : 2152-2158, 2000.
PubMed
P.91 掲載の参考文献
1) Gerle RD, et al : Congenital bronchopulmonary-foregut malformation. Pulmonary sequestration communicating with the gastrointestinal tract. N Engl J Med 278 : 1413-1419, 1968.
PubMed
2) Yang G, et al : Congenital bronchopulmonary foregut malformation : systematic review of the literature. BMC Pediatr 19 : 305, 2019.
 
3) Mullassery D, et al : Lung development. Semin Pediatr Surg 24 : 152-155, 2015.
PubMed
4) Newman B : Congenital bronchopulmonary foregut malformations : concepts and controversies. Pediatr Radiol 36 : 773-791, 2006.
PubMed
5) 黒川達夫, ほか : BPFMの発生学的概念. 小児外科 43 : 1307-1310, 2011.
 
6) Barnes NA. et al : Bronchopulmonary foregut malformations : embryology, radiology and quandary. Eur Radiol 13 : 2659-2673, 2003.
PubMed
7) Srikanth MS. et al : Communicating bronchopulmonary foregut malformations : classification and embryogenesis. J Pediatr Surg 27 : 732-736, 1992.
PubMed
8) 高村恭子, ほか : 両度の気管狭窄, 左肺無形成を伴う右bronchopulmonary foregut malformationの女児例. 日本未熟児新生児学会雑誌 24 : 275-278, 2012.
 
9) Parelkar SV, et al : Esophageal lung-A rare bronchopulmonary foregut malformation. J Pediatr Surg Case Rep 2 : 511-514, 2014.
 
10) Ren H, et al : Diagnosis and treatment of communicating bronchopulmonary foregut malformation : Report of two cases and review of the literature. Medicine (Baltimore) 96 : e6307, 2017.
PubMed
11) Harumatsu T, et al : Successful thoracoscopic treatment for tracheoesophageal fistula and esophageal atresia of communicating bronchopulmonary foregut malformation group IB with dextrocardia : a case report of VACTERL association. Surg Case Rep 7 : 11, 2021.
PubMed
12) He QM, et al : Communicating bronchopulmonary foregut malformation type IA : radiologic anatomy and clinical dilemmas. Surg Radiol Anat 37 : 1251-1256, 2015.
PubMed
13) Partridge EA, et al : Prenatal diagnosis of esophageal bronchus-first report of a rare foregut malformation in utero. J Pediatr Surg 50 : 306-310, 2015.
PubMed
14) Michel JL, et al : Successful bronchotracheal reconstruction in esophageal bronchus : two case reports. J Pediatr Surg 32 : 739-742, 1997.
PubMed
15) 高見澤滋, ほか : BPFMにおける気管支気管吻合. 小児外科 43 : 1316-1322, 2011.
Medical*Online
P.96 掲載の参考文献
1) Ramsay BH : Mucocele of the lung due to congenital obstruction of a segmental bronchus ; a case report ; relationship to congenital cystic disease of the lung and to congenital bronchiectasis. Dis Chest 24 : 96-103, 1953.
PubMed
2) 益田貞彦 : Bronchial atresiaの6例. 日本胸部臨床 48 : 99-107, 1989.
 
3) 広部誠一, ほか : 気管支閉鎖症の臨床病理学的検討-とくに左上区支閉鎖と気管支分岐異常の関係について-. 小児外科 36 : 627-631, 2004.
 
4) 気胸・嚢胞性肺疾患規約・用語・ガイドライン [2009年版] (日本気胸・嚢胞性肺疾患学会編), p15-19, 金原出版, 2009.
 
5) 朝田政克, ほか : 先天性気管支閉鎖症の1切除例-本邦報告43例の文献的考察-. 日本胸部外科学会雑誌 39 : 463-468, 1991.
Medical*Online
6) 渡辺稔彦, ほか : 胎児診断eraにおける先天性嚢胞性肺疾患. 日本小児呼吸器学会雑誌 24 : 14-19, 2013.
Medical*Online
7) 神崎正人, ほか : 多発閉鎖気管支を認めた気管支閉鎖症の1切除例. 気管支学 22 : 534-537, 2000.
Medical*Online
8) 矢野孝子, ほか : 先天性気管支閉鎖症の1切除例. 気管支学 18 : 45-50, 1996.
Medical*Online
9) 益田公彦, ほか : 先天性気管支閉鎖症成人例の臨床病理学的検討. 日本気胸・嚢胞性肺疾患学会雑誌 7 : 17-25, 2007.
 
10) 森川信行, ほか : 小児期に発見された気管支閉鎖症の臨床病理像-末梢性肺嚢胞と比較して-. 小児外科 36 : 619-626, 2004.
 
11) 福居嘉信, ほか : CTおよびMRIが診断に有用であった先天性気管支閉鎖症の1例. 呼吸 20 : 820-823, 2001.
Medical*Online
12) 廣部誠一, ほか : 気管支閉鎖に関連した嚢胞性肺疾患の検討. 日本小児放射線学会雑誌 31 : 138-141. 2015.
Medical*Online
13) 川崎一輝, 遠藤美紀 : 嚢胞性肺疾患術後の年長例の実際. 小児外科 47 : 748-752, 2015.
Medical*Online
14) 樋口昌孝 : 小児嚢胞性肺疾患の至適手術時期-小児科の立場から. 小児外科 43 : 1323-1326, 2011.
Medical*Online
15) 広部誠一, ほか : 嚢胞性肺疾患 : 特に気管支閉鎖症の診断に留意し, 1歳までに手術する理由について. 日本小児呼吸器疾患学会雑誌 23 : 77-82, 2012.
Medical*Online
P.100 掲載の参考文献
1) Reid LM : Reduction in bronchial subdivision in bronchiectasis. Thorax 5 : 233-247, 1950.
PubMed
2) Hill AT, et al : Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J 20 : 135-140, 2011.
PubMed
3) Polverino E, et al : European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 50 : 1700629, 2017.
PubMed
4) Gao YH, et al : Aetiology of bronchiectasis in adults : A systematic literature review. Respirology 21 : 1376-1383, 2016.
PubMed
5) Kadowaki T, et al : An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis. Respir Investig 53 : 37-44, 2015.
PubMed
6) 蛇沢晶, ほか : びまん性気管支拡張症の病理. 病理と臨床 20 : 898-903, 2002.
Medical*Online
7) Barker AF : Bronchiectasis. N Engl J Med 346 : 1383-1393, 2002.
PubMed
8) Chalmers JD, et al : The EMBARC European Bronchiectasis Registry : protocol for an international observational study. ERJ Open Res 2 : 00081-2015, 2016.
PubMed
9) Coche E, et al : Cystic bronchiectasis. Lancet 363 : 1578, 2004.
PubMed
10) O'Donnell AE, et al : Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 113 : 1329-1334, 1998.
 
P.106 掲載の参考文献
1) Salvatore D, et al : An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea. J Cyst Fibros 10 : 71-85, 2011.
PubMed
2) 吉村邦彦 : 日本人の嚢胞性線維症. 呼吸器内科 31 : 52-59, 2017.
 
3) 吉村邦彦, 太田春彦 : 嚢胞性線維症 (国際比較も含めて). 呼吸器内科 31 : 399-405, 2017.
 
4) Cystic Fibrosis Mutation Data Base. [http://www.genet.sickkids.on.ca/cftr/StatisticsPage.html] (2021年6月閲覧)
 
5) Ghigo A, et al : Dysfunctional inflammation in cystic fibrosis airways : from mechanisms to novel therapeutic approaches. Int J Mol Sci 22 : 1952, 2021.
PubMed
6) Elizur A, et al : Airway inflammation in cystic fibrosis. Chest 133 : 489-495, 2008.
PubMed
7) Cystic Fibrosis Foundation Patient Registry 2012 Annual Data Report, Bethesda, 2013. [http://www.cff.org/UploadedFiles/research/ClinicalResearch/PatientRegistryReport/2012-CFF-Patient-Registry.pdf]
 
8) de Jong PA, et al : Pulmonary disease assessment in cystic fibrosis : comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231 : 434-439, 2004.
PubMed
9) Davis SD, et al : Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175 : 943-950, 2007.
PubMed
10) Robinson TE : Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 4 : 310-315, 2007.
PubMed
11) Stick SM, et al : Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 155 : 623-628.e1, 2009.
 
12) Farrell PM, et al ; Cystic Fibrosis Foundation : Guidelines for diagnosis of cystic fibrosis in newborns through older adults : Cystic Fibrosis Foundation consensus report. J Pediatr 153 : S4-S14, 2008.
PubMed
13) 成瀬達, ほか : 膵嚢胞線維症の診断基準. 「膵嚢胞線維症の診療の手引き」. 厚生労働科学研 究費補助金難治性疾患克服研究事業難治性膵疾患に関する調査研究班 (主任研究者 : 大槻眞, 分担研究者 : 成瀬達), p18-19, アークメディア, 2008.
 
14) 吉村邦彦, ほか : 嚢胞性線維症の肺病変における重症度の評価基準と治療方針の確立. 厚生労働科学研究費補助金難治性疾患克服研究事業難治性膵疾患に関する調査研究, 平成27年度総括・分担研究報告書, p65-69, 2016.
 
15) 吉村邦彦, 安斎千恵子 : わが国における嚢胞性線維症症例のCFTR遺伝子変異解析. 厚生労働科学研究費補助金難治性疾患克服研究事業難治性膵疾患に関する調査研究, 平成23年度総合研究報告書, p371-374, 2012.
 
16) Yoshimura K, et al : A Japanese patient homozygous for the H1085R mutation in the CFTR gene presents with a severe form of cystic fibrosis. Clin Genet 56 : 173-175, 1999.
PubMed
17) Morokawa N, et al : Severe cystic fibrosis in a Japanese girl caused by two novel CFTR (ABCC7) gene mutations : M152R and 1540del10. Hum Mutat 15 : 485, 2000.
 
18) Izumikawa K, et al : Unique mutations of the cystic fibrosis transmembrane conductance regulator gene of three cases of cystic fibrosis in Nagasaki, Japan. Intern Med 48 : 1327-1331, 2009.
PubMed
19) Fujiki K, et al : Genetic evidence for CFTR dysfunction in Japanese : background for chronic pancreatitis. J Med Genet 41 : e55, 2004.
PubMed
20) Yoshimura K, et al : Diffuse panbronchiolitis is closely associated with mutations of the CFTR gene. Am J Respir Crit Care Med 161 : A77, 2000.
 
21) Jaffe A, et al : Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 351 : 420, 1998.
PubMed
22) Spagnolo P, et al : Long-term macrolide treatment for chronic respiratory disease. Eur Respir J 42 : 239-251, 2013.
PubMed
23) Wolter J, et al : Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis : a randomised trial. Thorax 57 : 212-216, 2002.
PubMed
24) Equi A, et al : Long term azithromycin in children with cystic fibrosis : a randomised, placebo-controlled crossover trial. Lancet 360 : 978-984, 2002.
PubMed
25) Saiman L, et al : Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa : a randomized controlled trial. JAMA 290 : 1749-1756, 2003.
PubMed
26) Clement A, et al : Long term effects of azithromycin in patients with cystic fibrosis : A double blind, placebo controlled trial. Thorax 61 : 895-902, 2006.
PubMed
27) Saiman L, et al : Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa : a randomized controlled trial. JAMA 303 : 1707-1715, 2010.
PubMed
28) Saiman L, et al : Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol 47 : 641-648, 2012.
 
29) Mogayzel PJ, et al : Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187 : 680-689, 2013.
PubMed
30) Southern KW, et al : Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 11 : CD002203, 2012.
PubMed
31) Robinson P, et al : Clarithromycin therapy for patients with cystic fibrosis : a randomized controlled trial. Pediatr Pulmonol 47 : 551-557, 2012.
PubMed
32) Ramsey BW, et al : A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365 : 1663-1672, 2011.
PubMed
33) Wainwright CE, et al : Lumacaftor-lvacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med 373 : 220-231, 2015.
PubMed
34) Taylor-Cousar JL, et al : Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del. N Engl J Med 377 : 2013-2023, 2017.
PubMed
35) Middleton PG, et al : Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 381 : 1809-1819, 2019.
PubMed
P.111 掲載の参考文献
1) 医療・介護関連肺炎診療ガイドライン (日本呼吸器学会医療・介護関連肺炎 (NHCAP) 診療ガイドライン作成委員会編), p32-35, 日本呼吸器学会, 2012.
 
2) Homma H, et al : Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 83 : 63-69, 1983.
PubMed
3) 福地義之助, ほか : 感染-びまん性嚥下性細気管支炎の臨床-. 日本胸部疾患学会雑誌 27 : 571-577, 1989.
 
4) Hu X, et al : Aspiration-related pulmonary syndromes. Chest 147 : 815-823, 2015.
PubMed
5) Hu X et al : Diffuse aspiration bronchiolitis : analysis of 20 consecutive patients. J Bras Pneumol 41 : 161-166, 2015.
PubMed
6) Matsuse T, et al : Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 110 : 1289-1293, 1996.
PubMed
7) 五十嵐知文, ほか : 食道アカラシアに併発したびまん性誤嚥性細気管支炎の1例. 日本胸部疾患学会雑誌 29 : 1059-1063, 1991.
 
8) 星朗, ほか : びまん性誤嚥性細気管支炎と考えられる像を呈したKlinefelter症候群の1例. 呼吸 9 : 1519-1524, 1990.
Medical*Online
9) 梅谷俊介, ほか : 習慣的飲酒が発症要因と考えられた胃食道逆流症によるびまん性嚥下性細気管支炎の1例. 日本呼吸器学会誌 5 : 199-203, 2016.
Medical*Online
10) 天野雅子, ほか : 神経性大食症が原因と考えられたびまん性誤嚥性細気管支炎の1例. 日本呼吸器学会誌 3 : 704-707, 2014.
Medical*Online
11) Arai T, et al : ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 64 : 573-574, 2005.
PubMed
12) Okimoto N, et al : Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly. J Infect Chemother 9 : 183-186, 2003.
PubMed
13) Yamaya M, et al : Interventions to prevent pneumonia among older adults. J Am Geriatr Soc 49 : 85-90, 2001.
PubMed
14) 平井圭太郎, ほか : 高齢者で誤嚥性肺炎を繰り返す食道裂孔ヘルニアに対し腹腔鏡下噴門形成 術が有用であった1例. The Kitakanto Medical Journal 61 : 193-197, 2011,
Medical*Online
15) Miyashita N, et al : Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis. J Am Geriatr Soc 64 : 665-666, 2016.
PubMed
P.116 掲載の参考文献
1) Homma H, et al : Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 83 : 63-69, 1983.
PubMed
2) 工藤翔二 : びまん性汎細気管支炎にたいするマクロライド系抗生剤の少量長期間投与の臨床効果. 日本胸部疾患学会雑誌 22 (増刊) : 254, 1984.
 
3) 松本武格, 藤田昌樹 : 治療の実際びまん性汎細気管支炎. 臨牀と研究 96 : 1469-1473, 2019.
 
4) Kono C, et al : Historical changes in epidemiology of diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis 29 : 19-25, 2012.
 
5) Kudoh S, et al : Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157 : 1829-1832, 1998.
PubMed
6) Sugiyama Y, et al : Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 141 : 1459-1462, 1990.
PubMed
7) 神尾孝一郎 : 閉塞性肺疾患 びまん性汎細気管支炎. 最新ガイドラインに基づく呼吸器疾患診療指針 2021-'22 (弦間昭彦編), p114-120, 総合医学社, 2020.
 
8) 中田紘一郎 : DPBの診断指針改訂と重症度分類策定. 呼吸器系疾患調査研究班びまん性肺疾患 分科会平成10年度研究報告書 (厚生省特定疾患), p109-111, 1999.
 
9) Keicho N, Hijikata M : Genetic predisposition to diffuse panbronchiolitis. Respirology 16 : 581-588, 2011.
PubMed
10) 松田潔, ほか : 気管支肺胞洗浄法によるびまん性肺疾患における気道系と肺胞系炎症の分析とその意義. 日本胸部疾患学会雑誌 30 : 827-834, 1992.
 
11) 慶長直人 : 各疾患のBAL所見と検査の意義 びまん性汎細気管支炎. 気管支肺胞洗浄 (BAL) 法の手引き [改訂第3版] (日本呼吸器学会びまん性肺疾患学術部会/厚生労働省難治性疾患政策研究事業びまん性肺疾患に関する調査研究班編), p144-147, 克誠堂出版, 2017.
 
P.120 掲載の参考文献
1) Thomson SC : Some of the syndrome and complication sinusitis. Practitioner 92 : 74, 1914.
 
2) Greenberg SD, Ainsworth JZ : Comparative morphology of chronic bronchitis and chronic sinusitis, with discussion of "Sinobronchial" syndrome. South Med J 59 : 64-74, 1966.
PubMed
3) 粟田口省吾 : 副鼻腔気管支炎, 臨床ならびに実験的研究. 東北医学会雑誌 67 : 81-106, 1963.
 
4) 三上理一郎, ほか : 副鼻腔気管支症候群の臨床-びまん性汎細気管支炎との関連-日本医事新報 2892 : 3-12, 1979.
 
5) 杉山幸比古, ほか : Young症候群 (慢性副鼻腔炎, 慢性気管支炎, 気管支拡張症を伴った特発性閉塞性無精子症) の2例. 日本胸部臨床 44 : 849-853, 1985.
 
6) Sugiyama Y, et al : Progressive sinobronchiectasis associated with the "bare lymphocyte syndrome" in an adult. Chest 89 : 398-401, 1986.
 
7) Kono C, et al : Historical changes in epidemiology of diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis 29 : 19-25, 2012.
 
8) 工藤翔二, ほか : 副鼻腔気管支症候群における細気管支病変の臨床的意義とその成因. 日本臨牀 36 : 2484-2495, 1978.
Medical*Online
9) 工藤翔二, ほか : びまん性汎細気管支炎にたいするエリスロマイシン少量長期投与の臨床効果に関する研究-4年間の治療成績. 日本胸部疾患学会雑誌 25 : 632-642, 1987.
 
10) 工藤翔二 : オーバービュウ : マクロライド療法の現状と将来. 呼吸器内科 38 : 1-8, 2020.
 
P.125 掲載の参考文献
1) Keal EE : Biochemistry and rheology of sputum in asthma. Postgrad Med J 47 : 171-177, 1971.
PubMed
2) Shimura S, et al : Chemical properties of bronchorrhea sputum in bronchial asthma. Chest 94 : 12111215, 1988.
 
3) 佐野靖之 : ブロンコレア. 臨床医 21 : 74-77, 1995.
 
4) Barkley JE, et al : Bronchioloalveolar carcinoma. J Clin Oncol 14 : 2377-2386, 1996.
PubMed
5) Sasamori K, et al : Cyclic ADP-ribose, a putative Ca2+ -mobilizing second messenger, operates in submucosal gland acinar cells. Am J Physiol Lung Cell Mol Physiol 287 : L69-78, 2004.
PubMed
6) Shimura S, Takishima T : Airway Submucosal Gland Secretion. In : Airway Secretion : Physiological Bases for the Control of Mucous Hypersecretion (ed by Takishima T, Shimura S), p325-398, Marcel Dekker, New York, 1994.
 
7) Shimura S : Signal transduction of mucous secretion by bronchial gland cells. Cell Signal 12 : 271-277, 2000.
PubMed
8) Shimura S, et al : Autonomic innervation to feline tracheal submucosal glands for mucus glycoprotein secretion. Am J Physiol 262 : L15-20, 1992.
PubMed
9) Yamada K, et al : HMT regulates histamine-induced Cl- secretion across the canine tracheal epithelium. Respir Physiol 97 : 105-109, 1994.
PubMed
10) 一木昌郎, ほか : Bronchorrheaを伴った気管支喘息の1例. 日本胸部疾患学会雑誌 53 : 424-428, 1994.
 
11) 党雅子 : ブロンレアの臨床. アレルギー科 12 : 615-621, 2001.
 
12) Nakajima T, et al : Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9. Intern Med 41 : 225-228, 2002.
 
13) Goswami SK, et al : Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 141 : 72-78, 1990.
PubMed
14) Tamaoki J, et al : Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 145 : 548-552, 1992.
PubMed
15) Roeder NL, et al : A Woman in Her 60s With Lung Adenocarcinoma Presents With Copious Watery Sputum and Respiratory Failure. Chest 152 : e143-e146, 2017.
PubMed
16) Sanz Rubiales A, et al : Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma. J Pain Symptom Manage 47 : e7-9, 2014.
PubMed
P.129 掲載の参考文献
1) Barker AF, et al : Obliterative bronchiolitis. N Engl J Med 370 : 1820-1828, 2014.
PubMed
2) Lai RS, et al : Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 348 : 83-85, 1996.
PubMed
3) 大中原研一, ほか : アマメシバによる閉塞性細気管支炎. 呼吸 27 : 283-288, 2008.
Medical*Online
4) 難治性びまん性肺疾患診療の手引き (日本呼吸器学会監, 厚生労働科学研究費補助金難治性疾患政策研究事業「びまん性肺疾患に関する調査研究」班難治性びまん性肺疾患診療の手引き作成委員会編), p18-70, 南江堂, 2017.
 
5) Hashimoto I, et al : Aqueous fraction of Sauropus androgynus might be responsible for bronchiolitis obliterans. Respirology 18 : 340-347, 2013.
PubMed
6) 長谷川好規, ほか : 第2回閉塞性細気管支炎全国調査研究-一次アンケート調査-. 厚生労働科学研究費補助金難治性疾患克服研究事業「びまん性肺疾患に関する調査研究」平成23年度研究報告書, p363, 2011.
 
7) Nicod LP : Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 3 : 444-449, 2006.
PubMed
8) Panoskaltsis-Mortari A, et al : A new murine model for bronchiolitis obliterans post-bone marrow transplant. Am J Respir Crit Care Med 176 : 713-723, 2007.
PubMed
9) Vos R, et al : A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 37 : 164-172, 2011.
 
10) Wuyts WA, et al : Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells : role for mitogen-activated kinases and nuclear factor-κB. J Heart Lung Transplant 24 : 875-881, 2005.
 
11) Estenne M, et al : Bronchiolitis obliterans syndrome 2001 : an update of the diagnostic criteria. J Heart Lung Transplant 21 : 297-310, 2002.
PubMed
12) Homma S, et al : Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. Respiration 73 : 481-487, 2006.
PubMed
13) Sugino K, et al : Histopathological bronchial reconstruction of human bronchiolitis obliterans. Pathol Int 61 : 192-201, 2011.
PubMed
14) Bergeron A, et al : Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 191 : 1242-1249, 2015.
PubMed
15) Kim SW, et al : Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Respir Res 17 : 63, 2016.
 
16) McKane BW, et al : Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model. Transplantation 77 : 664-669, 2004.
 
17) Watanabe S, et al : Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation. J Heart Lung Transplant 36 : 138-147, 2017.
PubMed
P.134 掲載の参考文献
1) COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 2018 [第5版] (日本呼吸器学会COPDガイドライン第5版作成委員会編), 一般社団法人日本呼吸器学会, 2018.
 
2) Fletcher CM : An Account of Chronic Bronchitis in Great Britain with a Comparison between British and American Experience of the Disease. Dis Chest 44 : 1-10, 1963.
PubMed
3) Ting EY, Williams MH Jr : The Mechanics of Breathing in Chronic Obstructive Pulmonary Disease. Am Rev Respir Dis 88 : 791-801, 1963.
PubMed
4) Kim V, Criner GJ : Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187 : 228-237, 2013.
PubMed
5) Pathak U, et al : Risk of COPD due to indoor air pollution from biomass cooking fuel : a systematic review and meta-analysis. Int J Environ Health Res 30 : 75-88, 2020.
PubMed
6) 咳嗽・喀痰の診療ガイドライン 2019 (日本呼吸器学会咳嗽・喀痰の診療ガイドライン2019作成委員会編), メディカルレビュー社, 2019.
 
7) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152 (5 Pt 2) : S77-121, 1995.
 
8) Vestbo J, et al : Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 153 : 1530-1535, 1996.
 
9) Burgel PR, et al : Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 135 : 975-982, 2009.
PubMed
10) Prescott E, et al : Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 8 : 1333-1338, 1995.
PubMed
11) Wang Z, et al : Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations : an analysis of the COPDMAP study. Thorax 73 : 331-338, 2018.
PubMed
12) Desai H, et al : Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 11 : 303-309, 2014.
PubMed
13) Woodruff PG, et al : Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med 374 : 1811-1821, 2016.
PubMed
14) Rennard SI, Drummond MB : Early chronic obstructive pulmonary disease : definition, assessment, and prevention. Lancet 385 : 1778-1788, 2015.
PubMed
P.139 掲載の参考文献
1) COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 2018 [第5版] (日本呼吸器学会COPDガイドライン第5版作成委員会編), 一般社団法人日本呼吸器学会, 2018.
 
2) Fukuchi Y, et al : COPD in Japan : the Nippon COPD Epidemiology study. Respirology 9 : 458-465, 2004.
PubMed
3) Lange P, et al : Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med 373 : 111-122, 2015.
PubMed
4) Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 Report. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Update November 2020. [http://www.goldcopd.org/]
 
5) 喘息とCOPDのオーバーラップ (Asthma and COPD Overlap : ACO) 診断と治療の手引き 2018 (喘息とCOPDのオーバーラップ (Asthma and COPD Overlap : ACO) 診断と治療の手引き2018作成委員会編), メディカルレビュー社, 2017.
 
P.144 掲載の参考文献
1) COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 2018 [第5版] (日本呼吸器学会COPDガイドライン第5版作成委員会編), p133-146, 一般社団法人日本呼吸器学会, 2018.
 
2) Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 Report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Update November 2020. [http://www.goldcopd.org/]
 
3) Donaldson GC, et al : Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 : 847-852, 2002.
PubMed
4) Spencer S, et al : Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 23 : 698-702, 2004.
PubMed
5) Hurst JR, et al : Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363 : 1128-1138, 2010.
PubMed
6) Papi A, et al : Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173 : 1114-1121, 2006.
PubMed
7) Turner MO, et al : Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med 157 : 1736-1744, 1997.
PubMed
8) Celli BR, MacNee W : Standards for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J 23 : 932-946, 2004.
PubMed
9) McCrory DC, Brown CD : Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4) : CD003900, 2002.
PubMed
10) Davies L, et al : Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease : a prospective randomised controlled trial. Lancet 354 : 456-460, 1999.
PubMed
11) Niewoehner DE, et al : Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 340 : 1941-1947, 1999.
 
12) Walters JA, et al : Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (10) : CD006897, 2011.
PubMed
13) Leuppi JD, et al : Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease : the REDUCE randomized clinical trial. JAMA 309 : 2223-2231, 2013.
PubMed
14) Sethi S : Bacteria in exacerbations of chronic obstructive pulmonary disease : phenomenon or epiphenomenon? Proc Am Thorac Soc 1 : 109-114, 2004.
PubMed
15) JAID/JSC感染症治療ガイド 2019 (JAID/JSC感染症治療ガイド・ガイドライン作成委員会編), 日本感染症学会・日本化学療法学会, ライフサイエンス出版, 2019.
 
P.149 掲載の参考文献
1) Swyer PR, James GC : Acase of unilateral pulmonary emphysema. Thorax 8 : 133-136, 1953.
 
2) Macleod WM : Abnormal transradiancy of one lung. Thorax 9 : 147-153, 1954.
PubMed
3) Gaensler EA : Unilateral hyperlucent lung. In : Frontiers of Pulmonary Radiology (ed by Simon M, et al), p312-359, Grune & Stratton, Orlando, 1969.
 
4) Abba AA, Al-Mobeireek AF : Clinical spectrum of Swyer-James-Macleod syndrome in adults. Saudi Med J 24 : 195-198, 2003.
PubMed
5) Kent DC : Physiologic Aspects of ldiopathic Uunilateral Hyperlucent Lung, with a Review of the Literature, Am Rev Respir Dis 90 : 202-212, 1964.
 
6) 富樫実, ほか : Idiopathic unilateral hyperlucent lung-with small (left) hilus-. 内科 14 : 577-580, 1964.
 
7) Reid L, Simon G : Unilateral lung transradiancy. Thorax 17 : 230-239, 1962.
PubMed
8) Cumming GR, et al : Unilateral hyperlucent lung syndrome in children. J Pediatr 78 : 250-260, 1971.
 
9) Stokes D, et al : Unilateral hyperlucent lung (Swyer-James syndrome) after severe Mycoplasma pneumoniae infection. Am Rev Respir Dis 117 : 145-152, 1978,
PubMed
10) Trimis G, et al : Swyer-James (MacLeod's) syndrome following Pertussis infection in an infant. Scand J Infect Dis 35 : 197-199, 2003.
 
11) Sen HS, et al : Adult diagnosis of Swyer-James-Macleod syndrome : retrospective analysis of four cases. Respir Care 59 : e51-54, 2014.
PubMed
12) Dirweesh A, et al : A unilateral hyperlucent lung-Swyer-James syndrome : A case report and literature review. Respir Med Case Rep 20 : 104-106, 2017.
PubMed
13) Sulaiman A, et al : Swyer-James-MacLeod syndrome ; repeated chest drainages in a patient misdiagnosed with pneumothorax. Interact Cardiovasc Thorac Surg 8 : 482-484, 2009.
 
14) Piquette CA, et al : Chronic bronchitis and emphysema. In : Textbook of Respiratory Medicine, 3rd ed (ed by Murray JF, Nadel JA), p1187-1245, WB Saunders, Philadelphia, 2000.
 
15) 安東優, ほか : 喘息発作を契機に縦隔・皮下気腫を合併したSwyer-James syndromeの1例. 日本胸部疾患学会雑誌 34 : 898-903, 1996.
 
16) 衛藤寿仁, ほか : Swyer-James症候群. 呼吸と循環 29 : 1049-1054, 1981.
 
17) Ando M, et al : Unilateral hyperlucent lung associated with bronchial atresia mimicking Swyer-James syndrome. Respir Care 59 : e182-185, 2014.
PubMed
18) Genereux GP : Bronchial atresia : a rare cause of unilateral lung hypertranslucency. J Can Assoc Radiol 22 : 71-82, 1971.
PubMed
19) Tasaki A, Nakanishi R : Lung volume reduction surgery for a professional athlete with Swyer-James syndrome. Ann Thorac Surg 80 : 342-344, 2005.
PubMed
P.153 掲載の参考文献
1) Spencer H : Amyloidosis of the lung. In : Pathology of the Lung, 4th ed, p733-739, Pergamon Press, Oxford, 1985.
 
2) Fraser RG, Pare JA : Amyloidosis. In : Diagnosis of Diseases of the Chest, 3rd ed (ed by Fraser RG, et al), p2578-2590, WB Saunders, Philadelphia, 1991.
 
3) Wechalekar AD, et al : Systemic amyloidosis. Lancet 387 : 2641-2654, 2016.
PubMed
4) Utz Jp, et al : Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med 124 : 407-413, 1996.
 
5) Chen KT : Amyloidosis presenting in the respiratory tract. Pathol Annu 24 (Pt 1) : 253-273, 1989.
 
6) Baqir M, et al : 18F-FDG PET scanning in pulmonary amyloidosis. J Nucl Med 55 : 565-568, 2014.
PubMed
7) Rajagopala S, et al : Pulmonary amyloidosis in Sjogren's syndrome : a case report and systematic review of the literature. Respirology 15 : 860-866, 2010.
PubMed
8) Hui AN, et al : Amyloidosis presenting in the lower respiratory tract. Clinicopathologic. radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med 110 : 212-218, 1986.
PubMed
9) O'Regan A, et al : Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999. Medicine (Baltimore) 79 : 69-79, 2000.
PubMed
10) Kumar S, et al : Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 30 : 989-995, 2012.
PubMed
P.158 掲載の参考文献
1) Strnad P, et al : Alpha1-Antitrypsin Deficiency, N Engl J Med 382 : 1443-1455, 2020.
 
2) Stoller JK, Aboussouan LS : α1-antitrypsin deficiency. Lancet 365 : 2225-2236, 2005.
 
3) 平井豊博, ほか : α1-アンチトリプシン欠乏症診療の手引き 2016. 日本呼吸器学会誌 5 : 159-165, 2016.
Medical*Online
4) Laurell CB, Eriksson S : The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 15 : 132-140, 1963.
 
5) Seyama K, et al : A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan. Respir Investig 54 : 201-206, 2016.
PubMed
6) 今村隆寿, 前田浩 : α1-プロテアーゼインヒビター : 構造と機能. 日本臨牀 63 (増刊 : 臨床免疫学 (上巻)) : 81-87, 2005.
 
7) 貫和敏博 : α1-アンチトリプシン. 日本臨牀 62 (増刊 : 広範囲血液・尿化学検査, 免疫学的検査 (1)) : 262-265, 2004.
 
8) Carrell RW, Lomas DA : Alpha1-antitrypsin deficiency-a model for conformational diseases. N Engl J Med 346 : 45-53, 2002.
 
9) Petrache I, et al : A novel antiapoptotic role for α1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 173 : 1222-1228, 2006.
 
10) 笠木聡ほか : 日本人のα1-アンチトリプシン欠損症. 臨床検査 47 : 894-898, 2003.
 
11) DeMeo DL, Silverman EK : α1-antitrypsin deficiency. 2 : genetic aspects of α1-antitrypsin deficiency : phenotypes and genetic modifiers of emphysema risk. Thorax 59 : 259-264, 2004.
 
12) McElvaney NG, et al : Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of α1-antitrypsin deficiency. α1-Antitrypsin Deficiency Registry Study Group. Chest 111 : 394-403, 1997.
 
13) Cuvelier A, et al : Distribution of α1-antitrypsin alleles in patients with bronchiectasis. Chest 117 : 415-419, 2000.
 
14) Sveger T : Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294 : 1316-1321, 1976.
PubMed
15) Larsson C : Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204 : 345-351, 1978.
 
P.161 掲載の参考文献
1) 気胸・嚢胞性肺疾患 規約・用語・ガイドライン 2009年版 (日本気胸・嚢胞性肺疾患学会編), 金原出版, 2009.
 
2) Fujino S, et al : Physical development of surgically treated patients with primary spontaneous pneumothorax. Chest 116 : 899-902, 1999.
PubMed
3) Wright JL : Chronic Airflow Obstruction. In : Thurlbeck's Pathology of the Lung, 3rd Ed (ed by Churg AM, et al), p688-689, Thieme Medical Publishers, New York, 2005.
 
4) Iyoda A, et al : A novel finding related to bulla and bleb formation in patients with primary spontaneous pneumothorax. BMC Pulm Med 21 : 20, 2021.
PubMed
P.165 掲載の参考文献
1) Burke RM : Vanishing lungs : a case report of bullous emphysema. Radiology 28 : 367-371, 1937.
 
2) Roberts L, et al : Vanishing lung syndrome : Upper lobe bullous pneumopathy. Rev Interam Radiol 12 : 249-255, 1987.
 
3) Schipper PH, et al : Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg 78 : 976-982, 2004.
PubMed
4) 土橋一仁, ほか : 気腫性肺嚢胞症の手術適応の検討. 日本呼吸器外科学会雑誌 7 : 429-435, 1993.
 
5) Noppen M, et al : Successful treatment of a giant emphysematous bulla by bronchoscopic placement of endobronchial valves. Chest 130 : 1563-1565, 2006.
PubMed
6) Strange C, et al : Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT) : a non-surgical method of lung volume reduction. BMC Pulm Med 7 : 10, 2007.
 
7) Santini M, et al : Endobronchial treatment of giant emphysematous bullae with one-way valves : a new approach for surgically unfit patients. Eur J Cardiothorac Surg 40 : 1425-1431, 2011.
 
8) Bhattacharyya P, et al : Transbronchial decompression of emphysematous bullae : a new therapeutic approach. Eur Respir J 29 : 1003-1006, 2007.
PubMed
P.170 掲載の参考文献
1) Ch'In KY, Tang MY : Congenital adenomatoid malformation of one lobe of a lung with general anasarca. Arch Pathol (Chic) 48 : 221-229, 1949.
PubMed
2) Stocker JT, et al : Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol 8 : 155-171, 1977.
PubMed
3) Stocker JT : Congenital and developmental disease. In : Pulmonary Pathology, 2nd ed (ed by Dail DH, Hammar SP), p174-180, Springer-Verlag, New York, 1994.
 
4) Riedlinger WFJ, et al : Bronchial atresia is common to extralober sequestration, intralobar sequestration, congenital cystic adenomatoid malformation, and lobar emphysema. Pediatr Dev Pathol 9 : 361-373, 2006.
 
5) EUROCAT : European Surveillance of Congenital anomalies. [www.eurocat-network.eu] (2021年4月閲覧)
 
6) 田中水緒, ほか : CCAM/CPAMの概念について. 小児外科 43 : 1283-1287, 2011.
Medical*Online
7) Langston C : New concepts in the pathology of congenital lung malformations. Semin Pediatr Surg 12 : 17-37, 2003.
PubMed
8) 黒田達夫, ほか : 先天性嚢胞性肺疾患に関する調査研究. 厚生労働科学研究費補助金難治性疾患等克服研究事業「胎児・新生児肺低形成の診断・治療実態に関する調査研究」平成24年度総括・分担研究報告書 (研究代表者 : 臼井規朗), p104-112, 2013.
 
9) 下高原昭廣 : 先天性嚢胞性肺疾患. 周産期医学 50 : 198-201, 2020.
Medical*Online
10) Kotecha S, et al : Antenatal and postnatal management of congenital cystic adenomatoid malformation. Paediatr Respir Rev 13 : 162-170 ; quiz 170-171, 2012.
 
P.177 掲載の参考文献
1) Miller WS : A study of the human pleura pulmonalis ; its relation to the blebs and bullae of emphysema. Am J Roentgenol Radium Ther 15 : 399-407, 1926.
 
2) Freedman E : Emphysematous Blebs and Bullae. Am J Roentgenol 35 : 324-334, 1936.
 
3) Murphy JD, et al : Cystic disease of the lung. Dis Chest 19 : 454-472, 1951.
 
4) Cooke FN, Blades B : Cystic disease of the lungs. J Thorac Surg 23 : 546-569, 1952.
PubMed
5) Mayer E, et al : Developmental origin of cystic, bronchiectatic and emphysematous changes in the lungs ; a new concept. Dis Chest 21 : 146-160, 1952.
PubMed
6) Mayer E, Rappaport I : Clinical observations and interpretations of abnormal air spaces in the lungs ; a new concept of their origin. JAMA 153 : 700-703, 1953.
 
7) Fraser RG, Pare JAP : Pulmonary abnormalities of developmental origin. In : Diagnosis of Diseases of the Chest, 2nd, ed, p602-656, WB Saunders, Philadelphia, 1977.
 
8) Haller JA Jr, et al : Surgical management of lung bud anomalies : lobar emphysema, bronchogenic cyst, cystic adenomatoid malformation, and intralobar pulmonary sequestration. Ann Thorac Surg 28 : 33-43, 1979.
PubMed
9) Kuroda T, et al : Clinical Features of Congenital Cystic Lung Diseases : A Report on a Nationwide Multicenter Study in Japan. Eur J Pediatr Surg 26 : 91-95, 2016.
PubMed
10) Spencer H : Congenital abnormalities of the lung, pulmonary vessels and lymphatics. In : Pathology of the Lungs. 3rd ed, p71-114, Pergamon Press, Oxford, 1977.
 
11) 石田治雄 : 先天性嚢胞性肺疾患の概念, 日本胸部臨床 59 : 81-90, 2000.
Medical*Online
12) Nuchtern JG, Harberg FJ : Congenital lung cyst. Seminar Pediatr Surg 3 : 233-243, 1994.
 
13) Kravitz RM : Congenital malformations of the lung. Pediatr Clin North Am 41 : 453-472, 1994.
PubMed
14) Stocker JT : Congenital and developmental diseases. In : Pulmonary Pathology, 2nd ed (ed by Dail DH, Hammar SP), p155-190 (174-180), Springer-Verlag, New York, 1994.
 
15) Sauvat F, et al : Management of asymptomatic neonatal cystic adenomatoid malformations. J Pediatr Surg 38 : 548-552, 2003.
PubMed
16) Stanton M, et al : Systematic review and meta-analysis of the postnatal management of congenital cystic lung lesions. J Pediatr Surg 44 : 1027-1033, 2009.
PubMed
17) 杉林里佳, ほか : 先天性嚢胞性肺疾患に対する胎児治療. 胎児疾患と胎児治療 : 病態生理, 診断・治療のすべて (中田雅彦編), p127-130, メディカ出版, 2020.
 
18) Cass DL, et al : EXIT-to-resection for fetuses with large lung masses and persistent mediastinal compression near birth. J Pediatr Surg 48 : 138-144, 2013.
 
P.183 掲載の参考文献
1) Hansell DM, et al : Fleischner Society : glossary of terms for thoracic imaging. Radiology 246 : 697-722, 2008.
PubMed
2) 気胸・嚢胞性肺疾患 規約・用語・ガイドライン [2009年版] (日本気胸・嚢胞性肺疾患学会編), 金原出版, 2009.
 
3) 飛野和則, 瀬山邦明 : 嚢胞性肺疾患 ; 閉塞性肺疾患, 気管支の異常. 嚢胞性肺疾患, 気管支異常. 別冊日本臨牀新領域別症候群シリーズ No. 8 呼吸器症候群 (第2版) I, p783-791, 日本臨牀社, 2008.
 
4) Webb WR, et al : High-resolution CT of the Lung, 5th ed, Wolters Kluwer Publishers, Philadelphia, 2015.
 
5) Lynch DA, et al : CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease : A Statement of the Fleischner Society. Radiology 277 : 192-205, 2015.
PubMed
6) Dal Sasso AA, et al : Birt-Hogg-Dub6 syndrome. State-of-the-art review with emphasis on pulmonary involvement. Respir Med 109 : 289-296, 2015.
PubMed
7) Furuya M, et al : Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dube syndrome. Clin Genet 90 : 403-412, 2016.
PubMed
8) 飛野和則, ほか : 稀な肺疾患 Birt-Hogg-Dube症候群. 呼吸 32 : 164-172, 2013.
 
9) Menko FH, et al : Birt-Hogg-Dube syndrome : diagnosis and management. Lancet Oncol 10 : 1199-1206, 2009.
PubMed
10) 気胸・肺のう胞スタディグループ : 解説詳細. [http://lungcare.jp/details04.html] (2021年7月閲覧)
 
P.188 掲載の参考文献
1) Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. A Report of the Conclusions of a Ciba Guest Symposium. Thorax 14 : 286-299, 1959.
 
2) Snider GL, et al : The Definition of Emphysema Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis 132 : 182-185, 1985.
 
3) 中村隆 : 会長演説 慢性肺気腫の現状と診断基準. 日本胸部疾患学会雑誌 1 : 43-48, 1963.
 
4) 日本呼吸器学会COPDガイドライン COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン (日本呼吸器学会COPDガイドライン作成委員会編), p2, メディカルレビュー社, 1999.
 
5) 臨床呼吸器病学 (原澤道美著, 吉村敬三編), p454, 朝倉書店, 1982.
 
6) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152 : S77-121, 1995.
PubMed
7) Siafakas NM, et al : Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8 : 1398-1420, 1995.
PubMed
8) BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 52 (Suppl 5) : S1-28, 1997.
 
9) Pauwels RA, et al : Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 : 1256-1276, 2001.
 
10) Timens W, et al : Chronic obstructive pulmonary disease and diseases of the airways. In : Spencer's Pathology of the Lung, 6th ed (ed by Hasleton P, Flieder DB), p605-660, Cambridge University Press, Cambridge, 2013.
 
11) Corrin B, Nicholson AG : Diseases of the airways. In : Pathology of the Lungs, 2nd ed, p87-130, Churchill Livingstone, Elsevier, Philadelphia, 2006.
 
12) Matsuba K, et al : The number and dimensions of small airways in emphysematous lungs. Am J Pathol 67 : 265-275, 1972.
PubMed
13) Hogg JC : Lung structure and function in COPD. Int J Tuberc Lung Dis 12 : 467-479, 2008.
PubMed

II 呼吸不全, 換気異常

P.196 掲載の参考文献
1) Hunt JR : On herpetic inflammation of the geniculate ganglion. A new syndrome and its complications. J Nerv Ment Dis 34 : 73-96, 1907.
 
2) Hunt JR : Dyssynergia cerebellaris progressiva : a chronic progressive form of cerebellar tremor. Brain 37 : 247-268, 1914.
 
3) Denny-Brown D, et al : Pathologic features of herpes zoster : a note on "geniculate herpes". Arch Neurol Psychiatry 51 : 216-231, 1944.
 
4) Crabtree JA : Herpes zoster oticus. Laryngoscope 78 : 1853-1878, 1968.
PubMed
5) Bethlem J : Herpetic geniculate ganglionitis. Acta Neuropathol (Berl) 2 : 97-101, 1962.
 
6) 阿部隆 : Bell麻痺及びRamsay-Hunt症候群の統計的観察-臨床像の検討と鑑別診断について-. 日本耳鼻咽喉科学会会報 84 : 607-617, 1981.
 
7) McKenzie D : Herpes zoster oticus combined with recurrent nerve paralysis. J Laryngol Rhinol Otol 36 : 339-344, 1915.
 
8) 平田賢三, 竹林脩文 : 多発性脳神経症状を示したHunt症候群の1例. 耳鼻咽喉科 47 : 205-208, 1975.
 
9) 佐藤勝重, ほか : 多発性脳神経麻痺と急性呼吸不全を合併したRamsay Hunt症候群の1例. 日本胸部疾患学会雑誌 29 : 1037-1041, 1991.
 
10) 鈴木詩織, ほか : 水痘・帯状疱疹ウイルスによる喉頭麻痺の5例. 喉頭 32 : 189-194, 2020.
Medical*Online
11) 宮崎雄生, ほか : 嗄声と嚥下困難にて発症したRamsay Hunt症候群の1例-合併脳神経障害とその伝播機序についての考察-. 臨床神経学 42 : 855-858, 2002.
 
12) Schriefer TN, et al : Evaluation of proximal facial nerve conduction by transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry 51 : 60-66, 1988.
PubMed
13) Murakami S, et al : Rapid diagnosis of varicella zoster virus infection in acute facial palsy. Neurology 51 : 1202-1205, 1998.
PubMed
14) Glasscock ME, et al : Middle fossa facial nerve decompression. Ann Otol Rhinol Laryngol 79 : 234-240, 1970.
PubMed
15) Murakami S, et al : Treatment of Ramsay Hunt syndrome with acyclovir-prednisone : significance of early diagnosis and treatment. Ann Neurol 41 : 353-357, 1997.
PubMed
P.200 掲載の参考文献
1) Rodriguez-Roisin R, et al : Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N Engl J Med 358 : 2378-2387, 2008.
PubMed
2) Hoeper MM, et al : Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363 : 1461-1468, 2004.
PubMed
3) Krowka MJ, et al : International Liver Transplant Society Practice Guidelines : Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation 100 : 1440-1452, 2016.
PubMed
4) Iqbal S, et al : Hepatopulmonary Syndrome and Portopulmonary Hypertension : Implications for Liver Transplantation. Clin Chest Med 38 : 785-795, 2017.
PubMed
5) Fallon MB : Hepatopulmonary syndrome : a good relationship gone bad. Gastroenterology 125 : 1261-1264, 2003.
PubMed
6) Castro M, et al : Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med 17 : 35-48, 1996.
PubMed
7) Schenk P, et al : Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125 : 1042-1052, 2003.
PubMed
8) Schenk P, et al : Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 133 : 701-706, 2000.
PubMed
9) Rodriguez-Roisin R, et al : Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 24 : 861-880, 2004.
PubMed
P.206 掲載の参考文献
1) 高山病と関連疾患の診療ガイドライン (日本登山医学会高山病と関連疾患の診療ガイドライン作成委員会編), 中外医学社, 2017.
 
2) Leon-Velarde F, et al : Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol 6 : 147-157, 2005.
PubMed
3) Hackett PH, Rennie D : The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 2 : 1149-1155, 1976.
PubMed
4) Morrell NW, et al : ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet 353 : 814, 1999.
PubMed
5) Hanaoka M, et al : Polymorphisms of human vascular endothelial growth factor gene in high-altitude pulmonary oedema susceptible subjects. Respirology 14 : 46-52, 2009.
PubMed
6) Liu H, et al : EPAS1 regulates proliferation of erythroblasts in chronic mountain sickness. Blood Cells Mol Dis 84 : 102446, 2020.
PubMed
7) Roach RC, et al : The 2018 Lake Louise Acute Mountain Sickness Score. High Alt Med Biol 19 : 4-6, 2018.
 
8) Hultgren HN : High-altitude pulmonary edema : current concepts. Annu Rev Med 47 : 267-284, 1996.
PubMed
9) The Lake Louise Consensus on the Definition and Quantification of Altitude Illness. In : Hypoxia and Mountain Medicine (ed by Sutton JR, et al), p327-330, Queen City Printers, Burlington, 1992.
 
10) Hurtado A : Chronic mountain sickness. JAMA 120 : 1278-1282, 1942.
 
11) Bloch KE, et al : Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Alt Med Biol 10 : 25-32, 2009.
PubMed
12) Luks AM, et al : Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness : 2014 update. Wilderness Environ Med 25 : S4-14, 2014.
PubMed
13) Maggiorini M, et al : Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema : a randomized trial. Ann Intern Med 145 : 497-506, 2006.
PubMed
14) Schoene RB, et al : High altitude pulmonary edema and exercise at 4, 400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest 87 : 330-333, 1985.
 
15) Villafuerte FC, et al : Chronic Mountain Sickness : Clinical Aspects, Etiology, Management, and Treatment. High Alt Med Biol 17 : 61-69, 2016.
PubMed
P.210 掲載の参考文献
1) ARDS Definition Task Force, et al : Acute respiratory distress syndrome : the Berlin Definition. JAMA 307 : 2526-2533, 2012.
PubMed
2) ARDS診療ガイドライン 2016 [Part 1] (3学会合同ARDS診療ガイドライン2016作成委員会編), 日本呼吸器学会, 2016.
 
3) Bellani G, et al : Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 315 : 788-800, 2016.
PubMed
4) Thille AW, et al : Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respirat Crit Care Med 187 : 761-767, 2013.
 
5) Frat JP, et al : High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372 : 2185-2196, 2015.
PubMed
P.215 掲載の参考文献
1) 在宅呼吸ケア白書 2010 (日本呼吸器学会肺生理専門委員会在宅呼吸ケア白書ワーキンググループ編), 日本呼吸器学会, 2010.
 
2) Long-Term Oxygen Treatment Trial Research Group : Albert RK, et al : A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med 375 : 1617-1627, 2016.
 
3) Lacasse Y, et al : Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. N Engl J Med 383 : 1129-1138, 2020.
PubMed
4) Visca D, et al : Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx) : a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med 6 : 759-770, 2018.
PubMed
5) NPPV (非侵襲的陽圧換気療法) ガイドライン [改訂第2版] (日本呼吸器学会NPPVガイドライン作成委員会編), 南江堂, 2015.
 
6) Gustafson T, et al : Survival of patients with kyphoscoliosis receiving mechanical ventilation or oxygen at home. Chest 130 : 1828-1833, 2006.
PubMed
7) Bourke SC, et al : Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis : a randomised controlled trial. Lancet Neurol 5 : 140-147, 2006.
PubMed
8) Kohnlein T, et al : Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease : a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2 : 698-705, 2014.
PubMed
9) Murphy PB, et al : Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation : A Randomized Clinical Trial. JAMA 317 : 2177-2186, 2017.
PubMed
10) Macrea M, et al : Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 202 : e74-e87, 2020.
PubMed
11) 非がん性呼吸器疾患緩和ケア指針 2021 (日本呼吸器学会/日本呼吸ケア・リハビリテーション学会合同 非がん性呼吸器疾患緩和ケア指針2021作成委員会編), 一般社団法人日本呼吸器学会/一般社団法人日本呼吸ケア・リハビリテーション学会, 2021.
 
12) Ekstr6m M, et al : Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc 12 : 1079-1092, 2015.
 
13) Barnes H, et al : Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev 3 : CD011008, 2016.
PubMed
14) Currow D, et al : Regular, sustained-release morphine for chronic breathlessness : a multicentre, double-blind, randomised, placebo-controlled trial. Thorax 75 : 50-56, 2020.
PubMed
P.221 掲載の参考文献
1) Beers MF : Oxygen Therapy and Pulmonary Oxygen Toxicity. In : Fishman's Pulmonary Diseases and Disorders, 4th ed (ed by Fishman AP, et al), p2613-2630, McGraw-HilL New York, 2008.
 
2) 吉矢生人, 天野勝 : 第9章 応用呼吸生理学 E. 酸素中毒. 新生理科学大系 [第17巻] 呼吸の生理学 (勝木保次, 内薗耕二監, 星猛, 伊藤正男総編集), p391-397, 医学書院, 2000.
 
3) Lumb AB : Oxygen Toxicity and Hyperoxia. In : Nunn's Applied Respiratory Physiology, 8th ed (ed by Lumb AB), p341-356, Elsevier, Edinburgh, 2017.
 
4) Hall JE (著), 煙山健仁 (訳) : 第45章 深海潜水やその他の高気圧状態の生理学. ガイトン生理学 [原著第13版] (石川義弘, ほか総監訳), p511-516, エルゼビア・ジャパン, 2018.
 
5) 鈴木幸男 : 第4章 ARDSの基礎疾患 高濃度酸素による肺損傷. 別冊「医学のあゆみ」ARDSのすべて, p198-202, 医歯薬出版, 2004.
 
6) Altemeier WA, et al : Hyperoxia in the intensive care unit : why more is not always better. Curr Opin Crit Care 13 : 73-78, 2007.
 
7) 鈴木聡 : 高濃度酸素の弊害-気道・肺への傷害と全身への影響. INTENSIVIST 10 : 353-363, 2018.
 
8) West JB, Luks AM : ウエスト呼吸生理学入門 : 正常肺編 [第2版] (桑平一郎訳), p171-192, メディカル・サイエンス・インターナショナル, 2017.
 
9) 鈴木信哉 : 「酸素の問題点を考える」酸素と痙攣. Medical Gases 21 : 40-46, 2019.
 
10) Bhandari V, et al : Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 41 : 4-18, 2006.
PubMed
11) Sinclair SE, Elias JA : Augmented lung injury due to interaction between hyperoxia and mechanical ventilation. Crit Care Med 32 : 2496-2501, 2004.
 
P.224 掲載の参考文献
1) 原田淳子, ほか : 肺性脳症を伴った急性毛細気管支炎の2例. 東京女子医科大学雑誌 47 : 685-690, 1977.
 
2) 笹本浩, ほか : 肺性脳症. 呼吸と循環 12 : 627-691, 1964.
 
3) Areza-Fegyveres R, et al : Cognition and chronic hypoxia in pulmonary diseases. Dement Neuropsychol 4 : 14-22, 2010.
PubMed
4) Thakur N, et al : COPD and cognitive impairment : the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 5 : 263-269, 2010.
PubMed
5) 後藤文男, 篠原幸人 : CO2ナルコーシスの発生機序. 臨床生理 4 : 127-132, 1974.
 
6) Kilburn KH : Neurologic manifestations of respiratory failure. Arch Intern Med 116 : 409-415, 1965.
PubMed
7) Sieker HO, et al : Carbon dioxide intoxication : the clinical syndrome, its etiology and management with particular reference to the use of mechanical respirators. Medicine (Baltimore) 35 : 389-423, 1956.
 
8) Kondo T, et al : A pharmacologic study on CO2 responsiveness of intracranial pressure in rats with chronic hypercapnia. Chest 115 : 1402-1406, 1999.
 
9) Graham GR, et al : [The effect of high concentrations of carbon dioxide on the circulation and respiration. Tolerance and supercarbia]. Anaesthesist 9 : 70-73, 1960.
PubMed
10) Fitzgerald RS, et al : Neural responses of the cat carotid and aortic bodies to hypercapnia and hypoxia. J Appl Physiol Respir Environ Exerc Physiol 52 : 596-601, 1982.
PubMed
11) Kondo T, et al : Ventilatory responses to hypercapnia and hypoxia following chronic hypercapnia in the rat. Respir Physiol 122 : 35-43, 2000.
PubMed
12) Scano G, et al : Carbon dioxide responsiveness in COPD patients with and without chronic hypercapnia. Eur Respir J 8 : 78-85, 1995.
PubMed
13) Aubier M, et al : Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 122 : 747-754, 1980.
PubMed
14) Robinson TD, et al : The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 : 1524-1529, 2000.
PubMed
15) Austen FK, et al : Neurologic manifestations of chronic pulmonary insufficiency. N Engl J Med 257 : 579-590, 1957.
PubMed
16) Huang Y, et al : High-flow nasal cannula in hypercapnic respiratory failure : asystematic review and meta-analysis. Can Respir J 2020 : 7406457, 2020. (DOI : 10.1155/2020/7406457)
 
P.226 掲載の参考文献
1) Austrian R, et al : Clinical and physiologic features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion ; the syndrome of "alveolar-capillary block". Am J Med 11 : 667-685, 1951.
 
2) Cadigan JB, et al : Clinical determination of the diffusion capacity of the lungs ; comparison of methods in normal subjects and patients with alveolar-capillary block syndrome. Am J Med 22 : 51-73, 1957.
PubMed
3) 村尾誠 : 肺胞-毛細管ブロック症候群. 日本臨牀 40 (春季増刊) : 1050-1051, 1982.
Medical*Online
4) 牧野荘平 : 肺胞-毛細管ブロック症候群. 日本臨牀 45 (春季増刊) : 418, 1987.
Medical*Online
5) 戸田正夫, 牧野荘平 : 肺胞-毛細管ブロック症候群 ; 換気の異常, 呼吸不全. 別冊日本臨牀領域別症候群シリーズ No. 4 呼吸器症候群 (下巻), p511-513, 日本臨牀社, 1994.
 
6) 長井苑子, ほか : A-Cブロック症候群. 医学書院医学大辞典 [第2版] (伊藤正男, ほか総編集), p249, 医学書院, 2009.
 
7) Kreukniet J : The alveolar-capillary block syndrome. Reversible forms. Acta Med Scand 170 : 215-230, 1961.
PubMed
8) American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152 (6 Pt 1) : 2185-2198, 1995.
 
9) Arndt H, et al : Diffusing capacities and ventilation : perfusion ratios in patients with the clinical syndrome of alveolar capillary block. J Clin Invest 49 : 408-422, 1970.
 
10) 日本呼吸器学会, ほか : ARDS診療ガイドライン 2016 (3学会合同ARDS診療ガイドライン2016作成委員会編), 日本呼吸器学会/日本呼吸療法医学会/日本集中治療医学会, 2016.
 
P.231 掲載の参考文献
1) Correa D, et al : Chronic opioid use and central sleep apnea : a review of the prevalence, mechanisms, and perioperative considerations. Anesth Analg 120 : 1273-1285, 2015.
PubMed
2) Mubashir T, et al : Prevalence of sleep-disordered breathing in opioid users with chronic pain : a systematic review and meta-analysis. J Clin Sleep Med 16 : 961-969, 2020.
PubMed
3) 厚生労働省 : 薬物乱用防止に関する情報現在の薬物乱用の状況. [https://wwwmhlw.go.jp/bunya/iyakuhin/yakubuturanyou/torikumi/] (2021年3月閲覧)
 
4) Pattinson KT : Opioids and the control of respiration. Br J Anaesth 100 : 747-758, 2008.
PubMed
5) Boon M, et al : Combining opioids and benzodiazepines : effects on mortality and severe adverse respiratory events. Ann Palliat Med 9 : 542-557, 2020.
PubMed
6) Gavidia R, et al : The influence of opioids and nonopioid central nervous system active medications on central sleep apnea : a case-control study. J Clin Sleep Med 17 : 55-60, 2021.
PubMed
7) Giannoni A, et al : Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea. N Engl J Med 375 : 1004-1006, 2016.
PubMed
8) Boom M, et al : Non-analgesic effects of opioids : opioid-induced respiratory depression. Curr Pharm Des 18 : 5994-6004, 2012.
PubMed
9) Santiago TV, et al : Control of breathing during methadone addiction. Am J Med 62 : 347-354, 1977.
PubMed
10) Teichtahl H, et al : Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients. Chest 128 : 1339-1347, 2005.
PubMed
11) 渡邉衡一郎 : 脳科学辞典 抗不安薬, Updated 2014. 2. 3. [https://bsd.neuroinfjp/wiki/抗不安薬#cite_ref-ref9_6-0]
 
12) Haji A, et al : Neuropharmacology of control of respiratory rhythm and pattern in mature mammals. Pharmacol Ther 86 : 277-304, 2000.
PubMed
13) Rosen IM, et al : Chronic Opioid Therapy and Sleep : An American Academy of Sleep Medicine Position Statement. J Clin Sleep Med 15 : 1671-1673, 2019.
PubMed
14) American Academy of Sleep Medicine : International Classification of Sleep Disorders : Diagnostic and Coding Manual, 3rd ed (ICSD-3), American Academy of Sleep Medicine, Darien, 2014.
 
15) Randerath W, et al : Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J 49 (1) : 1600959. (DOI : 10.1183/13993003.00959-2016)
 
P.234 掲載の参考文献
1) Riley EA : Idiopathic diaphragmatic paralysis ; a report of eight cases. Am J Med 32 : 404-416, 1962.
PubMed
2) Efthimiou J, et al : Diaphragm paralysis following cardiac surgery : role of phrenic nerve cold injury. Ann Thorac Surg 52 : 1005-1008, 1991.
PubMed
3) Joho-Arreola AL, et al : Incidence and treatment of diaphragmatic paralysis after cardiac surgery in children. Eur J Cardiothorac Surg 27 : 53-57, 2005.
PubMed
4) Ferdinande P, et al : Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant 23 : 105-109, 2004.
PubMed
5) Mier-Jedrzejowicz A, et al : Assessment of diaphragm weakness. Am Rev Respir Dis 137 : 877-883, 1988.
PubMed
6) 小林淳 : 機能温存を目指した胸部悪性腫瘍手術の現況と将来. 横隔神経-横隔膜の機能再建手術-. 日本外科学会雑誌 117 : 308-315, 2016.
 
7) Nishino T : Problems associated with diaphragm pacing. Respiration 69 : 12-13, 2002.
PubMed
8) 伊藤恒, ほか : 筋萎縮性側索硬化症に対する横隔膜ペーシング-安全性と有効性の長期評価-. 神経治療学 34 : 121-124, 2017.
Medical*Online
P.237 掲載の参考文献
1) Phillips JR, Eldridge FL : Respiratory myoclonus (Leeuwenhoek's disease). N Engl J Med 289 : 1390-1395, 1973.
 
2) Kondo T, et al : Dual-respiratory rhythms. A key to diagnosis of diaphragmatic flutter in patients with HVS. Chest 96 : 106-109, 1989.
PubMed
3) Chen R, et al : Electrophysiological study of diaphragmatic myoclonus. J Neurol Neurosurg Psychiatry 58 : 480-483, 1995.
PubMed
4) Rigatto M, de Medeiros N : Diaphragmatic flutter. Report of a case and review of literature. Am J Med 32 : 103-109, 1962.
PubMed
5) Dressler W, Kleinfeld M : Tic of the respiratory muscles ; report of three cases and review of literature. Am J Med 16 : 61-72, 1954.
PubMed
6) Katz ES, et al : Respiratory flutter syndrome : an underrecognized cause of respiratory failure in neonates. Am J Respir Crit Care Med 164 : 1161-1164, 2001.
PubMed
7) Borroni B, et al : Diaphragmatic myoclonus due to SARS-CoV-2 infection. Neurol Sci 41 : 3471-3474, 2020.
PubMed
8) Kobayashi I, et al : A case of the diaphragmatic flutter with an electromyographic study of the respiratory muscles. Tokai J Exp Clin Med 29 : 151-154, 2004.
PubMed
9) Soderstrom N : Diaphragm contractions synchronizing with the heart movements. Acta Med Scand 122 : 95-102, 1945.
PubMed
P.241 掲載の参考文献
1) 中野隆 : 呼吸筋の臨床解剖. 脊椎脊髄ジャーナル 32 : 33-44, 2019.
 
2) American Thoracic Society/European Respiratory Society : ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166 : 518-624, 2002.
PubMed
3) 谷口博之 : COPDにおける骨格筋, 呼吸筋の機能異常. COPD Frontier 2 : 294-300, 2003.
Medical*Online
4) NHLBI Workshop summary. Respiratory Muscle Fatigue ; Report of the Respiratory Muscle Fatigue Workshop Group. Am Rev Respir Dis 142 : 474-480, 1990.
 
5) 谷口博之, ほか : 呼吸リハビリテーションの評価. 理学療法 18 : 1094-1100, 2001.
 
6) 呼吸リハビリテーションマニュアル-運動療法- [第2版] (日本呼吸ケア・リハビリテーション学会呼吸リハビリテーション委員会ワーキンググループ, ほか編), 照林社, 2012.
 
7) NPPV (非侵襲的陽圧換気療法) ガイドライン [改訂第2版] (日本呼吸器学会NPPVガイドライン作成委員会編), 南江堂, 2015.
 
8) 宮本顕二 : 高流量鼻カニュラ酸素療法. 日本呼吸器学会誌 3 : 771-776, 2014.
Medical*Online
9) McKinstry S, et al : Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure : A randomized controlled cross-over trial. Respirology 24 : 1081-1087, 2019.
PubMed
10) Ries AL, et al : Pulmonary Rehabilitation : Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 131 : 4S-42S, 2007.
PubMed
11) 吉川雅則, 木村弘 : COPD : 診断と治療の進歩 合併症 (全身併存症) 栄養障害. 日本内科学会雑誌 101 : 1562-1570, 2012.
 
12) 植木純, ほか : 日本呼吸ケア・リハビリテーション学会/日本呼吸理学療法学会/日本呼吸器学会 呼吸リハビリテーションに関するステートメント. 日本呼吸ケア・リハビリテーション学会誌 27 : 95-114, 2018.
 
13) Aubier M, et al : Diaphragmatic contractility enhanced by aminophylline : role of extracellular calcium. J Appl Physiol Respir Environ Exerc Physiol 54 : 460-464, 1983.
PubMed
14) Suzuki S, et al : Effects and mechanism of fenoterol on fatigued canine diaphragm. Am Rev Respir Dis 137 : 1048-1054, 1988.
PubMed
15) Aubier M, et al : Effects of digoxin on diaphragmatic strength generation in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 135 : 544-548, 1987.
PubMed
16) Schols AM, et al : Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152 : 1268-1274, 1995.
PubMed
P.246 掲載の参考文献
1) デュシェンヌ型筋ジストロフィー診療ガイドライン 2014 (日本神経学会, ほか監, 「デュシェンヌ型筋ジストロフィー診療ガイドライン」作成委員会編), 南江堂, 2014.
 
2) Birnkrant DJ, et al ; DMD Care Considerations Working Group : Diagnosis and management of Duchenne muscular dystrophy, part 1-3. Lancet Neurol 17 : 251-267, 347-361, 445-455, 2018.
 
3) Windisch W, et al : German National Guideline for Treating Chronic Respiratory Failure with Invasive and Non-Invasive Ventilation : Revised Edition 2017-Part 1-2. Respiration 96 : 66-97, 171-203, 2018.
 
4) 筋萎縮性側索硬化症診療ガイドライン 2013 (日本神経学会, ほか監, 「筋萎縮性側索硬化症診療ガイドライン」作成委員会編), 南江堂, 2013.
 
5) Guimaraes-Costa R, et al : Human diaphragm atrophy in amyotrophic lateral sclerosis is not predicted by routine respiratory measures. Eur Respir J 53 : 1801749, 2019. (DOI : 10.1183/13993003.01749-2018)
PubMed
6) Radunovic A, et al : Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Syst Rev 10 : CD004427, 2017. (DOI : 10.1002/14651858.D004427.pub4)
 
7) Aboussouan LS, Mireles-Cabodevila E : Sleep-Disordered Breathing in Neuromuscular Disease : Diagnostic and Therapeutic Challenges. Chest 152 : 880-892, 2017.
PubMed
8) Marchese S, et al : Outcome and attitudes toward home tracheostomy ventilation of consecutive patients : a 10-year experience. Respir Med 102 : 430-436, 2008.
PubMed
P.250 掲載の参考文献
1) 厚生労働省 : 重篤副作用疾患別対応マニュアル末梢神経障害, 平成21年5月.
 
2) 本村政勝, ほか : 筋肉・末梢神経に影響を及ぼす薬物 神経・筋接合部に影響を及ぼす薬物. 日本内科学会雑誌 96 : 1604-1607, 2007.
 
3) 樋口逸郎 : 筋肉・末梢神経に影響を及ぼす薬物 筋肉に影響を及ぼす薬物. 日本内科学会雑誌 96 : 15984-1603, 2007.
 
P.255 掲載の参考文献
1) Khalsa SB, et al : A phase response curve to single bright light pulses in human subjects. J Physiol 549 : 945-952, 2003.
PubMed
2) Burgess HJ, et al : A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol 586 : 639-647, 2008.
PubMed
3) Ebisawa T, et al : Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2 : 342-346, 2001.
PubMed
4) Takano A, et al : A missense variation in human casein kinase I epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders. Neuropsychopharmacology 29 : 1901-1909, 2004.
PubMed
5) Richardson GS, et al : Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. J Clin Sleep Med 4 : 456-461, 2008.
PubMed
6) 西田慎吾, ほか : 睡眠相後退障害 (DSPD) 治療におけるメラトニン受容体アゴニストramelteonの有効性-予備的な非盲検試験-. 精神科治療学 29 : 527-533, 2014.
 
7) Takeshima M, et al : Ramelteon for Delayed Sleep-wake Phase Disorder : A Case Report. Clin Psychopharmacol Neurosci 18 : 167-169, 2020.
PubMed
8) Yamadera H, et al : A multicenter study of sleep-wake rhythm disorders : therapeutic effects of vitamin B12, bright light therapy, chronotherapy and hypnotics. Psychiatry Clin Neurosci 50 : 203-209, 1996.
PubMed
9) Saeed Y, et al : Clinical neurophysiology of circadian rhythm sleep-wake disorders. Handb Clin Neurol 161 : 369-380, 2019.
PubMed
10) Kitamura S, et al : Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type. Biol Psychiatry 73 : 63-69, 2013.
PubMed
11) Yanagihara M, et al : The melatonin receptor agonist is effective for free-running type circadian rhythm sleep disorder : case report on two sighted patients. Tohoku J Exp Med 234 : 123-128, 2014.
PubMed
12) Watanabe A, et al : A Case of Non-24-Hour Sleep-Wake Rhythm Disorder Treated With a Low Dose of Ramelteon and Behavioral Education. J Clin Sleep Med 14 : 1265-1267, 2018.
 
13) Iwata M, Kaneko K : Non-24-hour sleep-wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder. Neuropsychopharmacol Rep 40 : 383-387, 2020.
 
14) Malkani RG, et al : Diagnostic and Treatlnent Challenges of Sighted Non-24-Hour Sleep-Wake Disorder. J Clin Sleep Med 14 : 603-613, 2018.
PubMed
15) Zee PC, et al : Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. Sleep Med 11 : 525-533, 2010.
PubMed
P.260 掲載の参考文献
1) 米国睡眠医学会 : 睡眠障害国際分類 第3版 (日本睡眠学会診断分類委員会監訳), 一般社団法人日本睡眠学会, 2018.
 
2) Gottlieb DJ, Punjubi NM : Diagnosis and Management of Obstructive Sleep Apnea : A Review. JAMA 323 : 1389-1400, 2020.
 
3) Johns MW : A new method for measuring daytime sleepiness : the Epworth sleepiness scale. Sleep 14 : 540-545, 1991.
PubMed
4) Kapur VK, et al : Sleepiness in patients with moderate to severe sleep-disordered breathing Sleep 28 : 472-477, 2005.
PubMed
5) Peppard PE, et al : Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177 : 1006-1014, 2013.
PubMed
6) Heinzer R, et al : Prevalence of sleep-disordered breathing in the general population : the HypnoLaus study. Lancet Respir Med 3 : 310-318, 2015.
PubMed
7) Fietze I, et al : Prevalence and association analysis of obstructive sleep apnea with gender and age differences-Results of SHIP-Trend. J Sleep Res 28 : e12770, 2019.
 
8) Avellar AB, et al : Pharmacotherapy for residual excessive sleepiness and cognition in CPAP-treated patients with obstructive sleep apnea syndrome : A systematic review and meta-analysis. Sleep Med Rev 30 : 97-107, 2016.
PubMed
9) Weaver TE, et al : Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30 : 711-719, 2007.
PubMed
10) Antic NA, et al : The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 34 : 111-119, 2011.
PubMed
11) Gasa M, et al : Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure. J Sleep Res 22 : 389-397, 2013.
PubMed
12) Koutsourelakis I, et al : Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients. Eur Respir J 34 : 687-693, 2009.
PubMed
13) Banks S, et al : Factors associated with maintenance of wakefulness test mean sleep latency in patients with mild to moderate obstructive sleep apnoea and normal subjects. J Sleep Res 13 : 71-78, 2004.
PubMed
14) Zhu Y, et al : Degeneration in Arousal Neurons in Chronic Sleep Disruption Modeling Sleep Apnea. Front Neurol 6 : 109, 2015.
PubMed
15) Dergacheva O, et al : Hypoxia and hypercapnia inhibit hypothalamic orexin neurons in rats. J Neurophysiol 116 : 2250-2259, 2016.
PubMed
16) Kheirandish-Gozal L, Gozal D : Obstructive Sleep Apnea and Inflammation : Proof of Concept Based on Two Illustrative Cytokines. Int J Mol Sci 20 : 459, 2019.
PubMed
17) Celle S, et al : Desperately seeking grey matter volume changes in sleep apnea : A methodological review of magnetic resonance brain voxel-based morphometry studies. Sleep Med Rev 25 : 112-120, 2016.
PubMed
18) Baril AA, et al : Gray Matter Hypertrophy and Thickening with Obstructive Sleep Apnea in Middle-aged and Older Adults. Am J Respir Crit Care Med 195 : 1509-1518, 2017.
PubMed
19) Rostampour M, et al : White matter alterations in patients with obstructive sleep apnea : a systematic review of diffusion MRI studies. Sleep Med 75 : 236-245, 2020.
PubMed
20) Xiong Y, et al : Brain white matter changes in CPAP-treated obstructive sleep apnea patients with residual sleepiness. J Magn Reson Imaging 45 : 1371-1378, 2017.
PubMed
21) Zhang J, et al : White matter structural differences in OSA patients experiencing residual daytime sleepiness with high CPAP use : a non-Gaussian diffusion MRI study. Sleep Med 53 : 51-59, 2019.
PubMed
22) Javaheri S, Javaheri S : Update on Persistent Excessive Daytime Sleepiness in OSA. Chest 158 : 776-786, 2020.
PubMed
23) Osorio RS, et al : Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 84 : 1964-1971, 2015.
PubMed
24) Peppard PE, et al : Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 166 : 1709-1715, 2006.
PubMed
25) Povitz M, et al : Effect of treatment of obstructive sleep apnea on depressive symptoms : systematic review and meta-analysis. PLoS Med 11 : e1001762, 2014.
PubMed
26) Littner MR, et al : Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28 : 113-121, 2005.
PubMed
27) Leng PH, et al : The clinical predictors of sleepiness correlated with the multiple sleep latency test in an Asian Singapore population. Sleep 26 : 878-881, 2003.
 
28) Chervin RD, Aldrich MS : The relation between multiple sleep latency test findings and the frequency of apneic events in REM and non-REM sleep. Chest 113 : 980-984, 1998.
PubMed
29) Fong SY, et al : Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome. J Psychosom Res 58 : 55-60, 2005.
PubMed
30) Brockmann PE, et al : Association of sleep spindle activity and sleepiness in children with sleep-disordered breathing. J Clin Sleep Med 16 : 583-589, 2020
PubMed
31) Weiner OM, Dang-Vu TT : Spindle Oscillations in Sleep Disorders : ASystematic Review. Neural Plast 2016 : 7328725, 2016.
 
32) Yetkin O, Aydogan D : Effect of CPAP on sleep spindles in patients with OSA. Respir Physiol Neurobiol 247 : 71-73, 2018.
PubMed
33) Roky R, et al : Daytime sleepiness during Ramadan intermittent fasting : polysomnographic and quantitative waking EEG study. J Sleep Res 12 : 95-101, 2003.
PubMed
34) Xiromeritis AG, et al : Quantitative spectral analysis of vigilance EEG in patients with obstructive sleep apnoea syndrome : EEG mapping in OSAS patients. Sleep Breath 15 : 121-128, 2011.
PubMed
35) Parekh A, et al : Slow-wave activity surrounding stage N2 K-complexes and daytime function measured by psychomotor vigilance test in obstructive sleep apnea. Sleep 42 : zsy256, 2019.
PubMed
36) Greenblatt K, Adams N : Modafinil. In : StatPearls [Internet], StatPearls Publishing, Treasure Island ; 2021 Jan. [updated 2020 Sep 11]
 
37) Hirshkowitz M, Black J : Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome : a 12-month, open-label extension study. CNS Drugs 21 : 407-416, 2007.
PubMed
P.266 掲載の参考文献
1) 米国睡眠医学会 : 睡眠障害国際分類 第3版 (日本睡眠学会診断分類委員会監訳), 一般社団法人日本睡眠学会, 2018.
 
2) Hornyak M, et al : Periodic leg movements in sleep and periodic limb movement disorder : prevalence, clinical significance and treatment. Sleep Med Rev 10 : 169-177, 2006.
PubMed
3) Ferri R : The time structure of leg movement activity during sleep : the theory behind the practice. Sleep Med 13 : 433-441, 2012.
PubMed
4) Ekbom K, et al : Restless legs syndrome. J Intern Med 266 : 419-431, 2009.
PubMed
5) Moore H, et al : Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BCO34767, MEIS1, MAP2K5/SKOR1, and PTPRD. Sleep 37 : 1535-1542, 2014.
PubMed
6) Stefansson H, et al : A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357 : 639-647, 2007.
 
7) Pockett C, et al : Periodic limb movements in sleep and attention deficit hyperactivity disorder : Are they related? Paediatr Child Health 11 : 355-358, 2006.
PubMed
8) Iriarte J, et al : Oscillatory cortical changes during Periodic limb movements. Sleep 27 : 1493-1498, 2004.
PubMed
9) De Mello MT, et al : Comparison between dopaminergic agents and physical exercise as treatment for periodic limb movements in patients with spinal cord injury. Spinal Cord 42 : 218-221, 2004.
PubMed
10) Parrino L, et al : The cyclic alternating pattern plays a gate-control on periodic limb movements during non-rapid eye movement sleep. J Clin Neurophysiol 13 : 314-323, 1996.
 
11) Koo BB, et al : Association of incident cardiovascular disease with periodic limb movements during sleep in older men : outcomes of sleep disorders in older men (MrOS) study. Circulation 124 : 1223-1231, 2011.
PubMed
12) Baran AS, et al : Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. Sleep 26 : 717-720, 2003.
PubMed
13) Hedli LC, et al : Unmasking of periodic limb movements with the resolution of obstructive sleep apnea during continuous positive airway pressure application. J Clin Neurophysiol 29 : 339-344, 2012.
PubMed
14) Senel GB, et al : Cyclic Alternating Pattern Analysis in Periodic Leg Movements in Sleep in Patients With Obstructive Sleep Apnea Syndrome Before and After Positive Airway Pressure Treatment. J Clin Neurophysiol, 2020. (DOI : 10.1097/WNP.0000000000000704)
 
15) Budhiraja R, et al : Prevalence and correlates of periodic limb movements in OSA and the effect of CPAP therapy. Neurology 94 : e1820-e1827, 2020.
PubMed
P.271 掲載の参考文献
1) Berry RB, et al ; for the American Academy of Sleep Medicine : The AASM Manual for the Scoring of Sleep and Associated Events : Rules, Terminology and Technical Specifications, Version 2.5, American Academy of Sleep Medicine, Darien, 2018.
 
2) Young T, et al : The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 : 1230-1235, 1993.
PubMed
3) Peppard PE, et al : Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177 : 1006-1014, 2013.
PubMed
4) Isono S, et al : Influences of head positions and bite opening on collapsibility of the passive pharynx. J Appl Physiol (1985) 97 : 339-346, 2004.
PubMed
5) Isono S, et al : Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol (1985) 82 : 1319-1326, 1997.
PubMed
6) Marin JM, et al : Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure : an observational study. Lancet 365 : 1046-1053, 2005.
PubMed
P.275 掲載の参考文献
1) Brack T, et al : Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 132 : 1463-1471, 2007.
PubMed
2) Javaheri S, et al : Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 122 : 487-492, 1995.
PubMed
3) 百村伸一, ほか : 循環器領域における睡眠呼吸障害の診断・治療に関するガイドライン. Circulation Journal 74 (Suppl 2) : 963-1051, 2010.
 
4) Ueno H, et al : Attenuated respiratory modulation of chemoreflex-mediated sympathoexcitation in patients with chronic heart failure. J Card Fail 10 : 236-243, 2004.
PubMed
5) Javaheri S, et al : Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49 : 2028-2034, 2007.
PubMed
6) Parra O, et al : Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 161 : 375-380, 2000.
PubMed
7) Walsh JT, et al : Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 73 : 237-241, 1995.
PubMed
8) Tamura A, et al : Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131 : 130-135, 2007.
PubMed
9) Solin P, et al : Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99 : 1574-1579, 1999.
PubMed
10) 清野精彦, ほか : 中枢性睡眠時無呼吸に対する夜間酸素療法の有効性. Heart View 10 : 252-258, 2006.
Medical*Online
11) Bradley TD, et al : Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 : 2025-2033, 2005.
PubMed
12) Arzt M, et al : Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure : a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115 : 3173-3180, 2007.
PubMed
13) Cowie MR, et al : Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 373 : 1095-1105, 2015.
PubMed
14) Jagielski D, et al : Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea : 12 months'experience with the remede System. Eur J Heart Fail 18 : 1386-1393, 2016.
PubMed
15) Costanzo MR, et al : Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail 20 : 1746-1754, 2018.
PubMed
P.282 掲載の参考文献
1) American Academy of Sleep Medicine : International Classification of Sleep Disorders, 3rd ed, American Academy of Sleep Medicine, Darien, 2014.
 
2) Randerath W, et al : Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J 49 (1) : 1600959, 2017. (DOI : 10.1183/13993003.00959-2016)
 
3) Eckert DJ, et al : Central sleep apnea : Pathophysiology and treatment. Chest 131 : 595-607, 2007.
PubMed
4) 睡眠時無呼吸症候群 (SAS) の診療ガイドライン 2020 (睡眠時無呼吸症候群 (SAS) の診療ガイドライン作成委員会編), 南江堂, 2020.
 
P.286 掲載の参考文献
1) Benjafield AV, et al : Estimation of the global prevalence and burden of obstructive sleep apnoea : a literature-based analysis. Lancet Respir Med 7 : 687-698, 2019.
PubMed
2) Young T, et al : The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 : 1230-1235, 1993.
PubMed
3) Peppard PE, et al : Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177 : 1006-1014, 2013.
PubMed
4) Ip MS, et al : A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 119 : 62-69, 2001.
 
5) Horner RL : Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. Sleep 19 : 827-853, 1996.
 
6) White DP : The pathogenesis of obstructive sleep apnea : advances in the past 100 years. Am J Respir Cell Mol Biol 34 : 1-6, 2006.
PubMed
7) American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea : Practice guidelines for the perioperative management of patients with obstructive sleep apnea : an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 120 : 268-286, 2014.
PubMed
8) Kuna ST, et al : Pathophysiology of upper airway closure during sleep. JAMA 266 : 1384-1389, 1991.
PubMed
9) White DP : Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 172 : 1363-1370, 2005.
PubMed
10) Younes M : Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med 168 : 645-658, 2003.
PubMed
11) Jordan AS, et al : Adult obstructive sleep apnoea. Lancet 383 : 736-747, 2014.
PubMed
12) Sankri-Tarbichi AG, et al : Expiratory pharyngeal narrowing during central hypocapnic hypopnea. Am J Respir Crit Care Med 179 : 313-319, 2009.
PubMed
13) 米国睡眠医学会 : 睡眠障害国際分類 第3版 (日本睡眠学会診断分類委員会監訳), 一般社団法人日本睡眠学会, 2018.
 
14) Young T, et al : Sleep disordered breathing and mortality : eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31 : 1071-1078, 2008.
PubMed
15) Marin JM, et al : Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure : an observational study. Lancet 365 : 1046-1053, 2005.
PubMed
P.291 掲載の参考文献
1) Roy-Byrne PP, et al : Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls. Arch Gen Psychiatry 43 : 895-899, 1986.
 
2) Krystal JH, et al : Characteristics of panic attack subtypes : assessment of spontaneous panic, situational panic, sleep panic, and limited symptom attacks. Compr Psychiatry 32 : 474-480, 1991.
PubMed
3) Lin AS, et al : Effects of intravenous caffeine administered to healthy males during sleep. Depress Anxiety 5 : 21-28, 1997.
PubMed
4) Uhde TW, et al : Anxiety and sleep problems : emerging concepts and theoretical treatment implications. Curr Psychiatry Rep 11 : 269-276, 2009.
PubMed
5) Craske MG, Barlow DH : Nocturnal panic. J Nerv Ment Dis 177 : 160-167, 1989.
 
6) Nakamura M, et al : Is nocturnal panic a distinct disease category? Comparison of clinical characteristics among patients with primary nocturnal panic, daytime panic, and coexistence of nocturnal and daytime panic. J Clin Sleep Med 9 : 461-467, 2013.
 
7) Llorente MD, et al : Night terrors in adults : phenomenology and relationship to psychopathology. J Clin Psychiatry 53 : 392-394, 1992.
PubMed
8) Geraci MF, Uhde TW : Diurnal rhythms and symptom severity in panic disorder. A preliminary study of 24-hour changes in panic attacks, generalised anxiety, and avoidance behaviour. Br J Psychiatry 161 : 512-516, 1992.
PubMed
9) Antypa N, et al : Chronotype Associations with Depression and Anxiety Disorders in a Large Cohort Study. Depress Anxiety 33 : 75-83, 2016.
 
10) Brown TM, Uhde TW : Sleep panic attacks : a micro-movement analysis. Depress Anxiety 18 : 214-220, 2003.
PubMed
11) Klein DF : False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 50 : 306-317, 1993.
 
12) Stein MB, et al : Irregular breathing during sleep in patients with panic disorder. Am J Psychiatry 152 : 1168-1173, 1995.
PubMed
13) Mellman TA, Uhde TW : Sleep panic attacks : new clinical findings and theoretical implications. Am J Psychiatry 146 : 1204-1207, 1989.
PubMed
14) Koenigsberg HW, et al : Cardiac and respiratory activity in panic disorder : effects of sleep and sleep lactate infusions. Am J psychiatry 151 : 1148-1152, 1994.
PubMed
15) Geraci M, et al : Pentagastrin-induced sleep panic attacks : panic in the absence of elevated baseline arousal. Biol Psychiatry 52 : 1183-1189, 2002.
PubMed
16) Babson KA, et al : An experimental investigation of the effects of acute sleep deprivation on panic-relevant biological challenge responding. Behav Ther 40 : 239-250, 2009.
PubMed
17) Uhde TW : The anxiety disorders. In : Principles and Practice of Sleep Medicine, 3rd ed (ed by Kryger MH, et al), p1123-1139, WB Saunders, Philadelphia, 2000.
 
18) Su VY, et al : Sleep Apnea and Risk of Panic Disorder. Ann Fam Med 13 : 325-330, 2015.
PubMed
19) Takaesu Y, et al : Effects of nasal continuous positive airway pressure on panic disorder comorbid with obstructive sleep apnea syndrome. Sleep Med 13 : 156-160, 2012.
PubMed
20) Lee HB, et al : Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 20 : 101-105, 2008.
PubMed
21) Johnson PL, et al : A key role for orexin in panic anxiety. Nat Med 16 : 111-115, 2010.
PubMed
P.295 掲載の参考文献
1) Bassetti CLA, et al : Narcolepsy-clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 15 : 519-539, 2019.
PubMed
2) Scheer D, et al : Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010. Sleep 42 : zsz091, 2019.
 
3) Scammell TE : Narcolepsy. N Engl J Med 373 : 2654-2662, 2015.
PubMed
4) 日本睡眠学会 : ナルコレプシーの診断・治療ガイドライン項目, 2008.
 
P.300 掲載の参考文献
1) American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 3rd ed (ICSD-3), p1-22, American Academy of Sleep Medicine, Darien, 2014.
 
2) Ohayon MM : Epidemiology of insomnia : what we know and what we still need to learn. Sleep Med Rev 6 : 97-111, 2002.
PubMed
3) Buysse DJ : Insomnia. JAMA 309 : 706-716, 2013.
PubMed
4) Dolsen MR, et al : Insomnia as a transdiagnostic process in psychiatric disorders. Curr Psychiatry Rep 16 : 471, 2014.
 
5) Verkuyl JM, et al : Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur J Neurosci 20 : 1665-1673, 2004.
PubMed
6) 金尚宏, 深田吉孝 : 生活時間と健康 生物時計と体のリズム. 学術の動向 24 : 8-19, 2019.
 
7) Pandi-Perumal SR, et al : Drug Insight : the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon. Nat Clin Pract Neurol 3 : 221-228, 2007.
PubMed
8) Borbely AA, et al : The two-process model of sleep regulation : a reappraisal. J Sleep Res 25 : 131-143, 2016.
PubMed
9) Aurora RN, et al : The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012 : practice parameters with an evidence-based systematic review and meta-analyses : an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 35 : 1039-1062, 2012.
PubMed
10) 睡眠薬の適正使用・休薬ガイドライン (三島和夫編), p37, じほう, 2014.
 
11) Sateia MJ, et al : Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults : An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13 : 307-349, 2017.
PubMed
12) 櫻井武 : 睡眠覚醒の制御機構とオレキシンの役割. 睡眠医療 8 (増刊号) : 490-499, 2014.
 
13) Haynes J, et al : Cognitive Behavioral Therapy in the Treatment of Insomnia. South Med J 111 : 75-80, 2018.
PubMed
P.306 掲載の参考文献
1) Allen RP, et al : Restless legs syndrome/Willis-Ekbom disease diagnostic criteria : updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 15 : 860-873, 2014.
 
2) Winkelman JW, et al : Practice guideline summary : Treatment of restless legs syndrome in adults : Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 87 : 2585-2593, 2016.
PubMed
3) Ekbom K, Ulfberg J : Restless legs syndrome. J Intern Med 266 : 419-431, 2009.
PubMed
4) Tsuboi Y, et al : Prevalence of restless legs syndrome in a Japanese elderly population. Parkinsonism Relat Disord 15 : 598-601, 2009.
 
5) Sevim S, et al : Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 61 : 1562-1569, 2003.
PubMed
6) Burtscher C, et al : Prevalence of restless legs syndrome in an urban population of eastern Africa (Tanzania). J Neurol Sci 346 : 121-127, 2014.
 
7) Fawale MB, et al : Restless Legs Syndrome in a Nigerian Elderly Population. J Clin Sleep Med 12 : 965-972, 2016.
 
8) Manconi M, et al : When gender matters : restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group. Sleep Med Rev 16 : 297-307, 2012.
 
9) American Academy of Sleep Medicine : The International Classification of Sleep Disorders, 3rd ed (ICSD-3), American Academy of Sleep Medicine, Darien, 2014.
 
10) Stefansson H, et al : A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357 : 639-647, 2007.
 
11) Winkelmann J, et al : Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39 : 1000-1006, 2007.
PubMed
12) Winkelmann J, et al : Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 7 : e1002171, 2011.
PubMed
13) Skagerberg G, et al : Schmidt. Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res Bull 9 : 237-244, 1982.
PubMed
14) Allen RP, Earley CJ : Restless legs syndrome : a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 : 128-147, 2001.
PubMed
15) Clemens S, Hochman S : Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci 24 : 11337-11345, 2004.
PubMed
16) Clemens S, et al : Restless legs syndrome : revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67 : 125-130, 2006.
PubMed
17) Ben-Shachar D, et al : Effect of iron chelators on dopamine D2 receptors. J Neurochem 45 : 999-1005, 1985.
PubMed
18) Lanza G, Ferri R : The neurophysiology of hyperarousal in restless legs syndrome : Hints for a role of glutamate/GABA. Adv Pharmacol 84 : 101-119, 2019.
PubMed
19) Montplaisir J, et al : Clinical, polysomnographic, and genetic characteristics of restless legs syndrome : a study of 133 patients diagnosed with new standard criteria. Mov Disord 12 : 61-65, 1997.
PubMed
20) Michaud M, et al : Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol 48 : 108-113, 2002.
PubMed
21) Abetz L, et al : The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting. Sleep Med 7 : 340-349, 2006.
 
22) Garcia-Borreguero D, et al : Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation : a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 21 : 1-11, 2016.
PubMed
23) Wanner V, et al : Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome. Adv Pharmacol 84 : 187-205, 2019.
PubMed
24) Winkelmann J, et al : Treatment of restless legs syndrome : Evidence-based review and implications for clinical practice (Revised 2017)+. Mov Disord 33 : 1077-1091, 2018.
PubMed
25) Allen RP, et al : Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children : an IRLSSG task force report. Sleep Med 41 : 27-44, 2018.
PubMed
26) Iftikhar IH, et al : Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome : a comparative meta-analysis. Eur J Neurol 24 : 1446-1456, 2017.
PubMed
P.312 掲載の参考文献
1) 米国睡眠医学会 : 睡眠障害国際分類 第3版 (日本睡眠学会診断分類委員会監訳), p165-210, 一般社団法人日本睡眠学会, 2018.
 
2) Singh S, et al : Parasomnias : A comprehensive review. Cureus 10 : e3807, 2018.
PubMed
3) Erickson J, et al : Non-REM Parasomnia : The Promise of Precisiop Medicine. Sleep Med Clin 14 : 363-370, 2019.
PubMed
4) Bjorvatn B, et al : Prevalence of different parasomnias in the general population. Sleep Med 11 : 1031-1034, 2010.
PubMed
5) Ekinci O, et al : Understanding sleep problems in children with epilepsy : Associations with quality of life, Attention-Deficit Hyperactivity Disorder and maternal emotional symptoms. Seizure 40 : 108-113, 2016.
PubMed
6) Ohayon MM, et al : Night terrors, sleepwalking, and confusional arousals in the general population : their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 60 : 268-276 ; quiz 277, 1999.
 
7) Trosman I, Ivanenko A : Classification and Epidemiology of Sleep Disorders in Children and Adolescents. Child Adolesc Psychiatr Clin N Am 30 : 47-64, 2021.
PubMed
8) Zadra A, et al : Somnambulism : clinical aspects and pathophysiological hypotheses. Lancet Neurol 12 : 285-294. 2013.
PubMed
9) Sarilar AC, et al : Electroencephalogram abnormalities in patients with NREM parasomnias. Sleep Med 77 : 256-260, 2021.
PubMed
10) Vetrugno R, et al : Nocturnal eating : sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep 29 : 949-954, 2006.
 
11) Goodwin JL, et al : Parasomnias and sleep disordered breathing in Caucasian and Hispanic children-the Tucson children's assessment of sleep apnea study. BMC Med 2 : 14, 2004.
 
12) Tavasoli A, et al : Sleep Symptoms and Polysomnographic Patterns of Obstructive Sleep Apnea in Obese Children. Iran J Child Neurol 10 : 14-20, 2016.
PubMed
P.316 掲載の参考文献
1) Schenck CH, et al : Chronic behavioral disorders of human REM sleep : a new category of parasomnia. Sleep 9 : 293-308, 1986.
PubMed
2) American Academy of Sleep Medicine : The International Classification of Sleep Disorders : Diagnostic and Coding Manual, 3rd ed, American Academy of Sleep Medicine, Darien, 2014.
 
3) Schenck CH, et al : Symposium : Normal and abnormal REM sleep regulation : REM sleep behaviour disorder : an update on a series of 96 patients and a review of the world literature. J Sleep Res 2 : 224-231, 1993.
 
4) Postuma RB, et al : Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder : a multicentre study. Brain 142 : 744-759, 2019.
PubMed
5) Braak H, et al : Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 : 197-211, 2003.
PubMed
6) Jouvet M, Delorme F : Locus coeruleus et sommeil paradoxal. C R Soc Biol (Paris) 159 : 895-899, 1965.
 
7) 三上章良, ほか : 睡眠の脳波 ; 最近の話題 (II) 老人の睡眠障害. 臨床脳波 37 : 401-406, 1995.
 
8) McKeith IG, et al : Diagnosis and management of dementia with Lewy bodies : Fourth consensus report of the DLB Consortium. Neurology 89 : 88-100, 2017.
PubMed
9) Zhang F, et al : Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases : An Update. Aging Dis 11 : 315-326, 2020.
PubMed
10) Kunz D, Mahlberg R : A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 19 : 591-596, 2010.
 
11) Esaki Y, et al : An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. J Clin Sleep Med 12 : 689-693, 2016.
PubMed
12) Matsui K, et al : Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder : A Retrospective Analysis of Consecutive Patients. J Clin Sleep Med 15 : 1173-1178, 2019.
PubMed
P.321 掲載の参考文献
1) McConviUe JF, et al, 坪井知正 (訳) : 第318章 換気障害. 過換気. ハリソン内科学 [第5版] (福井次矢, 黒川清監), p1768, メディカル・サイエンス・インターナショナル, 2017.
 
2) Bass C : Hyperventilation syndrome : achimera? J Psychosom Res 42 : 421-426, 1997.
PubMed
3) Jones M, et al : Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev (5) : CD009041, 2013. (DOI : 10.1002/14651858.CD009041.pub2)
 
4) Tavel ME : Hyperventilation Syndrome : Why Is It Regularly Overlooked? Am J Med 134 : 13-15, 2021.
PubMed
5) Gardner N : Orthostatic increase of respiratory gas exchange in hyperventilation syndrome. Thorax 55 : 257-259, 2000.
 
6) Gardner N : The pathophysiology of hyperventilation disorders. Chest 109 : 516-534, 1996.
 
7) 村松芳幸, 村松公美子 : 第16章 心身症 呼吸器系の心身症過換気症候群. 今日の精神疾患治療指針 (樋口輝彦, ほか編), p650-651, 医学書院, 2012.
 
8) Callaham M : Hypoxic hazards of traditional paper bag rebreathing in hyperventilating patients. Ann Emerg Med 18 : 622-628, 1989.
PubMed
9) 村松芳幸, 村松公美子 : 呼吸器疾患. 青春期精神医学 (清水將之監, 高宮静男, 渡邉直樹編), p151-158, 診断と治療社, 2010.
 
P.326 掲載の参考文献
1) American Academy of Sleep Medicine : International Classification of Sleep Disorders, 3rd ed (ICSD-3), American Academy of Sleep Medicine, Darien, 2014.
 
2) 難病情報センター : 肺胞低換気症候群 (指定難病 230). [https://www.nanbyou.or.jp/entry/316]
 
3) 厚生労働科学研究費補助金 難治性疾患政策研究事業 難治性呼吸器疾患・肺高血圧症に関する調査研究 肺胞低換気症候群. [http://irdph.jp/ahs/index.php] (2021年6月閲覧)
 
4) Severinghaus JW, Mitchell RA : Ondine's curse : Failure of respiratory center automaticity while awake. Clin Res 10 : 122, 1962.
 
5) Amiel J, et al : Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33 : 459-461, 2003.
PubMed
6) 栗山喬之 : 呼吸不全調査研究班総合研究報告. 厚生省特定疾患呼吸不全調査研究班, 平成10年度研究報告書, p1-16, 1999.
 
7) 飛田渉 : 肺胞低換気の原因と鑑別診断. 呼吸と循環 55 : 75-81, 2007.
 
8) 陶山時彦, ほか : 原発性肺胞低換気症候群 ; 換気の異常, 呼吸不全. 別冊日本臨牀領域別症候群シリーズ No. 4 呼吸器症候群 (下巻), p471-473, 日本臨牀社, 1994.
 
P.331 掲載の参考文献
1) 難病情報センター : 肺胞低換気症候群 (指定難病 230). [https://www.nanbyou.or.jp/entry/172] (2021年3月閲覧)
 
P.335 掲載の参考文献
1) 藤村正哲 : 新生児慢性肺疾患の定義と診断科学的根拠に基づいた新生児慢性肺疾患の診療指針 [改訂2版] (藤村正哲監, 田村正徳, 森臨太郎編), p1-7, メディカ出版, 2010.
 
2) Keller RL, Ballard RA : Bronchopulmonary Dysplasia. In : Avery's Diseases of the Newborn, 10th ed (ed by Gleason CA, Juul SE), p678-694, Elsevier, Philadelphia, 2018.
 
3) 難波文彦 : 病態-出生後因子とその対応 酸素障害. 周産期医学 44 : 1053-1057, 2014.
 
4) McCurnin D, et al : Ibuprofen-induced patent ductus arteriosus closure : physiologic, histologic, and biochemical effects on the premature lung. Pediatrics 121 : 945-956, 2008.
PubMed
5) Klingenberg C, et al : Volume-targeted versus pressure-limited ventilation in neonates. Cochrane Database Syst Rev (10) : CD003666, 2017. (DOI : 10.1002/14651858.CD003666.pub4)
 
6) Subramaniam P, et al : Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev (6) : CD001243, 2016. (DOI : 10.1002/14651858.CD001243.pub3)
 
7) Wilkinson D, et al : High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev (2) : CD006405, 2016. (DOI : 10.1002/14651858.CD006405.pub3)
 
8) Vento M, et al : Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 124 : e439-449, 2009.
PubMed
9) Cummings JJ, Polin RA ; Committee on Fetus and Newborn : Oxygen Targeting in Extremely Low Birth Weight Infants. Pediatrics 138 : e20161576, 2016.
PubMed
10) Watterberg KL ; American Academy of Pediatrics. Committee on Fetus and Newborn : Policy statement-postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics 126 : 800-808, 2010.
PubMed
11) Rademaker KJ, de Vries WB : Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart. Semin Fetal Neonatal Med 14 : 171-177, 2009.
PubMed
12) Shah VS, et al : Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database Syst Rev (1) : CD001969, 2017. (DOI : 10.1002/14651858.CD001969.pub4)
 
13) Mandell EW, et al : Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol 46 : 291-310, 2019.
PubMed
14) Darlow BA, et al : Vitamin A supplementation to prevent mortality and short-and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev (8) : CD000501, 2016. (DOI : 10.1002/14651858.CD000501.pub4)
 
15) Murthy K, et al : Predicting death or tracheostomy placement in infants with severe bronchopulmonary dysplasia. J Perinatol 34 : 543-548, 2014.
 
P.341 掲載の参考文献
1) Wilson MG, Mikity VG : A new form of respiratory disease in premature infants. AMA J Dis Child 99 : 489-499, 1960.
PubMed
2) Krauss AN, et al : Physiologic studies on infants with Wilson-Mikity syndrome. Ventilation-perfusion abnormalities and cardiac catheterization angiography. J Pediatr 77 : 27-36, 1970.
 
3) Hoepker A, et al : Wilson-Mikity syndrome : updated diagnostic criteria based on nine cases and a review of the literature. Pediatr Pulmonol 43 : 1004-1012, 2008.
 
4) Northway WH, et al : Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276 : 357-368, 1967.
 
5) 小川雄之亮, ほか : 1990年出生児における慢性肺疾患の疫学調査 (分担研究 : 慢性肺障害の管理と予防に関する研究). 平成3年度厚生省心身障害研究「新生児期・乳児期の生活管理のあり方に関する総合的研究」報告, p54-64, 1992.
 
6) Jobe AH, Bancalari E : Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 : 1723-1729, 2001.
PubMed
7) Hodgman JE : Relationship between Wilson-Mikity syndrome and the new bronchopulmonary dysplasia. Pediatrics 112 : 1414-1415, 2003.
PubMed
8) Fujimura M, et al : Chorioamnionitis and serum IgM in Wilson-Mikity syndrome. Arch Dis Child 64 : 1379-1383, 1989.
PubMed
9) Hirata K, et al : Perinatal factors associated with long-term respiratory sequelae in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 100 : F314-319, 2015.
PubMed
10) Fujimura M, et al : Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics 92 : 564-569, 1993.
PubMed
11) Cools F, et al : Elective high-frequency oscillatory versus conventional ventilation in preterm infants : a systematic review and meta-analysis of individual patients' data. Lancet 375 : 2082-2091, 2010.
PubMed
12) Zivanovic S, et al : Late outcomes of a randomized trial of high-frequency oscillation in neonates. N Engl J Med 370 : 1121-1130, 2014.
PubMed
13) Isayama T, et al : Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants : A Systematic Review and Meta-analysis. JAMA 316 : 611-624, 2016.
PubMed
14) Baud O, et al ; PREMILOC trial study group : Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC) : a double-blind, placebo-controlled, multicentre, randomised trial. Lancet 387 : 1827-1836, 2016.
 
15) Chang YS, et al : Mesenchymal stem cells for bronchopulmonary dysplasia : phase 1 dose-escalation clinical trial. J Pediatr 164 : 966-972. e6, 2014.
 
P.344 掲載の参考文献
1) Yadav S, et al : Neonatal Respiratory Distress Syndrome. In : StatPearls [Internet], StatPearls Publishing, Treasure Island ; 2021 Jan. [updated 2021 Jan 5]
 
2) Smith PB, et al : Approach to infants born at 22 to 24 weeks' gestation : relationship to outcomes of more-mature infants. Pediatrics 129 : e1508-1516, 2012.
PubMed
3) Kusuda S, et al : Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan. Pediatr Res 72 : 531-538, 2012.
PubMed
4) Gao Y, et al : Unique aspects of the developing lung circulation : structural development and regulation of vasomotor tone. Pulm Circ 6 : 407-425, 2016.
PubMed
5) Joshi S, Kotecha S : Lung growth and development. Early Hum Dev 83 : 789-794, 2007.
PubMed
6) 第11章 呼吸器系の基礎と臨床. 新生児学入門 [第5版] (仁志田博司, ほか編), p150-155, 医学書院2018.
 
7) Roberts D, et al : Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 : CD004454, 2017.
PubMed
8) Polin RA, Carlo WA : Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics 133 : 156-163, 2014.
PubMed
9) Sweet DG, et al : European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update. Neonatology 103 : 353-368, 2013.
PubMed
10) De Luca D, et al : Personalized Medicine for the Management of RDS in Preterm Neonates. Neonatology, 118 : 127-138, 2021.
PubMed
11) Bahadue FL, Soll R : Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 11 : CD001456, 2012.
PubMed
12) 長和俊 : 肺サーファクタント. 周産期医学 49 : 529-532, 2019.
Medical*Online
13) Stevens TP, et al : Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev (3) : CD003063, 2004.
 
14) Isayama T, et al : Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants : A Systematic Review and Meta-analysis. JAMA 316 : 611-624, 2016.
PubMed
15) Kribs A, et al : Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants : A Randomized Clinical Trial. JAMA Pediatr 169 : 723-730, 2015.
PubMed
P.350 掲載の参考文献
1) 乳幼児突然死症候群 (SIDS) の診断のためのガイドライン作成およびその予防と発症率軽減に関する研究 (主任研究者 : 坂上正道), 平成17年度厚生労働科学研究報告書, 2005.
 
2) 山中龍宏 : 乳幼児突然死症候群 (SIDS). 小児科 61 : 1312-1318, 2020.
 
3) 田中哲郎, ほか : 乳幼児突然死症候群の育児環境因子に関する研究-保健婦による聞き取り調査結果-. 日本公衆衛生雑誌 46 : 364-372, 1999.
 
4) Mitchell EA, et al : Geographic Variation in Sudden Unexpected Infant Death in the United States. J Pediatr 220 : 49-55. e2, 2020.
 
5) Piumelli R, et al : Apparent Life-Threatening Events (ALTE) : Italian guidelines. Ital J Pediatr 43 : 111, 2017.
PubMed
6) 小保内俊雅, ほか : 保育施設内で発生した死亡事案. 日本小児科学会雑誌 118 : 1628-1635, 2014.
 
7) Hunt CE, et al : Assigning cause for sudden unexpected infant death. Forensic Sci Med Pathol 11 : 283-288, 2015.
PubMed
8) Trachtenberg FL, et al : Risk factor changes for sudden infant death syndrome after initiation of Back-to-Sleep campaign. Pediatrics 129 : 630-638, 2012.
PubMed
9) 住友直方 : 遺伝性不整脈の進歩. 日本小児科学会雑誌 117 : 1079-1092, 2013.
 
10) 中山雅弘, ほか : 乳幼児突然死症候群 (SIDS) 診断の手引き 改訂第2版. 日本SIDS学会雑誌 6 : 73-97, 2006.
Medical*Online
11) Jensen LL, et al : Reclassification of SIDS cases-a need for adjustment of the San Diego classification? Int J Legal Med 126 : 271-277, 2012.
 
12) 厚生労働科学研究「乳幼児突然死症候群 (SIDS) および乳幼児突発性危急事態 (ALTE) の病態解明および予防法開発に向けた複数領域専門家による統合的研究」 (研究代表者 : 戸苅創) : 乳幼児突然死症候群 (SIDS) 診断ガイドライン (第2版). 日本SIDS・乳幼児突然死予防学会雑誌 12 : 41-45, 2012.
 
13) McGuone D, et al : Neuropathologic Changes in Sudden Unexplained Death in Childhood. J Neuropathol Exp Neurol 79 : 336-346, 2020.
PubMed
14) Sedmak G, et al : Infant deaths associated with human parechovirus infection in Wisconsin. Clin Infect Dis 50 : 357-361, 2010.
PubMed
15) Tieder JS, et al : Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants. Pediatrics 137 : e20160590, 2016.
PubMed
16) Tseng WC, et al : Cumulative postnatal risk of pediatric sudden death and all-cause mortality in nationwide birth cohorts of Taiwan and the United States. J Formos Med Assoc 119 : 1842-1853, 2020.
PubMed
P.355 掲載の参考文献
1) Fischer C, et al : A population-based study of meconium aspiration syndrome in neonates born between 37 and 43 weeks of gestation. Int J Pediatr 2012 : 321545, 2012.
 
2) Balchin I, et al : Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol 117 : 828-835, 2011.
PubMed
3) Whitfield JM, et al : Prevention of meconium aspiration syndrome : an update and the Baylor experience. Proc (Bayl Univ Med Cent) 22 : 128-131, 2009.
PubMed
4) Wiswell TE, Bent RC : Meconium staining and the meconium aspiration syndrome. Unresolved issues. Pediatr Clin North Am 40 : 955-981, 1993.
PubMed
5) Dargaville PA, et al : The epidemiology of meconium aspiration syndrome : incidence, risk factors, therapies, and outcome. Pediatrics 117 : 1712-1721, 2006.
PubMed
6) van Ierland Y, et al : Meconium-stained amniotic fluid : discharge vigorous newborns. Arch Dis Child Fetal Neonatal Ed 95 : F69-71, 2010.
PubMed
7) Dehan M, et al : Diagnosis of meconium aspiration by spectrophotometric analysis of urine. Arch Dis Child 53 : 74-76, 1978.
PubMed
8) 松尾雅文, ほか : Meconium aspiration syndrome (MAS) のUrinary meconium index (UMI) による診断法について. 小児科臨床 33 : 749-754, 1980.
Medical*Online
9) CQ407 羊水混濁時の対応は? 産婦人科診療ガイドライン-産科編 2020 (日本産科婦人科学会, 日本産婦人科医会編), p214-216, 日本産科婦人科学会事務局, 2020.
 
10) Lee KA, et al : The frequency of meconium-stained amniotic fluid increases as a function of the duration of labor. J Matern Fetal Neonatal Med 24 : 880-885, 2011.
PubMed
11) 日本版救急蘇生ガイドライン2020に基づく新生児蘇生法テキスト [第4版] (細野茂春監), メジカルビュー社, 2021.
 
12) Kinsella Jp, et al : Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131 : 55-62, 1997.
PubMed
13) Wiswell TE, et al : A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 109 : 1081-1087, 2002.
PubMed
14) Ward M, Sinn J : Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev 2003 (4) : CD003485, 2003. (DOI : 10.1002/14651858.CD003485)
 
15) Hahn S, et al : Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev (4) : CD003486, 2003. (DOI : 10.1002/14651858.CD003486.pub2)
 
16) El Shahed AI, et al : Surfactant for meconium aspiration syndrome in term and late preterm infants. Cochrane Database Syst Rev 2014 (12) : CD002054, 2014. (DOI : 10.1002/14651858.CD002054.pub3)
 
17) El Shahed AI, et al : Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev (3) : CD002054, 2007. (DOI : 10.1002/14651858.CD002054.pub2)
 
18) Beligere N, Rao R : Neurodevelopmental outcome of infants with meconium aspiration syndrome : report of a study and literature review. J perinatol 28 (Suppl 3) : S93-101, 2008.
 
19) Yuksel B, et al : Neonatal meconium aspiration syndrome and respiratory morbidity during infancy. Pediatr Pulmonol 16 : 358-361, 1993.
PubMed
20) Macfarlane PI, Heaf DP : Pulmonary function in children after neonatal meconium aspiration syndrome. Arch Dis Child 63 : 368-372, 1988.
PubMed

III 胸膜疾患

P.360 掲載の参考文献
1) Meigs JV, Cass JW : Fibroma of the Ovary with Ascites and Hydrothorax : With a Report of Seven Cases. Am J Obstet Gynecol 33 : 249-267, 1937,
 
2) Meigs JV : Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol 3 : 471-486, 1954.
PubMed
3) Krenke R, et al : Pleural Effusion in Meigs' Syndrome-Transudate or Exudate? : Systematic Review of the Literature. Medicine (Baltimore) 94 : e2114, 2015.
PubMed
4) Agranoff D, et al : Pleural effusion and a pelvic mass. Postgrad Med J 74 : 265-267, 1998.
 
5) Shiau CS, et al : Meigs' syndrome in a young woman with a normal serum CA-125 level. Chang ung Med J 28 : 587-591, 2005.
 
6) Abramov Y, et al : Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol 184 : 354-355, 2001.
PubMed
7) Meigs JV : Fibroma of the ovary with ascites and hydrothorax ; Meigs' syndrome. Am J Obstet Gynecol 67 : 962-985, 1954.
PubMed
8) 春田道男, ほか : Meigs症候群と子宮筋腫によるPseudo-Meigs症候群. 産婦人科の進歩 28 : 53-67, 1976.
Medical*Online
9) Benjapibal M, et al : Meigs' Syndrome with Elevated Serum CA125 : Case Report and Review of the Literature. Case Rep Oncol 2 : 61-66, 2009.
PubMed
10) Moran-Mendoza A, et al : Elevated CA125 level associated with Meigs' syndrome : case report and review of the literature. Int J Gynecol Cancer 16 (Suppl 1) : 315-318, 2006.
 
11) Meigs JV, et al : AFurther Contribution to the Syndrome of Fibroma of the Ovary with Fluid in the Abdomen and chest, Meigs' Syndrome. Am J Obstet Gynecol 46 : 19-37, 1943.
 
12) Riker D, Goba D : Ovarian mass, pleural effusion, and ascites : revisiting Meigs syndrome. J Bronchology Interv Pulmonol 20 : 48-51, 2013.
PubMed
P.364 掲載の参考文献
1) 千野修ほか : 特発性食道破裂の治療方針と胸腔ドレナージ法に関する臨床的検討. 日本腹部救急医学会雑誌 24 : 717-725, 2004.
 
2) Brinster CJ, et al : Evolving options in the management of esophageal perforation. Ann Thorac Surg 77 : 1475-1483, 2004.
PubMed
3) Joseph J, et al : A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis. Chest 102 : 1455-1459, 1992.
 
4) Korn O, et al : Anatomy of the Boerhaave syndrome. Surgery 141 : 222-228, 2007.
PubMed
5) Cameron JL, et al : Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg 27 : 404-40&1979.
 
6) 千野修, ほか : 特発性食道破裂の診断と治療. 成人病と生活習慣病 47 : 1483-1488, 2017.
Medical*Online
7) 西出憲史, ほか : 胃ESDにおける偶発症 (穿孔, 出血, 狭窄) の特徴とその対処法. 消化器内視鏡 22 : 1555-1560, 2010.
Medical*Online
8) Ikeda Y, et al : Thoracoscopic repair of a spontaneous perforation of the esophagus with the endoscopic suturing device. J Thorac Cardiovasc Surg 121 : 178-179, 2001.
 
9) Lazar G, et al : A successful strategy for surgical treatment of Boerhaave's syndrome. Surg Endosc 25 : 3613-3619, 2011.
 
10) Nesbitt JC, et al : Surgical management of esophageal perforation. Am Surg 53 : 183-191, 1987.
PubMed
11) Biancari F, et al : Current treatment and outcome of esophageal perforations in adults : systematic review and meta-analysis of 75 studies. World J Surg 37 : 1051-1059, 2013.
PubMed
12) Markar SR, et al : Management and Outcomes of Esophageal Perforation : A National Study of 2,564 Patients in England. Am J Gastroenterol 110 : 1559-1566, 2015.
 
P.367 掲載の参考文献
1) Oba Y, Abu-Salah T : The prevalence and diagnostic significance of eosinophilic pleural effusions : a meta-analysis and systematic review. Respiration 83 : 198-208, 2012.
PubMed
2) Adelman M, et al : Diagnostic utility of pleural fluid eosinophilia. Am J Med 77 : 915-920, 1984.
PubMed
3) Chu FY, et al : Eosinophilia in Pleural Effusions : a Speculative Negative Predictor for Malignancy. Asian Pac J Cancer Prev 17 : 1411-1414, 2016.
PubMed
4) Krenke R, et al : Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J 34 : 1111-1117, 2009,
PubMed
5) Maltais F, et al : Blood hypereosinophilia in the course of posttraumatic pleural effusion. Chest 98 : 348-351, 1990.
PubMed
6) Romero Candeira S, et al : Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism. Chest 121 : 465-469, 2002.
PubMed
7) Erzurum SC, et al : Pleural effusion in Churg-Strauss syndrome. Chest 95 : 1357-1359, 1989.
PubMed
8) 水島豊, ほか : 特発性好酸球性胸水の1例-本邦報告例5例と自験例からみた臨床像-. 気管支学15 : 475-481, 1993.
 
9) Porcel JM, Light RW : Diagnostic approach to pleural effusion in adults. Am Fam Physician 73 : 1211-1220, 2006.
PubMed
P.372 掲載の参考文献
1) Light RW : Anatomy of the Pleura. In : Pleural Diseases, 6th ed (ed by Light RW), p1-7, Lippincott Williams & Wilkins, Philadelphia, 2013.
 
2) 正岡昭, ほか : 胸膜の構造. 呼吸器外科学 [第3版] (正岡昭監, 藤井義敬編), p342, 南山堂, 2003.
 
3) Noppen M, et al : Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 162 : 1023-1026, 2000.
PubMed
4) Light RW : Physiology of the pleural space. In : Pleural Diseases, 6th ed (ed by Light RW), p8-18, Lippincott Williams & Wilkins, Philadelphia, 2013.
 
5) Light RW, et al : Pleural effusions : the diagnostic separation of transudates and exudates. Ann Intern Med 77 : 507-513, 1972.
PubMed
6) 木村吉成, 小林紘一 : 術後胸水貯留. 臨床外科 62 : 353-359, 2007.
 
7) Light RW : Clinical Manifestations and Useful Tests. In : Pleural Diseases, 6th ed (ed by Light RW), p86-127, Lippincott Williams & Wilkins, Philadelphia, 2013.
 
8) Colins JD, et al : Minimal detectable pleural effusions. A roentgen pathology model. Radiology 105 : 51-53, 1972.
PubMed
9) Light RW : Radiographic Examination. In : Pleural Diseases, 6th ed (ed by Light RW), p64-85, Lippincott Williams & Wilkins, Philadelphia, 2013.
 
10) Emamian SA, et al : Accuracy of the diagnosis of pleural effusion on supine chest X-ray. Eur Radiol 7 : 57-60, 1997.
PubMed
11) Ibitoye BO, et al : Ultrasonographic quantification of pleural effusion : comparison of four formulae. Ultrasonography 37 : 254-260, 2018.
PubMed
12) Misthos P, et al : Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg 28 : 599-603, 2005.
PubMed
13) 上林孝豊, 鈴木卓 : フィブリン製剤に起因すると思われた好酸球性胸水貯留. 胸部外科 65 : 141-144, 2012.
 
14) Light RW : Approach to the Patient. In : Pleural Diseases, 6th ed (ed by Light RW), p128-139, Lippincott Williams & Wilkins, Philadelphia, 2013.
 
15) Feller-Kopman D, et al : Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Ann Thorac Surg 84 : 1656-1661, 2007.
PubMed
P.376 掲載の参考文献
1) Cohen M, Sahn SA : Resolution of pleural effusions. Chest 119 : 1547-1562, 2001.
PubMed
2) Miller WT Jr, et al : CT of viral lower respiratory tract infections in adults : comparison among viral organisms and between viral and bacterial infections. AJR Am J Roentgenol 197 : 1088-1095, 2011.
PubMed
3) Krenke K, et al : Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Respir Med 116 : 28-33, 2016.
PubMed
4) Telles JN, et al : Viral and bacterial pathogens identification in children hospitalised for severe pneumonia and parapneumonic empyema. Pneumonia (Nathan) 1 : 11-19, 2012.
PubMed
5) Kim MC, et al : CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus. Medicine (Baltimore) 95 : e4003, 2016.
PubMed
6) Koo HJ, et al : Clinical and Radiologic Characteristics of Human Metapneumovirus Infections in Adults, South Korea. Emerg Infect Dis 25 : 15-24, 2019.
PubMed
7) Shen CF, et al : Clinical features of community acquired adenovirus pneumonia during the 2011 community outbreak in Southern Taiwan : role of host immune response. BMC Infect Dis 17 : 196, 2017.
PubMed
8) Tan D, et al : Severe Community-Acquired Pneumonia Caused by Human Adenovirus in Immunocompetent Adults : A Multicenter Case Series. PLoS One 11 : e0151199, 2016.
PubMed
9) Zhao W, et al : Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia : A Multicenter Study. AJR Am J Roentgenol 214 : 1072-1077, 2020.
PubMed
10) Devie A, et al : COVID-19 : A qualitative chest CT model to identify severe form of the disease. Diagn Interv Imaging 102 : 77-84, 2021.
PubMed
11) Zhan N, et al : Clinical characteristics of COVID-19 complicated with pleural effusion. BMC Infect Dis 21 : 176, 2021.
PubMed
12) Kuang PD, et al : Comparison of the clinical and CT features between COVID-19 and H1N1 influenza pneumonia patients in Zhejiang, China. Eur Rev Med Pharmacol Sci 25 : 1135-1145, 2021.
PubMed
13) Bennett D, et al : SARS-CoV-2 in pleural fluid in a kidney transplant patient. Postgrad Med 133 : 540-543, 2021.
 
14) Malik MI, et al : Positive pleural fiuid RT-PCR for virus detection in SARS-CoV-2 pneumonia. QJM 113 : 888-889, 2020.
 
15) Huang WT, et al : Epidemic pleurodynia caused by coxsackievirus B3 at a medical center in northern Taiwan. J Microbiol Immunol Infect 43 : 515-518, 2010.
 
P.379 掲載の参考文献
1) Garcia-Zamalloa A, et al : Pseudochylothorax. Report of 2 cases and review of the literature. Medicine (Baltimore) 78 : 200-207, 1999.
PubMed
2) Lama A, et al : Characteristics of patients with pseudochylothorax-a systematic review. J Thorac Dis 8 : 2093-2101, 2016.
PubMed
3) Thewjitcharoen Y, Poopitaya S : Paragonimiasis presenting with unilateral pseudochylothorax : case report and literature review. Scand J Infect Dis 38 : 386-388, 2006.
PubMed
4) Inoue Y, et al : Paragonimiasis miyazakii associated with bilateral pseudochylothorax. Intern Med 39 : 579-582, 2000.
PubMed
5) Huggins JT : Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31 : 743-750, 2010.
PubMed
6) Hamm H, et al : Lipoprotein analysis in a chyliform pleural effusion : implications for pathogenesis and diagnosis. Respiration 58 : 294-300, 1991.
 
7) Hibino M, et al : Cholesterol crystals in pleural effusion. Intern Med 52 : 2685, 2013.
PubMed
8) Heffner JE : Clinical presentation, diagnosis, and management of cholesterol pleural effusions. In : UpToDate, Post TW (Ed), UpToDate, Waltham, MA. [https://www.uptodate.com/contents/clinical-presentation-diagnosis-and-management-of-cholesterol-pleural-effusions] (2021年4月閲覧)
 
P.382 掲載の参考文献
1) Roberts ME, et al ; BTS Pleural Disease Guideline Group : Management of a malignant pleural effusion : British Thoracic Society pleural disease guideline 2010. Thorax 65 (Suppl 2) : ii32-40, 2010.
 
2) Sugiura S, et al : Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 3 : 47-50, 1997.
PubMed
3) Light RW : Clinical practice. Pleural effusion. N Engl J Med 346 : 1971-1977, 2002.
PubMed
4) 石井芳樹, ほか : 局所麻酔下胸腔鏡所見記載方法の標準化. 気管支学 41 : 337-349, 2019.
Medical*Online
5) Livingston RB, et al : Isolated pleural effusion in small cell lung carcinoma : favorable prognosis. A review of the Southwest Oncology Group experience. Chest 81 : 208-211, 1982.
 
6) Jones SE, et al : Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer 36 : 90-97, 1975.
PubMed
7) Herrstedt J, et al : Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer. Eur J Cancer 28A : 1070-1073, 1992.
PubMed
8) Little AG, et al : Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg 208 : 443-450, 1988.
PubMed
9) Walker-Renard PB, et al : Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120 : 56-64, 1994.
PubMed
10) Austin EH, Flye MW : The treatment of recurrent malignant pleural effusion. Ann Thorac Surg 28 : 190-203, 1979.
PubMed
11) Izbicki R, et al : Pleural effusion in cancer patients. A prospective randomized study of pleural drainage with the addition of radioactive phosphorous to the pleural space vs. pleural drainage alone. Cancer 36 : 1511-1518, 1975.
 
12) Luh KT, et al : Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 69 : 674-679, 1992.
PubMed
13) Saka H, et al : Interim analysis of randomized trial of OK-432 vs. bleomycin in malignant pleural effusion : a Nagoya Oncology Group Study. Proc ASCO 11 : 389, 1992.
 
14) Ruckdeschel JC, et al : Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest 100 : 1528-1535, 1991. [published erratum appears in Chest 103 : 1640, 1993]
 
15) Maiche AG, et al : Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. Acomparative study. Am J Clin Oncol 16 : 50-53, 1993.
 
16) Yoshida K, et al : Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer : JCOG 9515. Lung Cancer 58 : 362-368, 2007.
PubMed
17) Shaw P, Agarwal R : Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (1) : CD002916, 2004. [DOI : 10.1002/14651858.CD002916.pub2]
 
18) Saka H, et al : Sterilized talc pleurodesis for malignant pleural effusions : a Phase II study for investigational new drug application in Japan. Jpn J Clin Oncol 48 : 376-381, 2018.
PubMed
19) Dresler CM, et al : Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127 : 909-915, 2005.
PubMed
20) Davies HE, et al : Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion : the TIME2 randomized controlled trial. JAMA 307 : 2383-2389, 2012.
PubMed
P.388 掲載の参考文献
1) 石井芳樹 : 局所麻酔下胸腔鏡検査-手技の実際 (気管支鏡セミナーより). 気管支学 24 : 557-563, 2002.
 
2) 結核の統計 2020 (公益財団法人結核予防会編).
 
3) 千葉保之, 所沢政雄 : 結核初感染の臨床的研究, p41-45, 保健同人社, 1948.
 
4) 長山直弘 : 胸膜炎, 膿胸の治療. 結核Up to Date : 結核症+非定型抗酸菌症+肺アスペルギルス症 (毛利昌史, ほか編), p136, 南江堂, 1999.
 
5) Stead WW, et al : Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Tuberc 71 : 473-502, 1955.
PubMed
6) Paterson RC : The pleural reaction to inoculation with tubercle bacilli in vaccinated and normal guinea pigs. Am Rev Tuberc 1 : 353-371, 1917.
 
7) Valdes L, et al : Tuberculous pleurisy : a study of 254 patients. Arch Intern Med 158 : 2017-2021, 1998.
PubMed
8) Berger HW, Mejra E : Tuberculous pleurisy. Chest 63 : 88-92, 1973.
 
9) Gopi A, et al : Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 131 : 880-889, 2007.
PubMed
10) 泉孝英, 網谷良一 : 結核 [第3版], p200-205, 医学書院, 1998.
 
11) Shah S, et al : Rapid diagnosis of tuberculosis in various biopsy and body fluid specimens by the AMPLICOR Mycobacterium tuberculosis polymerase chain reaction test. Chest 113 : 1190-1194, 1998.
PubMed
12) Kuwano K, et al : Evaluation of nested polymerase chain reaction for detecting mycobacterial DNA in pleural fluid. Kansenshogaku Zasshi 69 : 175-180, 1995.
PubMed
13) Levine H, et al : Diagnosis of tuberculous pleurisy by culture of pleural biopsy specimen. Arch Intern Med 126 : 269-271, 1970.
PubMed
14) Burgess LJ, et al : Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest 109 : 414-419, 1996.
PubMed
15) Ariga H, et al : Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells. Clin Infect Dis 45 : 1559-1567, 2007.
PubMed
16) Jiang J, et al : Diagnostic value of interferon-gamma in tuberculous pleurisy : a meta-analysis. Chest 131 : 1133-1141, 2007.
PubMed
17) 沢村献児, ほか : 最近の慢性膿胸765例の治療成績 ; 国療膿胸研究班の集計 (その2) -治療前のrisk score別にみた各治療法の成績-. 日本胸部臨床 41 : 507-514, 1982.
 
18) V 結核の治療. 結核診療ガイドライン (日本結核病学会編), p71-87, 南江堂, 2009.
 
19) Lai YF, et al : Pigtail drainage in the treatment of tuberculous pleural effusions : a randomised study. Thorax 58 : 149-151, 2003.
PubMed
20) Lee CH, et al : Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 94 : 1256-1259, 1988.
PubMed
21) Wyser C, et al : Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 110 : 333-338, 1996.
PubMed
P.393 掲載の参考文献
1) Cagle PT, Allen TC : Pathology of the pleura : what the pulmonologists need to know. Respirology 16 : 430-438, 2011.
PubMed
2) Huggins JT, Sahn SA : Causes and management of pleural fibrosis. Respirology 9 : 441-447, 2004.
PubMed
3) Fujimoto N, et al : Clinical Investigation of Benign Asbestos Pleural Effusion. Pulm Med 2015 : 416179, 2015.
PubMed
4) Huggins JT, Sahn SA : Drug-induced pleural disease. Clin Chest Med 25 : 141-153, 2004.
 
5) Epler GR, et al : Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 247 : 617-622, 1982.
 
6) Idell S : Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31 : S213-220, 2003.
PubMed
7) Sasse SA, et al : Pleural fluid transforming growth factor-betal correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 168 : 700-705, 2003.
 
8) Nishimura SL, Broaddus VC : Asbestos-induced pleural disease. Clin Chest Med 19 : 311-329, 1998.
 
9) Light RW : Clinical practice. Pleural effusion. N Engl J Med 346 : 1971-1977, 2002.
PubMed
10) Heffner JE, et al : Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 111 : 970-980, 1997.
 
11) Fujimoto N, et al : Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma. Respir Investig 51 : 92-97, 2013.
PubMed
12) Janssen J, et al : What is the significance of non-specific pleuritis? A trick question. Clin Respir J 12 : 2407-2410, 2018.
PubMed
13) Jimenez Castro D, et al : Pleural fluid parameters identifying complicated parapneumonic effusions. Respiration 72 : 357-364, 2005.
PubMed
14) Miller A, et al : Ventilatory failure due to asbestos pleurisy. Am J Med 75 : 911-919, 1983.
PubMed
15) Metintas M, et al : Outcome of patients diagnosed with fibrinous pleuritis after medical thoracoscopy. Respir Med 106 : 1177-1183, 2012.
PubMed
P.397 掲載の参考文献
1) 薬剤性肺障害の診断・治療の手引き [第2版] 2018 (日本呼吸器学会薬剤性肺障害の診断・治療の手引き第2版作成委員会編), p1-11, p52-66, メディカルレビュー社, 2018.
 
2) Huggins JT, et al : Drug-induced pleural disease. Clin Chest Med 25 : 141-153, 2004.
 
3) 大河内康実 : 胸膜炎, 胸水貯留. 日本臨牀 77 (増刊 : 医薬品副作用学 (第3版) 下) : 243-248, 2019.
 
4) 独立行政法人医薬品医療機器総合機構 [https://www.pmda.go.jp/index.html] (2021年2月閲覧)
 
5) Arnaud L, et al : Drug-induced systemic lupus : revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database. Ann Rheum Dis 78 : 504-508, 2019.
PubMed
6) Vaglio A, et al : Drug-induced lupus : Traditional and new concepts. Autoimmun Rev 17 : 912-918, 2018.
PubMed
7) Alagha K, et al : Iatrogenic eosinophilic pleural effusion. Eur Respir Rev 20 : 118-120, 2011.
PubMed
8) McElvaney NG, et al : Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. Arch Intern Med 148 : 2231-2236, 1988.
PubMed
9) De Bandt M, et al : Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy : a French national survey. Arthritis Res Ther 7 : R545-551, 2005.
PubMed
10) Keane J, et al : Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 : 1098-1104, 2001.
PubMed
11) Malik SW, et al : Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 154 : 1851-1856, 1996.
PubMed
12) Beynat-Mouterde C, et al : Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J 44 : 523-527, 2014.
PubMed
13) Quintas-Cardama A, et al : Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. J Clin Oncol 25 : 3908-3914, 2007.
PubMed
14) がん免疫療法ガイドライン [第2版] (日本臨床腫瘍学会編), p28-31, 金原出版, 2019.
 
P.401 掲載の参考文献
1) MacDuff A, et al : Management of spontaneous pneumothorax : British Thoracic Society Pleural Disease Guideline 2010. Thorax 65 (Suppl 2) : ii18-31, 2010.
 
2) Henry M, et al : BTS guidelines for the management of spontaneous pneumothorax. Thorax 58 (Suppl 2) : ii39-52, 2003.
 
3) Tsuboshima K, et al : The clinical characteristics and surgical results of smoking-related young pneumothorax. Gen Thorac Cardiovasc Surg 67 : 1070-1074, 2019.
PubMed
4) Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, et al : Thoracic and cardiovascular surgeries in Japan during 2017 : Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 68 : 414-449, 2020.
PubMed
5) Kurihara M, et al : Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg 58 : 113-119, 2010.
PubMed
6) Baumann MH, et al : Management of spontaneous pneumothorax : an American College of Chest Physicians Delphi consensus statement. Chest 119 : 590-602, 2001.
PubMed
7) TschoPP JM, et al : ERS task force statement : diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J 46 : 321-335, 2015.
PubMed
8) Tsuboshima K, et al : Is conventional management of primary spontaneous pneumothorax appropriate? Gen Thorac Cardiovasc Surg 69 : 716-721, 2021.
PubMed
9) Son BS, et al : Small Single-Incision Thoracoscopic Surgery Using an Anchoring Suture in Patients With Primary Spontaneous Pneumothorax : A Safe and Feasible Procedure. Ann Thorac Surg 100 : 1224-1229, 2015.
PubMed
10) Hirai K, et al : Covering the staple line with a polyglycolic acid sheet after bullectomy for primary spontaneous pneumothorax prevents postoperative recurrent pneumothorax. J Thorac Dis 7 : 1978-1985, 2015.
PubMed
11) Yamanaka S, et al : A novel dual-covering method in video-assisted thoracic surgery for pediatric primary spontaneous pneumothorax. Surg Today 49 : 587-592, 2019.
 
12) Tsuboshima K, et al : Natural history of bulla neogenesis for primary spontaneous pneumothorax : a propensity score analysis. Gen Thorac Cardiovasc Surg 67 : 464-469, 2019.
PubMed
13) Hwong TM, et al : Video-assisted thoracic surgery for primary spontaneous hemopneumothorax. Eur J Cardiothorac Surg 26 : 893-896, 2004.
PubMed
P.405 掲載の参考文献
1) Maurer ER, et al : Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm. JAMA 168 : 2013-2014, 1958.
 
2) Lillington GA, et al : Catamenial pneumothorax. JAMA 219 : 1328-1332, 1972.
PubMed
3) Joseph J, et al : Thoracic endometriosis syndrome : new observations from an analysis of 110 cases. Am J Med 100 : 164-170, 1996,
PubMed
4) Johnson MM : Catamenial pneumothorax and other thoracic manifestations of endometriosis. Clin Chest Med 25 : 311-319, 2004.
PubMed
5) Alifano M, et al : Endometriosis-related pneumothorax : clinicopathologic observations from a newly diagnosed case. J Thorac Cardiovasc Surg 127 : 1219-1221, 2004.
 
6) 胸腔子宮内膜症. 稀少部位子宮内膜症診療ガイドライン (「難治性稀少部位子宮内膜症の集学的治療のための分類・診断・治療ガイドライン作成」研究班編), p15-17, 診断と治療社, 2018.
 
7) Meyers MA, : Distribution of intra-abdominal malignant seeding : dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119 : 198-206, 1973.
PubMed
8) Fukuoka M, et al : Clinical characteristics of catamenial and non-catamenial thoracic endometriosis-related pneumothorax. Respirology 20 : 1272-1276, 2015.
PubMed
9) 栗原正利 : 肺病態から見た気胸 女性気胸・日本気胸・嚢胞性肺疾患学会雑誌 20 : 23-30, 2020.
 
10) 栗原正利 : 稀少部位子宮内膜症-月経随伴性気胸. 産婦人科の実際 64 : 925-931, 2015.
 
11) Berlanda N, et al : Ureteral and vesical endometriosis. Two different clinical entities sharing the same pathogenesis. Obstet Gynecol Surv 64 : 830-842, 2009.
PubMed
12) Haga T, et al : Clinical-pathological findings of catamenial pneumothorax : comparison between recurrent cases and non-recurrent cases. Ann Thorac Cardiovasc Surg 20 : 202-206, 2014.
PubMed
13) 栗原正利 : 横隔膜疾患に対する胸腔鏡下横隔膜切除術. 手術 50 : 2149-2156, 1996.
 
P.408 掲載の参考文献
1) NC, et al : Management of nontuberculous empyema. A statement of the subcommittee on surgery. Am Rev Respir Dis 85 : 935-936, 1962.
 
2) Light RW : Parapneumonic effusions and empyema. Clin Chest Med 6 : 55-62, 1985.
PubMed
3) 松岡隆久, ほか : 市中発生の急性膿胸に対する胸腔鏡下膿胸掻爬術100例の検討. 日本呼吸器外科学会雑誌 29 : 572-575, 2015.
 
4) 肺癌登録合同委員会 : 2004年肺癌外科切除例の全国集計に関する報告. 日本呼吸器外科学会雑誌 25 : 107-123, 2011.
 
5) Kanno R, et al : Endoscopic closure of bronchopleural fistula after pneumonectomy by submucosal injection of polidocanol. Jpn J Thorac Cardiovasc Surg 50 : 30-33, 2002.
PubMed
6) 渡辺洋一 : 気管支充填術. 気管支学 27 : 475-478, 2005.
Medical*Online
P.411 掲載の参考文献
1) 日本結核病学会治療委員会 : 結核性膿胸の取扱いに関する見解. 結核 50 : 215-219, 1975.
 
2) Iseman MD, Madsen LA : Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance. Chest 100 : 124-127, 1991.
PubMed
3) Elliott AM, et al : Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tuber Lung Dis 76 : 463-467, 1995.
PubMed
4) Shiraishi Y : Surgical treatment of chronic empyema. Gen Thorac Cardiovasc Surg 58 : 311-316, 2010.
PubMed
5) Thurer RJ : Decortication in thoracic empyema. Indications and surgical technique. Chest Surg Clin N Am 6 : 461-490, 1996.
PubMed
6) Shiraishi Y, et al : Morbidity and mortality after 94 extrapleural pneumonectomies for empyema Ann Thorac Surg 70 : 1202-1206 ; discussion 1206-1207, 2000.
 
7) 白石裕治 : まい・てくにっく : 慢性膿胸の開窓法. 胸部外科 59 : 25, 2006.
 
8) 葛城直哉, ほか : 慢性有瘻性結核性膿胸に対する開窓術. 胸部外科 58 : 175-183, 2005.
 
9) Shen KR, et al : The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg 153 : e129-e146, 2017.
 
10) 北野司久, ほか : 有瘻性慢性膿胸に対する有茎性大網充填術の臨床的意義. 日本胸部外科学会雑誌 36 : 1255-1263, 1988.
Medical*Online
11) Horrigan TP, Snow NJ : Thoracoplasty : current application to the infected pleural space. Ann Thorac Surg 50 : 695-699, 1990.
 
12) Scarci M, et al : EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg 48 : 642-653, 2015.
PubMed
13) Palmen M, et al : Open window thoracostomy treatment of empyema is accelerated by vacuum-assisted closure. Ann Thorac Surg 88 : 1131-1136, 2009.
PubMed
14) Iwasaki M, et al : Negativepressure wound therapy in combination with bronchial occlusion to treat bronchopleural fistula : a case report. Surg Case Rep 7 : 61, 2021.
PubMed
15) Nishii K, et al : Management of thoracic empyema with broncho-pulmonary fistula in combination with negative-pressure wound therapy. Gen Thorac Cardiovasc Surg 69 : 843-849, 2021.
PubMed
P.416 掲載の参考文献
1) 三笠桂一, ほか : JAID/JSC感染症治療ガイドライン-呼吸器感染症-. 日本化学療法学会雑誌 62 : 1-109, 2014.
 
2) 對馬敬夫, ほか : 無菌性膿胸 : 胸膜疾患. 別冊日本臨牀新領域別症候群シリーズ No. 10 呼吸器症候群 (第2版) III, p363-365, 日本臨牀社, 2009.
 
3) 林真一郎 : 膿胸 ; 胸膜疾患. 別冊日本臨牀新領域別症候群シリーズ No. 10 呼吸器症候群 (第2版) III, p355-359, 日本臨牀社, 2009.
 
4) 門屋講太郎, ほか : 肺膿瘍・膿胸7例における歯周病細菌PCR検査の臨床的意義の検討. 日本呼吸器学会誌 2 : 79-84, 2013.
Medical*Online
5) Davies HE, et al : Management of pleural infection in adults : British Thoracic Society Pleural Disease Guideline 2010. Thorax 65 (Suppl 2) : ii41-53, 2010.
 
6) 比嘉太 : 膿胸 [私の治療]. 日本医事新報 4986 : 51, 2019.
 
7) 久志本成樹 : プロカルシトニンは何をし, その上昇の意味するものは? 日本集中治療医学会雑誌 18 : 330-333, 2011.
 
8) Smolikov A, et al : Prevalence and clinical significance of pleural microbubbles in computed tomography of thoracic empyema. Clin Radiol 61 : 513-519, 2006.
PubMed
9) Kraus GJ : The split pleura sign. Radiology 243 : 297-298, 2007.
PubMed
10) 古泉貴久, ほか : 急性膿胸・肺炎随伴性胸水に対する線維素溶解療法の有効性. 日本呼吸器外科学会雑誌 33 : 107-112, 2019.
 
11) 持永浩史, ほか : 急性膿胸に対する治療方針に関する検討. 日本呼吸器外科学会雑誌 25 : 134-139, 2011.
 
P.420 掲載の参考文献
1) Grijalva CG, et al : Emergence of parapneumonic empyema in the USA. Thorax 66 : 663-668, 2011.
PubMed
2) Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, et al : Thoracic and cardiovascular surgeries in Japan during 2018 : Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 69 : 179-212, 2021.
PubMed
3) Reichert M, et al : Stage-directed therapy of pleural empyema. Langenbecks Arch Surg 402 : 15-26. 2017.
PubMed
4) Andrews NC, et al : Management of nontuberculous empyema. A statement of the subcommittee on surgery. Am Rev Respir Dis 85 : 935-936, 1962.
 
5) Molnar TF : Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg 32 : 422-430, 2007.
PubMed
6) 岡林寛, ほか : 急性および慢性膿胸の外科治療. 呼吸 29 : 28-32, 2010.
Medical*Online
7) Shiraishi Y : Surgical treatment of chronic empyema. Gen Thorac Cardiovasc Surg 58 : 311-316, 2010.
PubMed
8) Shen KR, et al : The American Association for Thoracic Surgery consensus guidelines for the managernent of empyema. J Thorac Cardiovasc Surg 153 : e129-e146, 2017.
 
9) Watanabe Y, et al : Bronchial occlusion with endobronchial Watanabe spigot. J Bronchol 10 : 264-267, 2003.
 
10) 浅野久敏, ほか : Endobronchial Watanabe Spigot (EWS) により外科治療を回避できた有瘻性膿胸の2症例. 気管支学 43 : 56-59, 2021.
Medical*Online
11) 村西佑介, 上島康生 : 保存的治療中に有瘻性膿胸となり開窓術とEWSによる気管支充填術が有用であった1例. 日本呼吸器学会雑誌 49 : 917-921, 2011.
Medical*Online
12) 大塚綱志, ほか : 膿胸に対する開窓術施行例における気管支充填術・持続陰圧吸引療法およびその併用療法の有用性に関する初期検討. 日本呼吸器外科学会雑誌 32 : 668-673, 2018.
 
13) 梶浦耕一郎, ほか : 人工呼吸器管理中の慢性有瘻性膿胸に対してEWSを用いた気管支充填術を施行した1例. 気管支学 37 : 409-413, 2015.
Medical*Online
14) Rahman NM, et al : A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest 145 : 848-855, 2014.
 
15) Yamazaki A, et al : Polymicrobial etiology as a prognostic factor for empyema in addition to the renal, age, purulence, infection source, and dietary factors score. Respir Investig 57 : 574-581, 2019.
 
P.425 掲載の参考文献
1) Shiobara J : A case of primary pulmonary reticulosarcoma associated with perforated tubeculous empyema. Nihon Kyobu Geka Gakkai Zasshi 29 : 115, 1970.
 
2) Iuchi K, et al : Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 60 : 1771-1775, 1987.
PubMed
3) Fukayama M, et al : Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 143 : 1044-1049, 1993.
PubMed
4) Nakatsuka S, et al : Pyothorax-associated lymphoma : a review of 106 cases. J Clin Oncol 20 : 4255-4260, 2002.
 
5) Narimatsu H, et al : Clinicopathological features of pyothorax-associated lymphoma ; a retrospective survey involving 98 patients. Ann Oncol 18 : 122-128, 2007.
PubMed
6) Aozasa K, et al : Prognostic factors for pleural lymphoma patients. Jpn J Clin Oncol 21 : 417-421, 1991.
PubMed
7) Fukayama M, et al : Pyothorax-associated lymphoma : development of Epstein-Barr virus-associated lymphoma within the inflammatory cavity. Pathol Int 45 : 825-831, 1995.
PubMed
8) Kashiwabara K, et al : [Increased neuron-specific enolase levels in patients with long-standing pyothorax-associated lymphoma]. Nihon Kokyuki Gakkai Zasshi 37 : 846-850, 1999.
PubMed
9) Nakatsuka S, et al : Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL). Jpn J Cancer Res 93 : 411-416, 2002.
PubMed
10) Iuchi K, et al : Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol 19 : 249-257, 1989.
 
11) Petitjean B, et al : Pyothorax-associated lymphoma : a pecuiiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 26 : 724-732, 2002.
 
12) Tomita S, et al : B-cell marker negative (CD7+, CD19-) Epstein-Barr virus-related pyothorax-associated lymphoma with rearrangement in the JH gene. Leuk Lymphoma 44 : 727-730, 2003.
PubMed
13) Hongyo T, et al : Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma. Cancer Res 58 : 1105-1107, 1998.
PubMed
14) Ascani S, et al : Pyothorax-associated lymphoma : description of the first two cases detected in Italy. Ann Oncol 8 : 1133-1138, 1997.
PubMed
P.431 掲載の参考文献
1) Patrini D, et al : Etiology and management of spontaneous haemothorax. J Thorac Dis 7 : 520-526, 2015.
PubMed
2) 向山憲男, ほか : 救急車で搬送中にショックを呈した特発性血胸の1例. 胸部外科 57 : 583-585, 2004.
 
3) 第5章 胸部外傷. 外傷初期診療ガイドライン-JATEC [改訂第5版] (日本外傷学会外傷初期診療ガイドライン改訂第5版編集委員会編), p75-90, へるす出版, 2016.
 
4) Hakuba T, et al : Surgical management and treatment of a traumatic right atrial rupture. Gen Thorac Cardiovasc Surg 56 : 551-554, 2008.
PubMed
5) 坂田省三, ほか : 特発性血気胸に対する緊急手術例の検討. 日本呼吸器外科学会雑誌 34 : 200-204, 2020.
 
6) 関村敦, 浦本秀隆 : 外傷後の遅発性血胸の1例. 日本臨床外科学会雑誌 79 : 2235-2239, 2018.
 
7) 永川寛徳, ほか : 血栓溶解剤の胸腔内投与が奏功した外傷後の遺残血胸の1例. 日本救急医学会雑誌 26 : 576-580, 2015.
 
8) 関村敦, ほか : 外傷性緊張性血胸 : 自験例と本邦における報告例. 日本呼吸器外科学会雑誌 32 : 469-474, 2018.
 
9) Light RW : Chapter 25 Hemothorax. In : Pleural Diseases, 6th ed, p405-411, Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, 2013.
 
10) 関村敦, ほか : 経皮的肺超音波断層画像を利用した癒着を伴う気胸への胸腔ドレーンの留置法. 日本呼吸器外科学会雑誌 34 : 392-397, 2020.
 
11) Katayama Y, et al : Delay of computed tomography is associated with poor outcome in patients with blunt traumatic aortic inj ury : A nationwide observational study in Japan. Medicine (Baltimore) 97 : e12112, 2018.
 
12) Hirshberg A, Mattox KL : Chapter 11 The No-nonsense Trauma Thoracotomy. In : TOP KNIFE : The Art and Craft of Trauma Surgery (ed by Allen MK), p157-170, tfm Publishing, Nr Shrewsbury, 2005
 
13) 目崎久美, ほか : 循環動態不安定となった外傷性血胸に対する経カテーテル動脈塞栓術. 胸部外科 67 : 379-381, 2014.
 
P.435 掲載の参考文献
1) Hanke R : [Round atelectasis (spherical and cylindrical atelectasis). Contribution to the differential diagnosis of intrapulmonal round foci]. Fortschr Geb Rontgenstr Nuklearmed 114 : 164-183, 1971.
 
2) Hillerdal G : Rounded atelectasis. Clinical experience with 74 patients. Chest 95 : 836-841, 1989.
PubMed
3) 岸本卓巳, ほか : 石綿ばく露による円形無気肺の検討. 日本呼吸器学会雑誌 46 : 707-711, 2008.
Medical*Online
4) Azour L, et al : Causative factors, imaging findings, and CT course of round atelectasis. Clin Imaging 50 : 250-257, 2018.
PubMed
5) Honma K, et al : Rounded atelectasis associated with silicosis. Wien Klin Wochenschr 107 : 585-589, 1995.
PubMed
6) Horita Y, et al : Prognosis of patients with rounded atelectasis undergoing long-term hemodialysis. Nephron 88 : 87-92, 2001.
PubMed
7) Dernevik L, Gatzinsky P : Pathogenesis of shrinking pleuritis with atelectasis- "rounded atelectasis". Eur J Respir Dis 71 : 244-249, 1987.
PubMed
8) Stathopoulos GT, et al : Rounded atelectasis of the lung. Respir Med 99 : 615-623, 2005.
PubMed
9) Sobocifiska M, et al : Rounded atelectasis of the lung : A pictorial review. Pol J Radiol 79 : 203-209, 2014.
 
10) Riley JY, Naidoo P : Imaging assessment of rounded atelectasis : A pictorial essay. J Med Imaging Radiat Oncol 62 : 211-216, 2018.
PubMed
11) Yamaguchi T, et al : Magnetic resonance imaging of rounded atelectasis. J Thorac Imaging 12 : 188-194, 1997.
PubMed
12) Mori T, et al : Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses : comparison with positron emission tomography. J Thorac Oncol 3 : 358-364, 2008.
PubMed
13) Kinoshita A, et al : Rounded atelectasis with pleuritis : diagnosis and surgical treatment. Intern Med 31 : 832-834, 1992.
PubMed
14) Smith LS, Schillaci RF : Rounded atelectasis due to acute exudative effusion. Spontaneous resolution. Chest 85 : 830-832, 1984.
PubMed
15) Dernevik L, Gatzinsky P : Long term results of operation for shrinking pleuritis with atelectasis. Thorax 40 : 448-452, 1985.
PubMed
P.441 掲載の参考文献
1) 肺癌診療ガイドライン-悪性胸膜中皮腫・胸腺腫瘍含む- [2020年版] (日本肺癌学会編), p305-366, 金原出版, 2021.
 
2) Hashimoto M, et al : Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 157 : 404-413, 2019.
PubMed
3) Nakamura A, et al : Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening. Int J Clin Oncol 26 : 95-103, 2021.
PubMed
4) Nakamura A, et al : Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. J Thorac Dis 12 : 6712-6721, 2020.
PubMed
5) Hasegawa S, et al : Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma. Semin Thorac Cardiovasc Surg 31 : 301-309, 2019.
PubMed
6) Cao C, et al : Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer 81 : 319-327, 2013.
PubMed
7) Cao C, et al : A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 83 : 240-245, 2014.
 
8) Nakamura A, et al : Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg 109 : 1537-1543, 2020.
PubMed
9) Rusch V, et al : The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma : meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg 145 : 909-910, 2013.
 
10) Meyerhoff RR, et al : Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surg Res 196 : 23-32, 2015.
PubMed
11) Casiraghi M, et al : Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 52 : 975-981, 2017.
PubMed
12) Stahel RA, et al : Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04) : a randomised, international, multicentre phase 2 trial. Lancet Oncol 16 : 1651-1658, 2015.
 
13) Nakamura A, et al : Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma. Jpn J Clin Oncol 50 : 920-925, 2020.
PubMed
14) Okada M, et al : Clinical Efficacy and Safety of Nivolumab : Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT). Clin Cancer Res 25 : 5485-5492, 2019.
PubMed
15) Baas P, et al : First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743) : a multicentre, randomised, open-label, phase 3 trial. Lancet 397 : 375-386, 2021.
PubMed
P.446 掲載の参考文献
1) Shekar K, et al : Bronchopleural fistula : an update for intensivists. J Crit Care 25 : 47-55, 2010.
PubMed
2) Lois M, et al : Bronchopleural fistulas : an overview of the problem with special focus on endoscopic management. Chest 128 : 3955-3965, 2005.
PubMed
3) Okuda M, et al : Risk factor of bronchopleural fistula after general thoracic surgery : review article. Gen Thorac Cardiovasc Surg 65 : 679-685, 2017.
PubMed
4) Endo S, et al : Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan, Gen Thorac Cardiovasc Surg 67 : 297-305, 2019.
PubMed
5) 酒井文和, ほか : 気管支胸膜瘻 ; 胸膜疾患. 別冊日本臨牀新領域別症候群シリーズ No. 10 呼吸器症候群 (第2版) III, p385-389, 日本臨牀社, 2009.
 
6) Ricci ZJ, et al : Role of computed tomography in guiding the management of peripheral bronchopleural fistula. J Thorac Imaging 17 : 214-218, 2002.
PubMed
7) Gaur P, et al : Bronchopleural fistula and the role of contemporary imaging. J Thorac Cardiovasc Surg 148 : 341-347, 2014.
PubMed
8) Sakata KK, et al : Methylene Blue for Bronchopleural Fistula Localization. J Bronchology Interv Pulmonol 25 : 63-66, 2018.
PubMed
9) Hartmann W, Rausch V : A new therapeutic application of the fiberoptic bronchoscope. Chest 71 : 237, 1977.
PubMed
10) Varoli F, et al : Endoscopic treatment of bronchopleural fistulas. Ann Thorac Surg 65 : 807-809, 1998.
PubMed
11) Fruchter O, et al : Endobronchial closure of bronchopleural fistulas with Amplatzer vascular plug. Eur J Cardiothorac Surg 41 : 46-49, 2012.
PubMed
12) Cardillo G, et al : The Rationale for Treatment of Postresectional Bronchopleural Fistula : Analysis of 52 Patients. Ann Thorac Surg 100 : 251-257, 2015.
PubMed
13) Ueno T, et al : Therapeutic Outcomes of 15 Postoperative Bronchopleural Fistulas Including Seven Endoscopic Interventions. Acta Med Okayama 73 : 325-331, 2019.
PubMed
P.451 掲載の参考文献
1) Galateau-Salle F, et al : Tumours of the pleura. In : WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p153-182, International Agency for Research on Cancer, Lyon, 2015.
 
2) Crotty EJ, et al : Epithelioid hemangioendothelioma of the pleura : clinical and radiologic features. AJR Am J Roentgenol 175 : 1545-1549, 2000.
PubMed
3) Aozasa K, et al : Angiosarcoma developing from chronic pyothorax. Mod Pathol 7 : 906-911, 1994.
PubMed
4) Guillou L, et al : Detection of the synovial sarcoma translocation t (X ; 18) (SYT ; SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction : a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol 32 : 105-112, 2001.
PubMed
5) Sawyer JR, et al : A novel reciprocal chromosome translocation t (11 : 22) (p13 ; q12) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol 16 : 411-416, 1992.
 
6) Hayry P, et al : The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 77 : 674-680, 1982.
 
7) Isaka M, et al : Disseminated calcifying tumor of the pleura : review of the literature and a case report with immunohistochemical study of its histogenesis. Gen Thorac Cardiovasc Surg 59 : 579-582, 2011.
 
8) Erb CT, et al : Rare pleural tumors. Clin Chest Med 34 : 113-136, 2013.
PubMed
P.455 掲載の参考文献
1) Kucuksu N, et al : Chemotherapy of malignant diffuse mesothelioma. Cancer 37 : 1265-1274, 1976.
PubMed
2) Klemperer P, Rabin CB : Primary neoplasms of the pleura, a report of five cases. Arch Pathol 11 : 385-412, 1931.
 
3) Stout AP, Murray RM : Localized pleural mesothelioma. Arch Pathol 34 : 951-954, 1942.
 
4) Churg A, et al : Tumors of the Pleura. In : World Health Organization Classification of Tumours, 3rd ed Vol 10, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p125-144, IARC Press, Lyon, 2004.
 
5) Ueda Y, et al : Thoracic and cardiovascular surgery in Japan during 2006, annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 56 : 365-388, 2008.
PubMed
6) Cardillo G, et al : Solitary fibrous tumors of the pleura. Curr Opin Pulm Med 18 : 339-346, 2012.
PubMed
7) Padovani B, et al : Benign fibrous mesothelioma of the pleura : MR study and pathologic correlation. Eur Radiol 6 : 425-428, 1996.
PubMed
8) England DM, et al : Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 13 : 640-658, 1989.
PubMed
9) Suter M, et al : Localized fibrous tumours of the pleura : 15 new cases and review of the literature. Eur J Cardiothorac Surg 14 : 453-459, 1998.
PubMed
10) De Perrot M, et al : Solitary fibrous tumors of the pleura. Ann Thorac Surg 74 : 285-293, 2002.
PubMed
11) Lahon B, et al : Solitary fibrous tumor of the pleura : outcomes of 157 complete resections in a single center. Ann Thorac Surg 94 : 394-400, 2012.
 
12) Harrison-Phipps KM, et al : Solitary fibrous tumors of the pleura, results of surgical treatment and long-term prognosis. J Thorac cardiovasc Surg 138 : 19-25, 2009.
 
13) Veronesi G, et al : Huge malignant localized fibrous tumor of the pleura. J Cardiovasc Surg (Torino) 41 : 781-784, 2000.
PubMed
P.458 掲載の参考文献
1) リチャード・W・ライト : 真菌感染症, 放線菌症, ノカルジア症に続発する胸水 (大西健児訳). 胸膜疾患のすべて [改訂第3版] (家城隆次, ほか監訳), p265-272, 診断と治療社, 2015.
 
2) Ko SC, et al : Fungal empyema thoracis : an emerging clinical entity. Chest 117 : 1672-1678, 2000.
PubMed
3) Hillerdal G : Pulmonary aspergillus infection invading the pleura. Thorax 36 : 745-751, 1981.
PubMed
4) Reyes CV, et al : Diagnostic value of calcium oxalate crystals in respiratory and pleural fluid cytology. A case report. Acta Cytol 23 : 65-68, 1979.
PubMed
5) Young EJ, et al : Pleural effusions due to Cryptococcus neoformans : a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis 121 : 743-747, 1980,
PubMed
6) Cadranel JL, et al : Causes of pleural effusion in 75 HIV-infected patients. Chest 104 : 655, 1993.
PubMed
7) Krakowka P, et al : Infection of the pleura by. Aspergillus fumigatus. Thorax 25 : 245-253, 1970.
PubMed
8) Chen M, et al : Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia : an unusual manifestation and a literature review. BMC Infect Dis 15 : 385, 2015.
 
9) 後藤昭彦, ほか : 局所麻酔下胸腔鏡検査で診断したアスペルギルス膿胸の1例. 気管支学 38 : 229-234, 2016.
Medical*Online
10) Tissot F, et al : β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 188 : 1100-1109, 2013.
 
11) Epstein R, et al : Pleural effusion secondary to pulmonary cryptococcosis. Chest 61 : 296-298, 1972.
PubMed
12) 深在性真菌症の診断・治療ガイドライン 2014 (深在性真菌症のガイドライン作成委員会編), 協和企画, 2014.
 
13) Chung HC, et al : Pleural aspergillosis. Yonsei Med J 29 : 84-88, 1988.
PubMed
14) 小阪真二, ほか : 術後残存腔感染にAmphotericin-B胸腔内注入が著効したアスペルギルス膿胸の1例. 日本呼吸器外科学会雑誌 12 : 524-528, 1998.
 
P.463 掲載の参考文献
1) Bessone LN, et al : Chylothorax. Ann Thorac Surg 12 : 527-550, 1971.
PubMed
2) Garcia-Zamalloa A, et al : Pseudochylothorax. Report of 2 cases and review of the literature. Medicine (Baltimore) 78 : 200-207, 1999.
PubMed
3) Huggins JT : Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31 : 743-750, 2010.
PubMed
4) Hillerdal G : Chylothorax and pseudochylothorax. Eur Respir J 10 : 1157-1162, 1997.
PubMed
5) Ulibarri JI, et al : Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 336 : 258, 1990.
PubMed
6) Bender B, et al : The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg 49 : 18-24, 2016.
PubMed
7) 砂川祐輝, ほか : 血液凝固第XIII因子製剤投与が有効であった胃切除術後難治性乳廉腹水の1例. 日本臨床外科学会雑誌 79 : 1453-1458, 2018.
 
8) Guillem P, et al : Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine. Dis Esophagus 12 : 155-156, 1999.
PubMed
9) Selle JG, et al : Chylothorax : indications for surgery. Ann Surg 177 : 245-249, 1973.
PubMed
10) Shimizu K, et al : Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg 124 : 499-502, 2002.
PubMed
11) Cerfolio RJ, et al : Postoperative chylothorax. J Thorac Cardiovasc Surg 112 : 1361-1365 ; discussion 1365-1366, 1996.
 
12) Nair SK, et al : Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 32 : 362-369, 2007.
PubMed
13) Lampson RS : Traumatic chylothorax ; a review of the literature and report of a case treated by mediastinal ligation of the thoracic duct. J Thorac Surg 17 : 778-791, 1948.
PubMed
14) Milsom JW, et al : Chylothorax : an assessment of current surgical management. J Thorac Cardiovasc Surg 89 : 221-227, 1985.
PubMed

書評

最近チェックした商品履歴

Loading...